EP3831947A1 - Products, uses & methods - Google Patents
Products, uses & methods Download PDFInfo
- Publication number
- EP3831947A1 EP3831947A1 EP20217137.7A EP20217137A EP3831947A1 EP 3831947 A1 EP3831947 A1 EP 3831947A1 EP 20217137 A EP20217137 A EP 20217137A EP 3831947 A1 EP3831947 A1 EP 3831947A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- vector
- promoter
- cas
- dna
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 186
- 238000004519 manufacturing process Methods 0.000 claims abstract description 131
- 230000001580 bacterial effect Effects 0.000 claims abstract description 75
- 239000002773 nucleotide Substances 0.000 claims description 172
- 125000003729 nucleotide group Chemical group 0.000 claims description 172
- 108090000623 proteins and genes Proteins 0.000 claims description 140
- 102000004169 proteins and genes Human genes 0.000 claims description 132
- 108020005004 Guide RNA Proteins 0.000 claims description 74
- 108091033409 CRISPR Proteins 0.000 claims description 69
- 230000014509 gene expression Effects 0.000 claims description 62
- 101710163270 Nuclease Proteins 0.000 claims description 50
- 230000010076 replication Effects 0.000 claims description 48
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 47
- 241000588724 Escherichia coli Species 0.000 claims description 39
- 238000012258 culturing Methods 0.000 claims description 39
- 230000002238 attenuated effect Effects 0.000 claims description 37
- 230000002147 killing effect Effects 0.000 claims description 37
- 239000002245 particle Substances 0.000 claims description 31
- 239000013612 plasmid Substances 0.000 claims description 25
- 201000010099 disease Diseases 0.000 claims description 24
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 24
- 108020004414 DNA Proteins 0.000 claims description 22
- 230000035772 mutation Effects 0.000 claims description 19
- 230000001939 inductive effect Effects 0.000 claims description 16
- 230000008685 targeting Effects 0.000 claims description 16
- 241000588747 Klebsiella pneumoniae Species 0.000 claims description 15
- 241001465754 Metazoa Species 0.000 claims description 15
- 238000010361 transduction Methods 0.000 claims description 15
- 230000026683 transduction Effects 0.000 claims description 15
- 241000282414 Homo sapiens Species 0.000 claims description 14
- 231100000419 toxicity Toxicity 0.000 claims description 14
- 230000001988 toxicity Effects 0.000 claims description 14
- 239000004098 Tetracycline Substances 0.000 claims description 13
- 230000002759 chromosomal effect Effects 0.000 claims description 13
- 230000002708 enhancing effect Effects 0.000 claims description 13
- 235000019364 tetracycline Nutrition 0.000 claims description 13
- 150000003522 tetracyclines Chemical class 0.000 claims description 13
- 108090000204 Dipeptidase 1 Proteins 0.000 claims description 12
- 102000006635 beta-lactamase Human genes 0.000 claims description 12
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 238000001228 spectrum Methods 0.000 claims description 12
- 230000003321 amplification Effects 0.000 claims description 11
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 11
- 239000008194 pharmaceutical composition Substances 0.000 claims description 11
- 230000003833 cell viability Effects 0.000 claims description 10
- 230000001737 promoting effect Effects 0.000 claims description 10
- 229960002180 tetracycline Drugs 0.000 claims description 10
- 229930101283 tetracycline Natural products 0.000 claims description 10
- 108010054278 Lac Repressors Proteins 0.000 claims description 9
- 239000013611 chromosomal DNA Substances 0.000 claims description 9
- 101710132601 Capsid protein Proteins 0.000 claims description 5
- 101710094648 Coat protein Proteins 0.000 claims description 5
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 5
- 101710125418 Major capsid protein Proteins 0.000 claims description 5
- 101710141454 Nucleoprotein Proteins 0.000 claims description 5
- 101710083689 Probable capsid protein Proteins 0.000 claims description 5
- 230000001419 dependent effect Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 108700010839 phage proteins Proteins 0.000 claims description 4
- 230000002463 transducing effect Effects 0.000 claims description 4
- 101150069031 CSN2 gene Proteins 0.000 claims description 3
- 101150055601 cops2 gene Proteins 0.000 claims description 3
- 244000005709 gut microbiome Species 0.000 claims description 3
- 230000004544 DNA amplification Effects 0.000 claims 1
- 239000013598 vector Substances 0.000 abstract description 451
- 210000004027 cell Anatomy 0.000 description 473
- 238000010354 CRISPR gene editing Methods 0.000 description 58
- 238000010453 CRISPR/Cas method Methods 0.000 description 51
- 239000003981 vehicle Substances 0.000 description 43
- 241000660147 Escherichia coli str. K-12 substr. MG1655 Species 0.000 description 41
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 26
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 26
- 239000005090 green fluorescent protein Substances 0.000 description 26
- 230000006698 induction Effects 0.000 description 22
- 241001013691 Escherichia coli BW25113 Species 0.000 description 17
- 230000001276 controlling effect Effects 0.000 description 14
- 241000894007 species Species 0.000 description 14
- 239000002609 medium Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 239000003242 anti bacterial agent Substances 0.000 description 12
- 229940088710 antibiotic agent Drugs 0.000 description 12
- 239000000411 inducer Substances 0.000 description 12
- 239000012212 insulator Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000013518 transcription Methods 0.000 description 12
- 230000035897 transcription Effects 0.000 description 11
- 238000011144 upstream manufacturing Methods 0.000 description 11
- 108020005345 3' Untranslated Regions Proteins 0.000 description 10
- 241000193163 Clostridioides difficile Species 0.000 description 10
- 241000193403 Clostridium Species 0.000 description 10
- 238000010790 dilution Methods 0.000 description 10
- 239000012895 dilution Substances 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 10
- 230000014621 translational initiation Effects 0.000 description 9
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 101100382541 Escherichia coli (strain K12) casD gene Proteins 0.000 description 8
- 101100005249 Escherichia coli (strain K12) ygcB gene Proteins 0.000 description 8
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 8
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 8
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 8
- 101150055191 cas3 gene Proteins 0.000 description 8
- 239000003999 initiator Substances 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 101100219625 Mus musculus Casd1 gene Proteins 0.000 description 7
- 101100387128 Myxococcus xanthus (strain DK1622) devR gene Proteins 0.000 description 7
- 101100387131 Myxococcus xanthus (strain DK1622) devS gene Proteins 0.000 description 7
- 244000057717 Streptococcus lactis Species 0.000 description 7
- 101150049463 cas5 gene Proteins 0.000 description 7
- 101150044165 cas7 gene Proteins 0.000 description 7
- 101150055766 cat gene Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 125000006850 spacer group Chemical group 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 6
- 101100273269 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) cse3 gene Proteins 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 229940126575 aminoglycoside Drugs 0.000 description 6
- 229940124307 fluoroquinolone Drugs 0.000 description 6
- 101150106467 cas6 gene Proteins 0.000 description 5
- 239000003085 diluting agent Substances 0.000 description 5
- -1 fluoroquinolones Chemical compound 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 229960005322 streptomycin Drugs 0.000 description 5
- 108700020534 tetracycline resistance-encoding transposon repressor Proteins 0.000 description 5
- 101150074775 Csf1 gene Proteins 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 101100273274 Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) cas8b gene Proteins 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 241000193445 [Clostridium] stercorarium Species 0.000 description 4
- 229960000723 ampicillin Drugs 0.000 description 4
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 4
- 229960005091 chloramphenicol Drugs 0.000 description 4
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 4
- 230000001332 colony forming effect Effects 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- 238000013207 serial dilution Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 229930186147 Cephalosporin Natural products 0.000 description 3
- 241000186542 Clostridium baratii Species 0.000 description 3
- 241000688734 Clostridium estertheticum Species 0.000 description 3
- 101100219622 Escherichia coli (strain K12) casC gene Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 description 3
- 239000006142 Luria-Bertani Agar Substances 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000863391 Methylophilus Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000283984 Rodentia Species 0.000 description 3
- 241001496920 Tenacibaculum Species 0.000 description 3
- 241000589634 Xanthomonas Species 0.000 description 3
- 230000006978 adaptation Effects 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 229940041011 carbapenems Drugs 0.000 description 3
- HVFLCNVBZFFHBT-ZKDACBOMSA-N cefepime Chemical compound S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1C[N+]1(C)CCCC1 HVFLCNVBZFFHBT-ZKDACBOMSA-N 0.000 description 3
- 229960002100 cefepime Drugs 0.000 description 3
- 229960000484 ceftazidime Drugs 0.000 description 3
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 229960002227 clindamycin Drugs 0.000 description 3
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 229960005287 lincomycin Drugs 0.000 description 3
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 150000002960 penicillins Chemical class 0.000 description 3
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 3
- 229960002292 piperacillin Drugs 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- LPQZKKCYTLCDGQ-WEDXCCLWSA-N tazobactam Chemical compound C([C@]1(C)S([C@H]2N(C(C2)=O)[C@H]1C(O)=O)(=O)=O)N1C=CN=N1 LPQZKKCYTLCDGQ-WEDXCCLWSA-N 0.000 description 3
- 229960003865 tazobactam Drugs 0.000 description 3
- 229940040944 tetracyclines Drugs 0.000 description 3
- 241000607574 Aeromonas veronii Species 0.000 description 2
- 241000589158 Agrobacterium Species 0.000 description 2
- 241000224489 Amoeba Species 0.000 description 2
- 241000186063 Arthrobacter Species 0.000 description 2
- 241000193836 Atopobium rimae Species 0.000 description 2
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 241000588676 Bergeriella denitrificans Species 0.000 description 2
- 241000193155 Clostridium botulinum Species 0.000 description 2
- 241000193167 Clostridium cochlearium Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 108091029795 Intergenic region Proteins 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 2
- 241001647418 Lactobacillus paralimentarius Species 0.000 description 2
- 241000589248 Legionella Species 0.000 description 2
- 241000589579 Planomicrobium okeanokoites Species 0.000 description 2
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
- 241000426682 Salinispora Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 241000589262 Tatlockia micdadei Species 0.000 description 2
- 241001581232 Tepidibacter Species 0.000 description 2
- 241001661387 Umezawaea tangerina Species 0.000 description 2
- 241000827162 Winogradskyella Species 0.000 description 2
- 241000589506 Xanthobacter Species 0.000 description 2
- 241000269370 Xenopus <genus> Species 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000022534 cell killing Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 241000201856 Abiotrophia defectiva Species 0.000 description 1
- 241001133251 Acaricomes phytoseiuli Species 0.000 description 1
- 241000204555 Acetitomaculum ruminis Species 0.000 description 1
- 241001223493 Acetoanaerobium noterae Species 0.000 description 1
- 241000193451 Acetoanaerobium sticklandii Species 0.000 description 1
- 235000007847 Acetobacter aceti Nutrition 0.000 description 1
- 241000776564 Acetobacter cerevisiae Species 0.000 description 1
- 241001310540 Acetobacter cibinongensis Species 0.000 description 1
- 241001497693 Acetobacter estunensis Species 0.000 description 1
- 241000209191 Acetobacter fabarum Species 0.000 description 1
- 241000452744 Acetobacter senegalensis Species 0.000 description 1
- 244000235858 Acetobacter xylinum Species 0.000 description 1
- 235000002837 Acetobacter xylinum Nutrition 0.000 description 1
- 241001468161 Acetobacterium Species 0.000 description 1
- 241000511260 Acetobacterium bakii Species 0.000 description 1
- 241000511215 Acetobacterium paludosum Species 0.000 description 1
- 241000915445 Acetobacterium tundrae Species 0.000 description 1
- 241000549912 Acetofilamentum Species 0.000 description 1
- 241001135190 Acetohalobium Species 0.000 description 1
- 241001135192 Acetohalobium arabaticum Species 0.000 description 1
- 241000245947 Acetomicrobium flavidum Species 0.000 description 1
- 241000204396 Acetonema Species 0.000 description 1
- 241000204392 Acetonema longum Species 0.000 description 1
- 241001603747 Acetothermus paucivorans Species 0.000 description 1
- 241000078104 Acholeplasma granularum Species 0.000 description 1
- 241000078105 Acholeplasma hippikon Species 0.000 description 1
- 241000203022 Acholeplasma laidlawii Species 0.000 description 1
- 241000203057 Acholeplasma modicum Species 0.000 description 1
- 241000078102 Acholeplasma morum Species 0.000 description 1
- 241001495110 Acholeplasma oculi Species 0.000 description 1
- 241000319470 Acholeplasma pleciae Species 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- 241001611471 Achromobacter insolitus Species 0.000 description 1
- 241001250069 Achromobacter ruhlandii Species 0.000 description 1
- 241001611468 Achromobacter spanius Species 0.000 description 1
- 241000604451 Acidaminococcus Species 0.000 description 1
- 241000604450 Acidaminococcus fermentans Species 0.000 description 1
- 241001116699 Acidaminococcus intestini Species 0.000 description 1
- 241000588848 Acidiphilium angustum Species 0.000 description 1
- 241001468101 Acidiphilium organovorum Species 0.000 description 1
- 241000588846 Acidiphilium rubrum Species 0.000 description 1
- 241000673693 Acidisoma tundrae Species 0.000 description 1
- 241001478307 Acidomonas Species 0.000 description 1
- 241001134630 Acidothermus cellulolyticus Species 0.000 description 1
- 241000726119 Acidovorax Species 0.000 description 1
- 241000697956 Acidovorax caeni Species 0.000 description 1
- 241001600126 Acidovorax citrulli Species 0.000 description 1
- 241000218592 Acidovorax delafieldii Species 0.000 description 1
- 241000726118 Acidovorax facilis Species 0.000 description 1
- 241001453304 Acidovorax konjaci Species 0.000 description 1
- 241001600692 Acidovorax temperans Species 0.000 description 1
- 241001135518 Acinetobacter lwoffii Species 0.000 description 1
- 241000930987 Acinetobacter parvus Species 0.000 description 1
- 241001556023 Acinetobacter schindleri Species 0.000 description 1
- 241000271152 Acinetobacter soli Species 0.000 description 1
- 241000508783 Acinetobacter venetianus Species 0.000 description 1
- 241000295662 Acrocarpospora Species 0.000 description 1
- 241000488066 Actibacter Species 0.000 description 1
- 241000488069 Actibacter sediminis Species 0.000 description 1
- 241000921775 Actinoalloteichus Species 0.000 description 1
- 241000606750 Actinobacillus Species 0.000 description 1
- 241000498200 Actinobacillus minor Species 0.000 description 1
- 241000498210 Actinobacillus porcinus Species 0.000 description 1
- 241001065789 Actinobacillus scotiae Species 0.000 description 1
- 241001291962 Actinobaculum Species 0.000 description 1
- 241000832184 Actinocatenispora Species 0.000 description 1
- 241000832185 Actinocatenispora sera Species 0.000 description 1
- 241000592981 Actinocorallia Species 0.000 description 1
- 241000202388 Actinocorallia aurantiaca Species 0.000 description 1
- 241000592982 Actinocorallia herbida Species 0.000 description 1
- 241000157187 Actinocorallia longicatena Species 0.000 description 1
- 241000187362 Actinomadura Species 0.000 description 1
- 241000187257 Actinomadura atramentaria Species 0.000 description 1
- 241000201753 Actinomadura coerulea Species 0.000 description 1
- 241000157189 Actinomadura oligospora Species 0.000 description 1
- 241000157202 Actinomadura pelletieri Species 0.000 description 1
- 241000199759 Actinomadura rubrobrunea Species 0.000 description 1
- 241000187253 Actinomadura rugatobispora Species 0.000 description 1
- 241000199757 Actinomadura vinacea Species 0.000 description 1
- 241000592900 Actinomadura viridis Species 0.000 description 1
- 241000157200 Actinomadura yumaensis Species 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 241001147824 Actinomyces hyovaginalis Species 0.000 description 1
- 241000132732 Actinomyces johnsonii Species 0.000 description 1
- 241000186045 Actinomyces naeslundii Species 0.000 description 1
- 241001464988 Actinomyces neuii Species 0.000 description 1
- 241000186066 Actinomyces odontolyticus Species 0.000 description 1
- 241000132734 Actinomyces oris Species 0.000 description 1
- 241000183228 Actinoplanes derwentensis Species 0.000 description 1
- 241000187841 Actinoplanes digitatis Species 0.000 description 1
- 241000183224 Actinoplanes ferrugineus Species 0.000 description 1
- 241000183222 Actinoplanes globisporus Species 0.000 description 1
- 241000187843 Actinoplanes missouriensis Species 0.000 description 1
- 241000183261 Actinoplanes rectilineatus Species 0.000 description 1
- 241000511219 Actinoplanes regularis Species 0.000 description 1
- 241000187840 Actinoplanes utahensis Species 0.000 description 1
- 241000187619 Actinopolyspora Species 0.000 description 1
- 241000123663 Actinosynnema Species 0.000 description 1
- 241000841740 Actinotalea Species 0.000 description 1
- 241000609850 Actinotignum schaalii Species 0.000 description 1
- 241000193792 Aerococcus viridans Species 0.000 description 1
- 241000203710 Aeromicrobium Species 0.000 description 1
- 241000203708 Aeromicrobium erythreum Species 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241001245632 Aeromonas encheleia Species 0.000 description 1
- 241000607548 Aeromonas media Species 0.000 description 1
- 241000202696 Agrococcus jenensis Species 0.000 description 1
- 241000134727 Agromyces mediolanus Species 0.000 description 1
- 241001467494 Agromyces ramosus Species 0.000 description 1
- 241000016254 Agromyces rhizospherae Species 0.000 description 1
- 241001179699 Algicola Species 0.000 description 1
- 241001234529 Algicola bacteriolytica Species 0.000 description 1
- 241001147780 Alicyclobacillus Species 0.000 description 1
- 241000162693 Alishewanella Species 0.000 description 1
- 241000162694 Alishewanella fetalis Species 0.000 description 1
- 241000324499 Alkalibacillus Species 0.000 description 1
- 241000186032 Alloiococcus otitis Species 0.000 description 1
- 241000722558 Allokutzneria Species 0.000 description 1
- 241001400674 Altererythrobacter Species 0.000 description 1
- 241000226889 Alteribacillus iranensis Species 0.000 description 1
- 241001621924 Aminomonas paucivorans Species 0.000 description 1
- 241000936849 Ammoniphilus Species 0.000 description 1
- 241000936840 Ammoniphilus oxalivorans Species 0.000 description 1
- 241000193373 Amphibacillus xylanus Species 0.000 description 1
- 241000187643 Amycolatopsis Species 0.000 description 1
- 241001509435 Amycolatopsis azurea Species 0.000 description 1
- 241001430311 Amycolatopsis lurida Species 0.000 description 1
- 241001468213 Amycolatopsis mediterranei Species 0.000 description 1
- 241000839543 Amycolatopsis rifamycinica Species 0.000 description 1
- 241000173880 Amycolatopsis rubida Species 0.000 description 1
- 241001246350 Amycolatopsis tolypomycina Species 0.000 description 1
- 241000192542 Anabaena Species 0.000 description 1
- 241000192537 Anabaena cylindrica Species 0.000 description 1
- 241001629573 Anaeroarcus Species 0.000 description 1
- 241000786447 Anaerobiospirillum thomasii Species 0.000 description 1
- 241000379991 Anaerococcus Species 0.000 description 1
- 241001464907 Anaerococcus hydrogenalis Species 0.000 description 1
- 241001464890 Anaerococcus prevotii Species 0.000 description 1
- 241001464898 Anaerococcus tetradius Species 0.000 description 1
- 241000193457 Anaerocolumna aminovalerica Species 0.000 description 1
- 241001424158 Anaerocolumna jejuensis Species 0.000 description 1
- 241001446754 Anaerocolumna xylanovorans Species 0.000 description 1
- 241001621846 Anaeromusa acidaminophila Species 0.000 description 1
- 241000337031 Anaeromyxobacter Species 0.000 description 1
- 241001629581 Anaerosinus Species 0.000 description 1
- 241001633960 Anaerosinus glycerini Species 0.000 description 1
- 241000319947 Anaerotignum lactatifermentans Species 0.000 description 1
- 241001509481 Anaerotignum neopropionicum Species 0.000 description 1
- 241001136167 Anaerotignum propionicum Species 0.000 description 1
- 241000823109 Anaerovirgula Species 0.000 description 1
- 241001239770 Anaerovirgula multivorans Species 0.000 description 1
- 241000586489 Ancylobacter aquaticus Species 0.000 description 1
- 241000555286 Aneurinibacillus Species 0.000 description 1
- 241000217428 Aneurinibacillus migulanus Species 0.000 description 1
- 241000192705 Aphanothece Species 0.000 description 1
- 241001600693 Aquaspirillum polymorphum Species 0.000 description 1
- 241000863425 Archangium disciforme Species 0.000 description 1
- 241001135163 Arcobacter Species 0.000 description 1
- 241001135164 Arcobacter butzleri Species 0.000 description 1
- 241001135165 Arcobacter cryaerophilus Species 0.000 description 1
- 241001501366 Arcobacter halophilus Species 0.000 description 1
- 241000243813 Arenicola Species 0.000 description 1
- 241001524201 Arthrobacter crystallopoietes Species 0.000 description 1
- 241000521449 Arthrobacter methylotrophus Species 0.000 description 1
- 241000186001 Arthrobacter pascens Species 0.000 description 1
- 241000024410 Arthrobacter woluwensis Species 0.000 description 1
- 241001147785 Asaccharospora irregularis Species 0.000 description 1
- 241000308413 Asaia Species 0.000 description 1
- 241000308412 Asaia bogorensis Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 241001313491 Asticcacaulis excentricus Species 0.000 description 1
- 241001377138 Atlantibacter subterranea Species 0.000 description 1
- 241000606618 Avibacterium volantium Species 0.000 description 1
- 241001478311 Azoarcus tolulyticus Species 0.000 description 1
- 241001239322 Azohydromonas Species 0.000 description 1
- 241001446526 Azohydromonas australica Species 0.000 description 1
- 241000408718 Azomonas insignis Species 0.000 description 1
- 241000589152 Azotobacter chroococcum Species 0.000 description 1
- 241000408717 Azotobacter nigricans Species 0.000 description 1
- 241000973041 Azotobacter salinestris Species 0.000 description 1
- 241000589149 Azotobacter vinelandii Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000118355 Bacillus acidiceler Species 0.000 description 1
- 241001260372 Bacillus acidicola Species 0.000 description 1
- 241001150381 Bacillus altitudinis Species 0.000 description 1
- 241001470576 Bacillus beringensis Species 0.000 description 1
- 241000452296 Bacillus berkeleyi Species 0.000 description 1
- 241001113888 Bacillus beveridgei Species 0.000 description 1
- 241001026324 Bacillus bogoriensis Species 0.000 description 1
- 241000966273 Bacillus boroniphilus Species 0.000 description 1
- 241001323694 Bacillus butanolivorans Species 0.000 description 1
- 241000006380 Bacillus carboniphilus Species 0.000 description 1
- 241000365704 Bacillus decolorationis Species 0.000 description 1
- 241000944721 Bacillus deserti Species 0.000 description 1
- 241000223006 Bacillus drentensis Species 0.000 description 1
- 241000268545 Bacillus eiseniae Species 0.000 description 1
- 241000363514 Bacillus enclensis Species 0.000 description 1
- 241000166175 Bacillus endoradicis Species 0.000 description 1
- 241001515794 Bacillus infernus Species 0.000 description 1
- 241000038661 Bacillus isabeliae Species 0.000 description 1
- 241001357355 Bacillus kochii Species 0.000 description 1
- 241000795180 Bacillus kokeshiiformis Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 241001208143 Bacillus mesonae Species 0.000 description 1
- 241000193398 Bacillus methanolicus Species 0.000 description 1
- 241001249117 Bacillus mojavensis Species 0.000 description 1
- 241000194106 Bacillus mycoides Species 0.000 description 1
- 241001354640 Bacillus nanhaiisediminis Species 0.000 description 1
- 241001643941 Bacillus paraflexus Species 0.000 description 1
- 241000331092 Bacillus patagoniensis Species 0.000 description 1
- 241000040009 Bacillus qingshengii Species 0.000 description 1
- 241001608774 Bacillus ruris Species 0.000 description 1
- 241000835167 Bacillus safensis Species 0.000 description 1
- 241000798395 Bacillus salarius Species 0.000 description 1
- 241000193399 Bacillus smithii Species 0.000 description 1
- 241000656516 Bacillus solimangrovi Species 0.000 description 1
- 241000460252 Bacillus songklensis Species 0.000 description 1
- 241000266830 Bacillus sonorensis Species 0.000 description 1
- 241000202341 Bacillus sporothermodurans Species 0.000 description 1
- 241001150380 Bacillus stratosphericus Species 0.000 description 1
- 241000821243 Bacillus subterraneus Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000438288 Bacillus taeanensis Species 0.000 description 1
- 241001249119 Bacillus vallismortis Species 0.000 description 1
- 241000563903 Bacillus velezensis Species 0.000 description 1
- 241001626895 Bacillus vietnamensis Species 0.000 description 1
- 241000223012 Bacillus vireti Species 0.000 description 1
- 241000602824 Bacillus wakoensis Species 0.000 description 1
- 241000311516 Bacillus xiaoxiensis Species 0.000 description 1
- 241000025044 Bacillus zhanjiangensis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 244000177578 Bacterium linens Species 0.000 description 1
- 235000012539 Bacterium linens Nutrition 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000217846 Bacteroides caccae Species 0.000 description 1
- 241001032450 Bacteroides cellulosilyticus Species 0.000 description 1
- 241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
- 241000606215 Bacteroides vulgatus Species 0.000 description 1
- 241001277519 Balneatrix Species 0.000 description 1
- 241001277523 Balneatrix alpica Species 0.000 description 1
- 241000841175 Balneola vulgaris Species 0.000 description 1
- 241000927512 Barnesiella Species 0.000 description 1
- 241000927510 Barnesiella viscericola Species 0.000 description 1
- 241000606660 Bartonella Species 0.000 description 1
- 241000511683 Bartonella alsatica Species 0.000 description 1
- 241001464952 Bartonella grahamii Species 0.000 description 1
- 241000774461 Bdellovibrio exovorus Species 0.000 description 1
- 241000190907 Beggiatoa alba Species 0.000 description 1
- 241000599985 Beijerinckia mobilis Species 0.000 description 1
- 241000616876 Belliella baltica Species 0.000 description 1
- 241001396713 Bellilinea caldifistulae Species 0.000 description 1
- 241000235122 Bensingtonia naganoensis Species 0.000 description 1
- 241001661339 Beutenbergia cavernae Species 0.000 description 1
- 241001553294 Bibersteinia Species 0.000 description 1
- 241000218561 Bibersteinia trehalosi Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186021 Bifidobacterium cuniculi Species 0.000 description 1
- 241000186020 Bifidobacterium dentium Species 0.000 description 1
- 241000186156 Bifidobacterium indicum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- 241001312954 Bifidobacterium pullorum Species 0.000 description 1
- 241000586490 Blastobacter Species 0.000 description 1
- 241000943710 Blastococcus endophyticus Species 0.000 description 1
- 241000186560 Blautia coccoides Species 0.000 description 1
- 241001394284 Bogoriella <ascomycete lichen> Species 0.000 description 1
- 241000565336 Bogoriella caseilytica Species 0.000 description 1
- 241000543043 Bordetella trematum Species 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- 241001148604 Borreliella afzelii Species 0.000 description 1
- 241001148534 Brachyspira Species 0.000 description 1
- 241001658772 Brachyspira alvinipulli Species 0.000 description 1
- 241000722022 Brachyspira innocens Species 0.000 description 1
- 241001658774 Brachyspira murdochii Species 0.000 description 1
- 241000033231 Bradyrhizobium denitrificans Species 0.000 description 1
- 241000556446 Brenneria salicis Species 0.000 description 1
- 241000191775 Brevibacillus borstelensis Species 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 241000534628 Brevibacillus centrosporus Species 0.000 description 1
- 241000534614 Brevibacillus parabrevis Species 0.000 description 1
- 241000534616 Brevibacillus reuszeri Species 0.000 description 1
- 241000436357 Brevibacterium aurantiacum Species 0.000 description 1
- 241001430355 Brevibacterium iodinum Species 0.000 description 1
- 241001482309 Brevibacterium jeotgali Species 0.000 description 1
- 241001478252 Brevinema Species 0.000 description 1
- 241001478253 Brevinema andersonii Species 0.000 description 1
- 241000206604 Brochothrix thermosphacta Species 0.000 description 1
- 241001509299 Brucella canis Species 0.000 description 1
- 241001398067 Bryobacter aggregatus Species 0.000 description 1
- 241001453380 Burkholderia Species 0.000 description 1
- 241001646647 Burkholderia ambifaria Species 0.000 description 1
- 241000790236 Burkholderia anthina Species 0.000 description 1
- 241000371430 Burkholderia cenocepacia Species 0.000 description 1
- 241000134107 Burkholderia plantarii Species 0.000 description 1
- 241000371422 Burkholderia stabilis Species 0.000 description 1
- 241001622816 Buttiauxella gaviniae Species 0.000 description 1
- 241001102661 Butyrivibrio hungatei Species 0.000 description 1
- 241000168061 Butyrivibrio proteoclasticus Species 0.000 description 1
- 101150078885 CSY3 gene Proteins 0.000 description 1
- 241000866631 Caballeronia glathei Species 0.000 description 1
- 241001488656 Caenimonas koreensis Species 0.000 description 1
- 241000199490 Caldalkalibacillus Species 0.000 description 1
- 241001068246 Caldalkalibacillus uzonensis Species 0.000 description 1
- 241001157085 Caldanaerobacter subterraneus Species 0.000 description 1
- 241001645400 Caldanaerobius Species 0.000 description 1
- 241000815917 Caldanaerobius fijiensis Species 0.000 description 1
- 241000465107 Caldanaerovirga acetigignens Species 0.000 description 1
- 241000556413 Caldicellulosiruptor owensensis Species 0.000 description 1
- 241000316922 Caldicoprobacter faecalis Species 0.000 description 1
- 241001147798 Caloramator fervidus Species 0.000 description 1
- 241000589985 Campylobacter curvus Species 0.000 description 1
- 241000606208 Campylobacter gracilis Species 0.000 description 1
- 241001137866 Campylobacter helveticus Species 0.000 description 1
- 241000589872 Campylobacter hyointestinalis Species 0.000 description 1
- 241000589875 Campylobacter jejuni Species 0.000 description 1
- 241000589995 Campylobacter mucosalis Species 0.000 description 1
- 241000589992 Campylobacter showae Species 0.000 description 1
- 241000190564 Capnocytophaga haemolytica Species 0.000 description 1
- 241000190885 Capnocytophaga ochracea Species 0.000 description 1
- 241000190882 Capnocytophaga sputigena Species 0.000 description 1
- 241000907319 Carnimonas Species 0.000 description 1
- 241000907317 Carnimonas nigrificans Species 0.000 description 1
- 241000206599 Carnobacterium funditum Species 0.000 description 1
- 241000206592 Carnobacterium gallinarum Species 0.000 description 1
- 241000734759 Carnobacterium viridans Species 0.000 description 1
- 241000520057 Catellatospora Species 0.000 description 1
- 241000358089 Catenococcus Species 0.000 description 1
- 241000358114 Catenococcus thiocycli Species 0.000 description 1
- 241000292566 Catenuloplanes crispus Species 0.000 description 1
- 241001467488 Catenuloplanes japonicus Species 0.000 description 1
- 241001645051 Catenuloplanes nepalensis Species 0.000 description 1
- 241001147794 Cellulosilyticum lentocellum Species 0.000 description 1
- 241000611330 Chryseobacterium Species 0.000 description 1
- 241000589585 Chryseobacterium balustinum Species 0.000 description 1
- 241000949041 Citrobacter murliniae Species 0.000 description 1
- 241000627108 Citrobacter pasteurii Species 0.000 description 1
- 241000949031 Citrobacter rodentium Species 0.000 description 1
- 241000949032 Citrobacter sedlakii Species 0.000 description 1
- 241000949039 Citrobacter werkmanii Species 0.000 description 1
- 241000920610 Citrobacter youngae Species 0.000 description 1
- 241000186584 Clostridioides mangenotii Species 0.000 description 1
- 241001656810 Clostridium aceticum Species 0.000 description 1
- 241001290510 Clostridium acetireducens Species 0.000 description 1
- 241000193401 Clostridium acetobutylicum Species 0.000 description 1
- 241000306283 Clostridium acidisoli Species 0.000 description 1
- 241000414748 Clostridium aciditolerans Species 0.000 description 1
- 241000402146 Clostridium aestuarii Species 0.000 description 1
- 241000306276 Clostridium akagii Species 0.000 description 1
- 241001522206 Clostridium algidicarnis Species 0.000 description 1
- 241001215936 Clostridium algifaecis Species 0.000 description 1
- 241001519498 Clostridium algoriphilum Species 0.000 description 1
- 241000274838 Clostridium amylolyticum Species 0.000 description 1
- 241000719667 Clostridium arbusti Species 0.000 description 1
- 241001147768 Clostridium argentinense Species 0.000 description 1
- 241000186522 Clostridium aurantibutyricum Species 0.000 description 1
- 241001656809 Clostridium autoethanogenum Species 0.000 description 1
- 241000193454 Clostridium beijerinckii Species 0.000 description 1
- 241001335108 Clostridium bornimense Species 0.000 description 1
- 241000915466 Clostridium bowmanii Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- 241000193455 Clostridium cadaveris Species 0.000 description 1
- 241001611022 Clostridium carboxidivorans Species 0.000 description 1
- 241000186562 Clostridium carnis Species 0.000 description 1
- 241000779795 Clostridium cavendishii Species 0.000 description 1
- 241001509496 Clostridium celatum Species 0.000 description 1
- 241000193169 Clostridium cellulovorans Species 0.000 description 1
- 241001147787 Clostridium chartatabidum Species 0.000 description 1
- 241000206044 Clostridium chauvoei Species 0.000 description 1
- 241000291085 Clostridium chromiireducens Species 0.000 description 1
- 241000788977 Clostridium colicanis Species 0.000 description 1
- 241001147788 Clostridium collagenovorans Species 0.000 description 1
- 241000193165 Clostridium cylindrosporum Species 0.000 description 1
- 241000272479 Clostridium diolis Species 0.000 description 1
- 241001656808 Clostridium disporicum Species 0.000 description 1
- 241000328950 Clostridium drakei Species 0.000 description 1
- 241001200944 Clostridium estertheticum subsp. laramiense Species 0.000 description 1
- 241000186571 Clostridium fallax Species 0.000 description 1
- 241001509499 Clostridium felsineum Species 0.000 description 1
- 241000193161 Clostridium formicaceticum Species 0.000 description 1
- 241001660538 Clostridium frigidicarnis Species 0.000 description 1
- 241001200945 Clostridium frigoris Species 0.000 description 1
- 241001239391 Clostridium ganghwense Species 0.000 description 1
- 241000360099 Clostridium gasigenes Species 0.000 description 1
- 241000123594 Clostridium grantii Species 0.000 description 1
- 241001656807 Clostridium haemolyticum Species 0.000 description 1
- 241001509473 Clostridium homopropionicum Species 0.000 description 1
- 241000126598 Clostridium huakuii Species 0.000 description 1
- 241000779784 Clostridium hydrogeniformans Species 0.000 description 1
- 241001509477 Clostridium intestinale Species 0.000 description 1
- 241001072406 Clostridium isatidis Species 0.000 description 1
- 241000186570 Clostridium kluyveri Species 0.000 description 1
- 241001200943 Clostridium lacusfryxellense Species 0.000 description 1
- 241000186566 Clostridium ljungdahlii Species 0.000 description 1
- 241001331740 Clostridium lundense Species 0.000 description 1
- 241001468167 Clostridium magnum Species 0.000 description 1
- 241000186565 Clostridium malenominatum Species 0.000 description 1
- 241000491294 Clostridium nitrophenolicum Species 0.000 description 1
- 241000186581 Clostridium novyi Species 0.000 description 1
- 241000186580 Clostridium oceanicum Species 0.000 description 1
- 241001147791 Clostridium paraputrificum Species 0.000 description 1
- 241000203642 Clostridium pascui Species 0.000 description 1
- 241000193469 Clostridium pasteurianum Species 0.000 description 1
- 241001446617 Clostridium peptidivorans Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000915467 Clostridium psychrophilum Species 0.000 description 1
- 241001147704 Clostridium puniceum Species 0.000 description 1
- 241000408944 Clostridium putrefaciens Species 0.000 description 1
- 241001509317 Clostridium quinii Species 0.000 description 1
- 241001656801 Clostridium roseum Species 0.000 description 1
- 241000429427 Clostridium saccharobutylicum Species 0.000 description 1
- 241001508458 Clostridium saccharoperbutylacetonicum Species 0.000 description 1
- 241001147706 Clostridium sardiniense Species 0.000 description 1
- 241001656793 Clostridium sartagoforme Species 0.000 description 1
- 241000186587 Clostridium scatologenes Species 0.000 description 1
- 241001041716 Clostridium schirmacherense Species 0.000 description 1
- 241000193466 Clostridium septicum Species 0.000 description 1
- 241000193470 Clostridium sporogenes Species 0.000 description 1
- 241000186524 Clostridium subterminale Species 0.000 description 1
- 241001318996 Clostridium sulfidigenes Species 0.000 description 1
- 241001396684 Clostridium tagluense Species 0.000 description 1
- 241001308971 Clostridium tepidiprofundi Species 0.000 description 1
- 241000186528 Clostridium tertium Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241000186520 Clostridium tetanomorphum Species 0.000 description 1
- 241001147721 Clostridium thermobutyricum Species 0.000 description 1
- 241001147708 Clostridium thermopalmarium Species 0.000 description 1
- 241001626428 Clostridium thiosulfatireducens Species 0.000 description 1
- 241000193452 Clostridium tyrobutyricum Species 0.000 description 1
- 241000264391 Clostridium uliginosum Species 0.000 description 1
- 241000192020 Clostridium ventriculi Species 0.000 description 1
- 241000511746 Clostridium vincentii Species 0.000 description 1
- 241000186244 Corynebacterium variabile Species 0.000 description 1
- 241001135265 Cronobacter sakazakii Species 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 241000203813 Curtobacterium Species 0.000 description 1
- 241000863004 Cystobacter Species 0.000 description 1
- 241000219206 Dactylosporangium roseum Species 0.000 description 1
- 241000218946 Dactylosporangium thailandense Species 0.000 description 1
- 241000520036 Dactylosporangium vinaceum Species 0.000 description 1
- 241000940696 Deinococcus caeni Species 0.000 description 1
- 241000192091 Deinococcus radiodurans Species 0.000 description 1
- 241001453175 Deinococcus radiophilus Species 0.000 description 1
- 241001313305 Dendrosporobacter quercicolus Species 0.000 description 1
- 241000588700 Dickeya chrysanthemi Species 0.000 description 1
- 244000101366 Diplotaxis muralis Species 0.000 description 1
- 241000192534 Dolichospermum flos-aquae Species 0.000 description 1
- 241001147784 Domibacillus aminovorans Species 0.000 description 1
- 241001430190 Eggerthia catenaformis Species 0.000 description 1
- 241000336502 Elsinoe arachidis Species 0.000 description 1
- 241000881810 Enterobacter asburiae Species 0.000 description 1
- 241001493237 Enterobacter mori Species 0.000 description 1
- 241000737206 Enterobacter soli Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588698 Erwinia Species 0.000 description 1
- 241001645942 Erwinia carnegieana Species 0.000 description 1
- 241000556426 Erwinia rhapontici Species 0.000 description 1
- 101100007788 Escherichia coli (strain K12) casA gene Proteins 0.000 description 1
- 101100326871 Escherichia coli (strain K12) ygbF gene Proteins 0.000 description 1
- 101100438439 Escherichia coli (strain K12) ygbT gene Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000193456 Eubacterium barkeri Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000186589 Faecalicatena orotica Species 0.000 description 1
- 241000404113 Fangia hongkongensis Species 0.000 description 1
- 241000661429 Fastidiosipila Species 0.000 description 1
- 241000661434 Fastidiosipila sanguinis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001179476 Fictibacillus nanhaiensis Species 0.000 description 1
- 241000496163 Fictibacillus rigui Species 0.000 description 1
- 241000845813 Fictibacillus solisalsi Species 0.000 description 1
- 241001147710 Filifactor villosus Species 0.000 description 1
- 241001020619 Flavobacterium cucumis Species 0.000 description 1
- 241000101455 Flavobacterium defluvii Species 0.000 description 1
- 241000101452 Flavobacterium filum Species 0.000 description 1
- 241000405386 Flavobacterium frigidarium Species 0.000 description 1
- 241001134569 Flavonifractor plautii Species 0.000 description 1
- 241000589278 Fluoribacter gormanii Species 0.000 description 1
- 241001135321 Francisella philomiragia Species 0.000 description 1
- 241000070950 Franconibacter pulveris Species 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 241001238246 Gaetbulibacter saemankumensis Species 0.000 description 1
- 241000606562 Gallibacterium anatis Species 0.000 description 1
- 241000220678 Gallicola barnesae Species 0.000 description 1
- 241001627085 Garciella nitratireducens Species 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 241000948428 Geobacillus vulcani Species 0.000 description 1
- 241001135750 Geobacter Species 0.000 description 1
- 241000290396 Geobacter bemidjiensis Species 0.000 description 1
- 241000168711 Geobacter chapellei Species 0.000 description 1
- 241000010919 Geobacter grbiciae Species 0.000 description 1
- 241001135751 Geobacter metallireducens Species 0.000 description 1
- 241000723998 Geobacter pickeringii Species 0.000 description 1
- 241001494297 Geobacter sulfurreducens Species 0.000 description 1
- 241000187832 Geodermatophilus obscurus Species 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- 241000032681 Gluconacetobacter Species 0.000 description 1
- 241001524188 Glutamicibacter nicotianae Species 0.000 description 1
- 241001337904 Gordonia <angiosperm> Species 0.000 description 1
- 241001509401 Gordonia rubripertincta Species 0.000 description 1
- 241000186530 Gottschalkia acidurici Species 0.000 description 1
- 241000193467 Gottschalkia purinilyticum Species 0.000 description 1
- 241000777639 Gracilibacillus dipsosauri Species 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000588731 Hafnia Species 0.000 description 1
- 241000588729 Hafnia alvei Species 0.000 description 1
- 241000862437 Halalkalibacillus halophilus Species 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 241000186568 Hathewaya limosa Species 0.000 description 1
- 241001147793 Hathewaya proteolytica Species 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001674997 Hungatella hathewayi Species 0.000 description 1
- 241000172412 Ignatzschineria Species 0.000 description 1
- 241000172414 Ignatzschineria larvae Species 0.000 description 1
- 241001183629 Ilumatobacter fluminis Species 0.000 description 1
- 241000411982 Ilyobacter tartaricus Species 0.000 description 1
- 241000037075 Intestinibacter bartlettii Species 0.000 description 1
- 241000831706 Jannaschia pohangensis Species 0.000 description 1
- 241000784339 Jannaschia rubra Species 0.000 description 1
- 241001148465 Janthinobacterium Species 0.000 description 1
- 241000346880 Jejuia pallidilutea Species 0.000 description 1
- 241000026999 Jeotgalicoccus halotolerans Species 0.000 description 1
- 241000396559 Kaistia adipata Species 0.000 description 1
- 241000452738 Kaistia soli Species 0.000 description 1
- 241000186778 Kandleria vitulina Species 0.000 description 1
- 241001212817 Kerstersia gyiorum Species 0.000 description 1
- 241000789944 Kiloniella laminariae Species 0.000 description 1
- 241000588749 Klebsiella oxytoca Species 0.000 description 1
- 241000498833 Kluyvera ascorbata Species 0.000 description 1
- 241000881812 Kluyvera intermedia Species 0.000 description 1
- 241000191953 Kocuria varians Species 0.000 description 1
- 241000186035 Kurthia zopfii Species 0.000 description 1
- 241000770727 Labrenzia marina Species 0.000 description 1
- 241000933069 Lachnoclostridium phytofermentans Species 0.000 description 1
- 241000110061 Lactobacillus acidifarinae Species 0.000 description 1
- 241000028630 Lactobacillus acidipiscis Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 241000186716 Lactobacillus agilis Species 0.000 description 1
- 241001507052 Lactobacillus algidus Species 0.000 description 1
- 241000186715 Lactobacillus alimentarius Species 0.000 description 1
- 241001647783 Lactobacillus amylolyticus Species 0.000 description 1
- 241000186714 Lactobacillus amylophilus Species 0.000 description 1
- 241000168643 Lactobacillus amylotrophicus Species 0.000 description 1
- 241000186713 Lactobacillus amylovorus Species 0.000 description 1
- 241000186712 Lactobacillus animalis Species 0.000 description 1
- 241000316282 Lactobacillus antri Species 0.000 description 1
- 241000954248 Lactobacillus apodemi Species 0.000 description 1
- 241000186711 Lactobacillus aviarius Species 0.000 description 1
- 241000186723 Lactobacillus bifermentans Species 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 241000186679 Lactobacillus buchneri Species 0.000 description 1
- 241000489238 Lactobacillus camelliae Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 241000902616 Lactobacillus ceti Species 0.000 description 1
- 241001061980 Lactobacillus coleohominis Species 0.000 description 1
- 241001468197 Lactobacillus collinoides Species 0.000 description 1
- 241000933456 Lactobacillus composti Species 0.000 description 1
- 241000838743 Lactobacillus concavus Species 0.000 description 1
- 241000186842 Lactobacillus coryniformis Species 0.000 description 1
- 241000218492 Lactobacillus crispatus Species 0.000 description 1
- 241000861211 Lactobacillus crustorum Species 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000500356 Lactobacillus dextrinicus Species 0.000 description 1
- 241000790171 Lactobacillus diolivorans Species 0.000 description 1
- 241000976279 Lactobacillus equi Species 0.000 description 1
- 241001026944 Lactobacillus equigenerosi Species 0.000 description 1
- 241000186841 Lactobacillus farciminis Species 0.000 description 1
- 241000831741 Lactobacillus farraginis Species 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000015236 Lactobacillus fornicalis Species 0.000 description 1
- 241000186839 Lactobacillus fructivorans Species 0.000 description 1
- 241001493843 Lactobacillus frumenti Species 0.000 description 1
- 241000370757 Lactobacillus fuchuensis Species 0.000 description 1
- 241000509544 Lactobacillus gallinarum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241000316283 Lactobacillus gastricus Species 0.000 description 1
- 241000950383 Lactobacillus ghanensis Species 0.000 description 1
- 241000866684 Lactobacillus graminis Species 0.000 description 1
- 241000111368 Lactobacillus hammesii Species 0.000 description 1
- 241000383778 Lactobacillus hamsteri Species 0.000 description 1
- 241000925032 Lactobacillus harbinensis Species 0.000 description 1
- 241000914114 Lactobacillus hayakitensis Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 241000186685 Lactobacillus hilgardii Species 0.000 description 1
- 241001468190 Lactobacillus homohiochii Species 0.000 description 1
- 241001324870 Lactobacillus iners Species 0.000 description 1
- 241001343376 Lactobacillus ingluviei Species 0.000 description 1
- 241001640457 Lactobacillus intestinalis Species 0.000 description 1
- 241001561398 Lactobacillus jensenii Species 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000316281 Lactobacillus kalixensis Species 0.000 description 1
- 241000108055 Lactobacillus kefiranofaciens Species 0.000 description 1
- 241001468191 Lactobacillus kefiri Species 0.000 description 1
- 241000674808 Lactobacillus kitasatonis Species 0.000 description 1
- 241001339775 Lactobacillus kunkeei Species 0.000 description 1
- 241001134654 Lactobacillus leichmannii Species 0.000 description 1
- 241000520745 Lactobacillus lindneri Species 0.000 description 1
- 241000751214 Lactobacillus malefermentans Species 0.000 description 1
- 241000186851 Lactobacillus mali Species 0.000 description 1
- 241000016642 Lactobacillus manihotivorans Species 0.000 description 1
- 241000414465 Lactobacillus mindensis Species 0.000 description 1
- 241000394636 Lactobacillus mucosae Species 0.000 description 1
- 241000186871 Lactobacillus murinus Species 0.000 description 1
- 241001635183 Lactobacillus nagelii Species 0.000 description 1
- 241000468580 Lactobacillus namurensis Species 0.000 description 1
- 241000938545 Lactobacillus nantensis Species 0.000 description 1
- 241001150383 Lactobacillus oligofermentans Species 0.000 description 1
- 241000186784 Lactobacillus oris Species 0.000 description 1
- 241000216456 Lactobacillus panis Species 0.000 description 1
- 241000692795 Lactobacillus pantheris Species 0.000 description 1
- 241001105994 Lactobacillus parabrevis Species 0.000 description 1
- 241001643453 Lactobacillus parabuchneri Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000972176 Lactobacillus paracollinoides Species 0.000 description 1
- 241000831743 Lactobacillus parafarraginis Species 0.000 description 1
- 241001643449 Lactobacillus parakefiri Species 0.000 description 1
- 241000866650 Lactobacillus paraplantarum Species 0.000 description 1
- 241000186684 Lactobacillus pentosus Species 0.000 description 1
- 241001448603 Lactobacillus perolens Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 241001495404 Lactobacillus pontis Species 0.000 description 1
- 241000220680 Lactobacillus psittaci Species 0.000 description 1
- 241000692139 Lactobacillus rennini Species 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 1
- 241001438705 Lactobacillus rogosae Species 0.000 description 1
- 241000602084 Lactobacillus rossiae Species 0.000 description 1
- 241000186870 Lactobacillus ruminis Species 0.000 description 1
- 241000318646 Lactobacillus saerimneri Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000186868 Lactobacillus sanfranciscensis Species 0.000 description 1
- 241001424195 Lactobacillus satsumensis Species 0.000 description 1
- 241000915257 Lactobacillus secaliphilus Species 0.000 description 1
- 241000186867 Lactobacillus sharpeae Species 0.000 description 1
- 241000755777 Lactobacillus siliginis Species 0.000 description 1
- 241001599932 Lactobacillus spicheri Species 0.000 description 1
- 241001643448 Lactobacillus suebicus Species 0.000 description 1
- 241000489237 Lactobacillus thailandensis Species 0.000 description 1
- 241000316280 Lactobacillus ultunensis Species 0.000 description 1
- 241000751212 Lactobacillus vaccinostercus Species 0.000 description 1
- 241000186783 Lactobacillus vaginalis Species 0.000 description 1
- 241001456524 Lactobacillus versmoldensis Species 0.000 description 1
- 241000692127 Lactobacillus vini Species 0.000 description 1
- 241000110060 Lactobacillus zymae Species 0.000 description 1
- 241000970318 Lechevalieria aerocolonigenes Species 0.000 description 1
- 241001441459 Legionella clemsonensis Species 0.000 description 1
- 241000189592 Legionella donaldsonii Species 0.000 description 1
- 241000589239 Legionella erythra Species 0.000 description 1
- 241000189481 Legionella gratiana Species 0.000 description 1
- 241000307151 Legionella gresilensis Species 0.000 description 1
- 241000589240 Legionella hackeliae Species 0.000 description 1
- 241000708794 Legionella impletisoli Species 0.000 description 1
- 241000589261 Legionella israelensis Species 0.000 description 1
- 241000589274 Legionella jamestowniensis Species 0.000 description 1
- 241001148226 Legionella monrovica Species 0.000 description 1
- 241001534810 Legionella moravica Species 0.000 description 1
- 241001437053 Legionella nagasakiensis Species 0.000 description 1
- 241000189498 Legionella nautarum Species 0.000 description 1
- 241000376856 Legionella norrlandica Species 0.000 description 1
- 241001148224 Legionella oakridgensis Species 0.000 description 1
- 241000189497 Legionella parisiensis Species 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 241000189496 Legionella quateirensis Species 0.000 description 1
- 241001222702 Legionella taurinensis Species 0.000 description 1
- 241000122902 Legionella tucsonensis Species 0.000 description 1
- 241000998049 Legionella tunisiensis Species 0.000 description 1
- 241001135523 Legionella wadsworthii Species 0.000 description 1
- 241000937844 Legionella waltersii Species 0.000 description 1
- 241000189514 Legionella worsleiensis Species 0.000 description 1
- 241000170964 Legionella yabuuchiae Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 244000309491 Leptothyrium zeae Species 0.000 description 1
- 241000371308 Listeria cornellensis Species 0.000 description 1
- 241000371306 Listeria floridensis Species 0.000 description 1
- 241000371298 Listeria grandensis Species 0.000 description 1
- 241000186806 Listeria grayi Species 0.000 description 1
- 241000186805 Listeria innocua Species 0.000 description 1
- 241001120504 Listeria marthii Species 0.000 description 1
- 241000186807 Listeria seeligeri Species 0.000 description 1
- 241000186814 Listeria welshimeri Species 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241001509487 Maledivibacter halophilus Species 0.000 description 1
- 241000206589 Marinobacter Species 0.000 description 1
- 241000662215 Marinobacter algicola Species 0.000 description 1
- 241001389726 Marinobacter bryozoorum Species 0.000 description 1
- 241000825080 Massilia alkalitolerans Species 0.000 description 1
- 241001467579 Microbacterium arborescens Species 0.000 description 1
- 241001633954 Microbacterium oxydans Species 0.000 description 1
- 241000193459 Moorella thermoacetica Species 0.000 description 1
- 241000186544 Moorella thermoautotrophica Species 0.000 description 1
- 241000948981 Muribacter muris Species 0.000 description 1
- 101100387132 Myxococcus xanthus (strain DK1622) devT gene Proteins 0.000 description 1
- 241001650546 Natranaerobius trueperi Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000588649 Neisseria lactamica Species 0.000 description 1
- 241000588645 Neisseria sicca Species 0.000 description 1
- 241001136170 Neisseria subflava Species 0.000 description 1
- 241001026748 Neptunomonas japonica Species 0.000 description 1
- 101100495430 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) hH3v gene Proteins 0.000 description 1
- 241001478326 Niveispirillum irakense Species 0.000 description 1
- 241000287241 Oceanibulbus indolifex Species 0.000 description 1
- 241001663457 Oceanicaulis alexandrii Species 0.000 description 1
- 241001348358 Oceanicola Species 0.000 description 1
- 241001348356 Oceanicola granulosus Species 0.000 description 1
- 241000625725 Oceanimonas baumannii Species 0.000 description 1
- 241001246353 Oceanithermus Species 0.000 description 1
- 241000316381 Oceanithermus desulfurans Species 0.000 description 1
- 241001115911 Oceanithermus profundus Species 0.000 description 1
- 241000634765 Oceanobacillus caeni Species 0.000 description 1
- 241000605010 Oceanospirillum linum Species 0.000 description 1
- 241001509479 Oxalophagus oxalicus Species 0.000 description 1
- 241001509483 Oxobacter pfennigii Species 0.000 description 1
- 241001147838 Paenarthrobacter nicotinovorans Species 0.000 description 1
- 241000193411 Paenibacillus amylolyticus Species 0.000 description 1
- 241000178959 Paenibacillus durus Species 0.000 description 1
- 241000881862 Paenibacillus edaphicus Species 0.000 description 1
- 241000611786 Paenibacillus glucanolyticus Species 0.000 description 1
- 241000611788 Paenibacillus kobensis Species 0.000 description 1
- 241000194109 Paenibacillus lautus Species 0.000 description 1
- 241000881860 Paenibacillus mucilaginosus Species 0.000 description 1
- 241000611735 Paenibacillus peoriae Species 0.000 description 1
- 241000178958 Paenibacillus validus Species 0.000 description 1
- 241001147789 Paeniclostridium ghonii Species 0.000 description 1
- 241000193465 Paeniclostridium sordellii Species 0.000 description 1
- 241000930993 Paraburkholderia caledonica Species 0.000 description 1
- 241001135514 Paraburkholderia caryophylli Species 0.000 description 1
- 241001238056 Paraburkholderia ginsengisoli Species 0.000 description 1
- 241000176271 Paraburkholderia rhizosphaerae Species 0.000 description 1
- 241000480193 Paraburkholderia soli Species 0.000 description 1
- 241000318919 Paraburkholderia tropica Species 0.000 description 1
- 241000193157 Paraclostridium bifermentans Species 0.000 description 1
- 241001057811 Paracoccus <mealybug> Species 0.000 description 1
- 241001478308 Paracoccus alcaliphilus Species 0.000 description 1
- 241000193390 Parageobacillus thermoglucosidasius Species 0.000 description 1
- 241001427615 Paramaledivibacter caminithermalis Species 0.000 description 1
- 241000943942 Pectobacterium aroidearum Species 0.000 description 1
- 241001148142 Pectobacterium atrosepticum Species 0.000 description 1
- 241000588701 Pectobacterium carotovorum Species 0.000 description 1
- 241000186529 Peptoclostridium litorale Species 0.000 description 1
- 241000193802 Planococcus citreus Species 0.000 description 1
- 241000606999 Plesiomonas shigelloides Species 0.000 description 1
- 241000881813 Pluralibacter gergoviae Species 0.000 description 1
- 241001621838 Pluralibacter pyrinus Species 0.000 description 1
- 241001646114 Prevotella brevis Species 0.000 description 1
- 241001299661 Prevotella bryantii Species 0.000 description 1
- 241000509620 Prevotella dentalis Species 0.000 description 1
- 241001135219 Prevotella disiens Species 0.000 description 1
- 241001482483 Prevotella histicola Species 0.000 description 1
- 241000124542 Prevotella maculosa Species 0.000 description 1
- 241001141018 Prevotella marshii Species 0.000 description 1
- 241001135223 Prevotella melaninogenica Species 0.000 description 1
- 241000782070 Prevotella multiformis Species 0.000 description 1
- 241001135262 Prevotella oris Species 0.000 description 1
- 241001103687 Prevotella oryzae Species 0.000 description 1
- 241000864367 Prevotella pallens Species 0.000 description 1
- 241001430102 Prevotella stercorea Species 0.000 description 1
- 241000530934 Prevotella timonensis Species 0.000 description 1
- 241001135264 Prevotella veroralis Species 0.000 description 1
- 241001656788 Propionispira Species 0.000 description 1
- 241000008322 Propionispira raffinosivorans Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 241000588778 Providencia stuartii Species 0.000 description 1
- 241000185994 Pseudarthrobacter oxydans Species 0.000 description 1
- 241000519590 Pseudoalteromonas Species 0.000 description 1
- 241000409196 Pseudoglutamicibacter albus Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241000589755 Pseudomonas mendocina Species 0.000 description 1
- 241000589615 Pseudomonas syringae Species 0.000 description 1
- 241001272810 Pseudooceanicola batsensis Species 0.000 description 1
- 241000193420 Psychrobacillus insolitus Species 0.000 description 1
- 241001148186 Psychrobacter phenylpyruvicus Species 0.000 description 1
- 241000186548 Quinella ovalis Species 0.000 description 1
- 241001513398 Ralstonia mannitolilytica Species 0.000 description 1
- 241000589625 Ralstonia pickettii Species 0.000 description 1
- 241000589771 Ralstonia solanacearum Species 0.000 description 1
- 241001135508 Ralstonia syzygii Species 0.000 description 1
- 241000588756 Raoultella terrigena Species 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241000185992 Rhizobium viscosum Species 0.000 description 1
- 241000191043 Rhodobacter sphaeroides Species 0.000 description 1
- 241001440631 Rhodoferax ferrireducens Species 0.000 description 1
- 241000186567 Romboutsia lituseburensis Species 0.000 description 1
- 241000379619 Ruegeria Species 0.000 description 1
- 241000193448 Ruminiclostridium thermocellum Species 0.000 description 1
- 241001147744 Saccharococcus thermophilus Species 0.000 description 1
- 241000187792 Saccharomonospora Species 0.000 description 1
- 241000125139 Saccharomonospora azurea Species 0.000 description 1
- 241000187810 Saccharomonospora viridis Species 0.000 description 1
- 241001670248 Saccharophagus degradans Species 0.000 description 1
- 241000187560 Saccharopolyspora Species 0.000 description 1
- 241000187559 Saccharopolyspora erythraea Species 0.000 description 1
- 241001468198 Saccharopolyspora gregorii Species 0.000 description 1
- 241000187558 Saccharopolyspora hirsuta Species 0.000 description 1
- 241000187581 Saccharopolyspora hordei Species 0.000 description 1
- 241001134661 Saccharopolyspora rectivirgula Species 0.000 description 1
- 241000868102 Saccharopolyspora spinosa Species 0.000 description 1
- 241000868105 Saccharopolyspora taberi Species 0.000 description 1
- 241001478477 Saccharothrix espanaensis Species 0.000 description 1
- 241001468274 Saccharothrix mutabilis Species 0.000 description 1
- 241001478482 Saccharothrix syringae Species 0.000 description 1
- 241001478458 Saccharothrix texasensis Species 0.000 description 1
- 241001282575 Salegentibacter Species 0.000 description 1
- 241001282574 Salegentibacter salegens Species 0.000 description 1
- 241000193000 Salinicoccus Species 0.000 description 1
- 241001343894 Salinicoccus alkaliphilus Species 0.000 description 1
- 241000026995 Salinicoccus hispanicus Species 0.000 description 1
- 241000193022 Salinicoccus roseus Species 0.000 description 1
- 241000426681 Salinispora tropica Species 0.000 description 1
- 241000499381 Salinivibrio costicola Species 0.000 description 1
- 241000191110 Saprospira grandis Species 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 241001453170 Sebaldella Species 0.000 description 1
- 241000606178 Sebaldella termitidis Species 0.000 description 1
- 241001147799 Sedimentibacter hydroxybenzoicus Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000218654 Serratia fonticola Species 0.000 description 1
- 241000607715 Serratia marcescens Species 0.000 description 1
- 241001105882 Siccibacter turicensis Species 0.000 description 1
- 241000976732 Solibacillus isronensis Species 0.000 description 1
- 241001478894 Sphaerotilus Species 0.000 description 1
- 241000605063 Sporohalobacter lortetii Species 0.000 description 1
- 241000193413 Sporosarcina globispora Species 0.000 description 1
- 241000193395 Sporosarcina pasteurii Species 0.000 description 1
- 241001147687 Staphylococcus auricularis Species 0.000 description 1
- 241001147736 Staphylococcus capitis Species 0.000 description 1
- 241001617353 Staphylococcus fleurettii Species 0.000 description 1
- 241000192085 Staphylococcus gallinarum Species 0.000 description 1
- 241001582999 Staphylococcus nepalensis Species 0.000 description 1
- 241000193817 Staphylococcus pasteuri Species 0.000 description 1
- 241000192097 Staphylococcus sciuri Species 0.000 description 1
- 241000967959 Staphylococcus simiae Species 0.000 description 1
- 241000191978 Staphylococcus simulans Species 0.000 description 1
- 241000193992 Streptococcus downei Species 0.000 description 1
- 241000194050 Streptococcus ferus Species 0.000 description 1
- 241001134658 Streptococcus mitis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- 241000194054 Streptococcus uberis Species 0.000 description 1
- 241000194051 Streptococcus vestibularis Species 0.000 description 1
- 241000970227 Streptomyces fimbriatus Species 0.000 description 1
- 241000187438 Streptomyces fradiae Species 0.000 description 1
- 241000187217 Streptomyces griseoruber Species 0.000 description 1
- 241000218527 Streptomyces tubercidicus Species 0.000 description 1
- 241000204007 Syntrophomonas bryantii Species 0.000 description 1
- 241001509489 Terrisporobacter glycolicus Species 0.000 description 1
- 241000186582 Terrisporobacter mayombei Species 0.000 description 1
- 241000105512 Thalassobacter stenotrophicus Species 0.000 description 1
- 241000521326 Thalassobius gelatinovorus Species 0.000 description 1
- 241001665566 Thalassocola Species 0.000 description 1
- 241001147805 Thermoanaerobacter thermocopriae Species 0.000 description 1
- 241000193447 Thermoanaerobacter thermohydrosulfuricus Species 0.000 description 1
- 241000193446 Thermoanaerobacterium thermosaccharolyticum Species 0.000 description 1
- 101100329497 Thermoproteus tenax (strain ATCC 35583 / DSM 2078 / JCM 9277 / NBRC 100435 / Kra 1) cas2 gene Proteins 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 101100007790 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) cse1 gene Proteins 0.000 description 1
- 241000167944 Tissierella praeacuta Species 0.000 description 1
- 241001147795 Tyzzerella nexilis Species 0.000 description 1
- 241000862965 Uliginosibacterium gangwonense Species 0.000 description 1
- 241000674806 Ulvibacter Species 0.000 description 1
- 241000305338 Ulvibacter litoralis Species 0.000 description 1
- 241001603532 Umezawaea Species 0.000 description 1
- 241000586989 Undibacterium pigrum Species 0.000 description 1
- 241000202921 Ureaplasma urealyticum Species 0.000 description 1
- 241001257810 Ureibacillus suwonensis Species 0.000 description 1
- 241000248785 Ureibacillus terrenus Species 0.000 description 1
- 241001489064 Ureibacillus thermophilus Species 0.000 description 1
- 241000498583 Ureibacillus thermosphaericus Species 0.000 description 1
- 241000507624 Vagococcus fessus Species 0.000 description 1
- 241000207193 Vagococcus fluvialis Species 0.000 description 1
- 241001609646 Vagococcus lutrae Species 0.000 description 1
- 241000207192 Vagococcus salmoninarum Species 0.000 description 1
- 241001488327 Veillonella criceti Species 0.000 description 1
- 241001533204 Veillonella dispar Species 0.000 description 1
- 241001116698 Veillonella montpellierensis Species 0.000 description 1
- 241001148135 Veillonella parvula Species 0.000 description 1
- 241001488326 Veillonella ratti Species 0.000 description 1
- 241001447270 Verminephrobacter Species 0.000 description 1
- 241001447269 Verminephrobacter eiseniae Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241001231453 Vibrio albensis Species 0.000 description 1
- 241000607594 Vibrio alginolyticus Species 0.000 description 1
- 241000607323 Vibrio campbellii Species 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241001407018 Vibrio coralliilyticus Species 0.000 description 1
- 241000607306 Vibrio diazotrophicus Species 0.000 description 1
- 241000607291 Vibrio fluvialis Species 0.000 description 1
- 241001234514 Vibrio halioticoli Species 0.000 description 1
- 241000607618 Vibrio harveyi Species 0.000 description 1
- 241001268204 Vibrio ichthyoenteri Species 0.000 description 1
- 241000607334 Vibrio mediterranei Species 0.000 description 1
- 241001135144 Vibrio metschnikovii Species 0.000 description 1
- 241000501793 Vibrio mytili Species 0.000 description 1
- 241000607359 Vibrio nereis Species 0.000 description 1
- 241001135145 Vibrio nigripulchritudo Species 0.000 description 1
- 241001135139 Vibrio ordalii Species 0.000 description 1
- 241001135140 Vibrio orientalis Species 0.000 description 1
- 241001659629 Virgibacillus Species 0.000 description 1
- 241000202221 Weissella Species 0.000 description 1
- 241000975185 Weissella cibaria Species 0.000 description 1
- 241000186838 Weissella halotolerans Species 0.000 description 1
- 241000186837 Weissella kandleri Species 0.000 description 1
- 241000384856 Weissella koreensis Species 0.000 description 1
- 241000010758 Weissella soli Species 0.000 description 1
- 241000028633 Weissella thailandensis Species 0.000 description 1
- 241000186882 Weissella viridescens Species 0.000 description 1
- 241001655291 Williamsia Species 0.000 description 1
- 241001630928 Williamsia marianensis Species 0.000 description 1
- 241000589495 Xanthobacter flavus Species 0.000 description 1
- 241000589951 Xanthobacter viscosus Species 0.000 description 1
- 241000589655 Xanthomonas citri Species 0.000 description 1
- 241000231754 Xanthomonas fragariae Species 0.000 description 1
- 241000567019 Xanthomonas vesicatoria Species 0.000 description 1
- 241001640585 Xenophilus azovorans Species 0.000 description 1
- 241001041741 Xenorhabdus cabanillasii Species 0.000 description 1
- 241001041739 Xenorhabdus doucetiae Species 0.000 description 1
- 241001041746 Xenorhabdus hominickii Species 0.000 description 1
- 241001041694 Xenorhabdus koppenhoeferi Species 0.000 description 1
- 241000123581 Xenorhabdus poinarii Species 0.000 description 1
- 241000204362 Xylella fastidiosa Species 0.000 description 1
- 241000529917 Xylophilus ampelinus Species 0.000 description 1
- 241000844081 Yeosuana Species 0.000 description 1
- 241000844082 Yeosuana aromativorans Species 0.000 description 1
- 241000607475 Yersinia bercovieri Species 0.000 description 1
- 241000290086 Yersinia entomophaga Species 0.000 description 1
- 241000607481 Yersinia intermedia Species 0.000 description 1
- 241001135251 Yersinia kristensenii Species 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241000043486 Yokenella Species 0.000 description 1
- 241000043489 Yokenella regensburgei Species 0.000 description 1
- 241000317522 Youngiibacter multivorans Species 0.000 description 1
- 241001513148 Zavarzinia compransoris Species 0.000 description 1
- 241000123669 Zoogloea resiniphila Species 0.000 description 1
- 241000588902 Zymomonas mobilis Species 0.000 description 1
- 241001517045 [Bacillus] vedderi Species 0.000 description 1
- 241000204291 [Bacteroides] coagulans Species 0.000 description 1
- 241001509492 [Clostridium] aerotolerans Species 0.000 description 1
- 241001118737 [Clostridium] aldenense Species 0.000 description 1
- 241001147803 [Clostridium] aldrichii Species 0.000 description 1
- 241000360105 [Clostridium] algidixylanolyticum Species 0.000 description 1
- 241001604192 [Clostridium] alkalicellulosi Species 0.000 description 1
- 241000193458 [Clostridium] aminophilum Species 0.000 description 1
- 241001350461 [Clostridium] amygdalinum Species 0.000 description 1
- 241000342876 [Clostridium] asparagiforme Species 0.000 description 1
- 241001246487 [Clostridium] bolteae Species 0.000 description 1
- 241000277654 [Clostridium] caenicola Species 0.000 description 1
- 241001147804 [Clostridium] celerecrescens Species 0.000 description 1
- 241001147786 [Clostridium] cellobioparum Species 0.000 description 1
- 241000193453 [Clostridium] cellulolyticum Species 0.000 description 1
- 241001147772 [Clostridium] cellulosi Species 0.000 description 1
- 241001118742 [Clostridium] citroniae Species 0.000 description 1
- 241000854263 [Clostridium] clariflavum Species 0.000 description 1
- 241000186561 [Clostridium] clostridioforme Species 0.000 description 1
- 241001509494 [Clostridium] colinum Species 0.000 description 1
- 241000408908 [Clostridium] fimetarium Species 0.000 description 1
- 241000696045 [Clostridium] glycyrrhizinilyticum Species 0.000 description 1
- 241001531305 [Clostridium] herbivorans Species 0.000 description 1
- 241000030487 [Clostridium] hiranonis Species 0.000 description 1
- 241000229117 [Clostridium] hungatei Species 0.000 description 1
- 241000030493 [Clostridium] hylemonae Species 0.000 description 1
- 241000985249 [Clostridium] indolis Species 0.000 description 1
- 241000193462 [Clostridium] innocuum Species 0.000 description 1
- 241000193158 [Clostridium] josui Species 0.000 description 1
- 241001098250 [Clostridium] lavalense Species 0.000 description 1
- 241000186569 [Clostridium] leptum Species 0.000 description 1
- 241001621904 [Clostridium] methoxybenzovorans Species 0.000 description 1
- 241001656805 [Clostridium] methylpentosum Species 0.000 description 1
- 241001147790 [Clostridium] papyrosolvens Species 0.000 description 1
- 241001147800 [Clostridium] paradoxum Species 0.000 description 1
- 241000193460 [Clostridium] piliforme Species 0.000 description 1
- 241001147792 [Clostridium] polysaccharolyticum Species 0.000 description 1
- 241001522212 [Clostridium] populeti Species 0.000 description 1
- 241001509315 [Clostridium] rectum Species 0.000 description 1
- 241000685809 [Clostridium] saccharogumia Species 0.000 description 1
- 241001656794 [Clostridium] saccharolyticum Species 0.000 description 1
- 241001147801 [Clostridium] scindens Species 0.000 description 1
- 241001147717 [Clostridium] sphenoides Species 0.000 description 1
- 241001147796 [Clostridium] spiroforme Species 0.000 description 1
- 241000186586 [Clostridium] sporosphaeroides Species 0.000 description 1
- 241001147802 [Clostridium] stercorarium subsp. thermolacticum Species 0.000 description 1
- 241001351214 [Clostridium] straminisolvens Species 0.000 description 1
- 241000913097 [Clostridium] sufflavum Species 0.000 description 1
- 241000193450 [Clostridium] symbiosum Species 0.000 description 1
- 241001147719 [Clostridium] termitidis Species 0.000 description 1
- 241001147797 [Clostridium] thermoalcaliphilum Species 0.000 description 1
- 241001656792 [Clostridium] thermosuccinogenes Species 0.000 description 1
- 241000191758 [Clostridium] ultunense Species 0.000 description 1
- 241000215449 [Clostridium] viride Species 0.000 description 1
- 241001147712 [Clostridium] xylanolyticum Species 0.000 description 1
- 241000543172 [Haemophilus] felis Species 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940044726 anaerococcus tetradius Drugs 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000001065 anti-restriction Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 101150000705 cas1 gene Proteins 0.000 description 1
- 101150117416 cas2 gene Proteins 0.000 description 1
- 101150111685 cas4 gene Proteins 0.000 description 1
- 101150066299 cas6f gene Proteins 0.000 description 1
- 101150041129 casA gene Proteins 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 101150088252 csy1 gene Proteins 0.000 description 1
- 101150016576 csy2 gene Proteins 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000008519 endogenous mechanism Effects 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- CJNBYAVZURUTKZ-UHFFFAOYSA-N hafnium(IV) oxide Inorganic materials O=[Hf]=O CJNBYAVZURUTKZ-UHFFFAOYSA-N 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 244000005702 human microbiome Species 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 229940115932 legionella pneumophila Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000028744 lysogeny Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 239000007320 rich medium Substances 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 229940115922 streptococcus uberis Drugs 0.000 description 1
- 101150024821 tetO gene Proteins 0.000 description 1
- 101150061166 tetR gene Proteins 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/002—Vectors comprising a special origin of replication system inducible or controllable
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/007—Vectors comprising a special origin of replication system tissue or cell-specific
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2820/00—Vectors comprising a special origin of replication system
- C12N2820/55—Vectors comprising a special origin of replication system from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/20—Vector systems having a special element relevant for transcription transcription of more than one cistron
Definitions
- the invention relates to the production and use of Cas-encoding sequences and vectors comprising these. Aspects of the invention provide products, vectors, delivery vehicles, uses and methods for producing Cas-encoding sequences in bacterial or archaeal cells.
- the invention provides the following configurations.
- a nucleic acid vector for introduction into a host cell comprising a first nucleotide sequence encoding a Type I Cas3 and a second nucleotide sequence encoding one or more Cascade proteins, wherein the first and second sequences are under the control of one or more promoters comprised by the vector for expression of the proteins in the cell.
- the vector comprises an operon for expression in the cell of the Cas3 and Cascade proteins from a Cas module, the module comprising the nucleotide sequences encoding the Cas3 and Cascade proteins, and the operon comprising the Cas module under the control of a promoter for controlling the expression of both the Cas3 and Cascade proteins.
- the invention also provides a delivery vehicle comprising the vector, as well as a pharmaceutical composition comprising the vector or vehicle and a pharmaceutically acceptable diluent, excipient or carrier.
- the invention also provides a method of treating or reducing the risk of a disease or condition in a human or animal subject, the method comprising administering the vector, vehicle or compostion to the subject, and introducing the vector into target host bacterial or archaeal cells in the subject (eg, in a gut microbiota, lung, eye or blood of the subject), wherein the Cas cuts (or otherwise modifies) one or more target sequences in the target cells and the cells are killed or growth or proliferation of the cells is reduced.
- target host bacterial or archaeal cells eg, in a gut microbiota, lung, eye or blood of the subject
- a method of amplifying copies of a DNA encoding a functional Cas protein (optionally a Cas nuclease) in a bacterial or archaeal production strain of cells comprising
- an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for enhancing the yield of amplified DNA produced by the production host cells.
- an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing toxicity of the Cas in the production strain.
- an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain.
- an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for promoting production cell viability during the amplification of the DNA.
- an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing the occurrence of Cas cutting of DNA.
- a method for enhancing the yield of amplified copies of a DNA construct in a population of bacterial or archaeal production strain cells wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- the invention relates to the production and use of Cas-encoding sequences and vectors comprising these. Aspects of the invention provide products, vectors, delivery vehicles, uses and methods for producing Cas-encoding sequences in bacterial or archaeal cells.
- An aspect of the invention provides for the control of expression of Cas and optionally also Cascade proteins from single vectors, such as by regulated use of Cas modules in an operon and/or using attenuated promoters.
- An aspect of the invention provides nucleic acid vectors that are useful for introducing into target host cells of any eukaryotic or prokaryotic species (eg, ex vivo or in vitro ) for expressing Type I Cas and optionally other components of a Type I CRISPR/Cas system.
- the vector may in some examples therefore provide a single-vector means for introducing a complete exogenous Type I CRISPR/Cas system into a target cell for modification (eg, cutting by Cas3) of DNA in the target cell.
- a chromosomal target sequence ie, protospacer that is cognate with the Cas3 is modified.
- an episomal DNA sequence is modified, for example a plasmid sequence or a DNA that has been introduced into the cell.
- the latter may be useful in a recombineering method of the invention wherein exogenous DNA in the target cell is cut by the Cas3 and optionally this produces one or more recombinogenic ends for recombination of the cut DNA with a further DNA of interest, thereby producing a recombination product in the cell.
- the targt cell is a recombinongenic E coli cell, eg, comprising a red/ET system.
- the target cell is an undesired cell (eg, a cell of a species or strain that is pathogenic to humans or animals, such as a bacterial disease-causing species or strain) and the cutting by Cas3 kills the cell.
- an undesired cell eg, a cell of a species or strain that is pathogenic to humans or animals, such as a bacterial disease-causing species or strain
- the cutting by Cas3 kills the cell. This may be useful for treating or preventing an infection in a human or animal harbouring target cells.
- single-vector means that express minimally a Cas endonuclease (eg, Cas3), cognate accessory proteins (eg, Cascade proteins) and at least one CRISPR array (or nucleotide sequence encoding a guide RNA (eg, a single guide RNA)), wherein the Cas, accessory proteins and array (or nucleotide sequence) comprise a functional CRISPR/Cas system is more convenient and the inventors believe more efficient for introducing into a target cell and effecting CRISPR/Cas modification of a target sequence therein than the use of 2 or 3 or more separate vectors (eg, a vector encoding the Cas nuclease and a different vector encoding the accessory proteins, and possibly a further vector comprising the array (or gRNA-encoding nucleotide sequence) which all need to transform the target cell for the system to function).
- a Cas endonuclease eg, Cas3
- cognate accessory proteins eg
- an example of the invention therefore uses an operon for the coordinated expression in the target cells of the Cas and accessory proteins (and optionall also the array or gRNA-encoding sequence(s)).
- the introduction of a single vector eg, using an operon
- the introduction of a single vector may advantageously coordinate the expression of the Cas and accessory proteins (and optionally production of cRNAs or gRNAs) so that these are available to operate together without undue delay in the target cell.
- endogenous anti-restriction, endogenous Cas or other endogenous mechanisms that seek out and degrade invading phage and DNA and on the other hand efficient cell killing or deactivation of such mechanisms by the invading CRISPR components of the vector of the invention.
- the invention provides means to assist this.
- an aspect of the invention provides improved ways of amplifying DNA constructs in bacterial and archaeal production strain cells.
- the DNA may be a high copy number plasmid or phagemid comprising a constitutive promoter for controlling the expression of one or more Cas proteins when the DNA has been introduced into a target host bacterial or host cell. It is desirable, according to an aspect of the invention, to consider attenuating the promoter activity during amplification of the DNA in the production strain. This is useful, since the inventors have found that Cas expression in production strains may be toxic to production strain cells, thereby reducing the yield of amplified DNA.
- Toxicity may be due, for example, to off-target cutting of the production strain chromosomal DNA when the Cas is a nuclease (such as Cas9 or Cas3) and/or due to relatively high levels of expression of the Cas in the cells.
- a nuclease such as Cas9 or Cas3
- the Cas expression or activity may impose a selective pressure that favours mutation and propagation of mutated DNA constructs (such as mutation in one more or all of a CRISPR/Cas operon, Cas-encoding gene, Cascade-encoding gene, CRISPR array and gRNa-encoding sequence of the DNA construct) in production cells, thereby reducing the yield of desired amplified constructs and imposing an undesired step of separating desired from mutated DNA constructs for further formulation into useful compositions.
- Such compositions may be pharmaceutical compositions, herbicides, pesticides, environmental remediation compositions etc.
- the promoter attenuation in production strains is achieved by using a medium strength (not high or low) promoter to control the Cas-encoding nucleotide sequence of the DNA constructs.
- a medium level of Cas expression may be tolerable in the production strains, and yet once the DNA is subsequently introduced into target host cells the Cas is expressed at sufficiently high levels to produce desired activity to modify (eg, cut) target sequences in target cells.
- the invention uses a repressible promoter, wherein the promoter is repressed in production strain, but not repressed in target host cells.
- aspects of the invention use a tetracycline repressor (tetR) expressed in production strain cells that represses the promoter.
- tetR tetracycline repressor
- the yield can be enhanced by one or more of
- the invention provides the following Paragraphs, which are supported by the Examples below. Any features of the Concepts are combinable with any features of the Embodiments. Any features of the Concpets are combinable with any features of the Embodiments. Any features of the Paragraphs are combinable with any features of the Embodiments.
- any cell herein may be a bacterial cell, archaeal cell, algal cell, fungal cell, protozoan cell, invertebrate cell, vertebrate cell, fish cell, bird cell, mammal cell, companion animal cell, dog cell, cat cell, horse cell, mouse cell, rat cell, rabbit cell, eukaryotic cell, prokaryotic cell, human cell, animal cell, rodent cell, insect cell or plant cell.
- the cell is a bacterial cell.
- the cell is a human cell.
- the production strain cell(s) and target host cell(s) are of the same phylum, order, family, genus, species or strain.
- the Cas is any Cas (eg, a Cas2, 3, 4, 5, or 6) of a Type I system.
- the Cas may be fused or conjugated to a moiety that is operable to increase or reduce transcription of a gene comprising the target sequence.
- the nucleic acid encoding the Cas may comprise a nucleotide sequence encoding the moiety, wherein the Cas and moiety are expressed in the host cell as a fusion protein.
- the Cas is N-terminal of the moiety; in another embodiment it is C-terminal to the moiety.
- the words “comprising” (and any form of comprising, such as “comprise” and “comprises”), “having” (and any form of having, such as “have” and “has”), "including” (and any form of including, such as “includes” and “include”) or “containing” (and any form of containing, such as “contains” and “contain”) are inclusive or openended and do not exclude additional, unrecited elements or method steps
- A, B, C, or combinations thereof refers to all permutations and combinations of the listed items preceding the term.
- A, B, C, or combinations thereof is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB.
- expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, MB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth.
- the skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.
- compositions and/or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
- the examples illustrate fast and precision killing of Escherichia coli strains.
- a model programmable nuclease system we used a CRISPR guided vector (CGVTM) to specifically target Escherichia coli MG1655.
- CRISPR guided vector CRISPR guided vector
- EXAMPLE 1 Single-Vector Cas3 & Cascade: Type I CRISPR-Cas system targeting E. coli.
- a plasmid (which we call a CRISPR Guided VectorTM, CGVTM) was constructed comprising an operon with nucleotide sequences encoding a Type I Cas3 and Cascade proteins under the control of a common promoter.
- C . a Type I Cas3 and Cascade proteins under the control of a common promoter.
- C . a Type I Cas3 and Cascade proteins under the control of a common promoter.
- the cas3 gene is 3' of the Cascade genes ( cas8b1, cas7 and cas5 ) and thus spaced away from the promoter upstream of the Cascade genes.
- FIG. 1 Results using this synthetic operon arrangement are shown in Figure 1 .
- Fig 1B there is shown a dilution series (10 1 -10 6 ) of drop spots (5 ⁇ l) of target E . coli MG1655 cells harboring the CGV on LB agar plates with and without inducers.
- CRISPR/Cas induction surprisingly killed 99.9% of the population ( Fig 1C , grey bar). Growth in absence of induction is shown in black.
- CGVTM refers to a CRISPR Guided VectorTM, which is a nucleic acid vector comprising nucleotide sequences encoding CRISPR/Cas components.
- E coli Type IE Cas and Cascade were used, together with a cognate array targeting host cell E coli chromosomal DNA (data not shown).
- a vector was used comprising (in 5' to 3' direction) a promoter controlling the expression of Cas3, Cas8e, Cas11, Cas7, Cas5 and Cas6 in an operon.
- E. coli MG1655 was grown in lysogeny broth (LB) with shaking (250 rpm) at 37 °C. When necessary, cultures were supplemented with tetracycline (10 ⁇ g/mL), and spectinomycin (400 ⁇ g/mL) .
- cas3, cas6, cas8b, cas7 and cas5 genes from C. difficile were amplified and cloned in a low copy number plasmid (pSC101 ori).
- cas3 was located in the beginning of the operon followed by cas6, cas8b, cas7 and cas5.
- the adaptation module (consisting of cas1, cas2, and cas4 ) was omitted in the vector ( Fig. 1A ).
- a second plasmid containing an IPTG inducible single-spacer array targeting a chromosomal intergenic region in E. coli MG1655 was constructed ( Fig. 1A ).
- the spacer was cloned under control of the IPTG-inducible Ptrc promoter, in a CloDF13 ori backbone. It contains 37 nucleotides from the genome of E. coli MG1655 (ctttgccgcgcgcttcgtcacgtaattctcgtcgcaa) (SEQ ID NO: 26). Additionally, the 3'-CCT protospacer adjacent motif (PAM) is located adjacent to the selected target sequence in the genome of E. coli MG1655 ( Fig. 1A ).
- PAM 3'-CCT protospacer adjacent motif
- both plasmids were transformed into E. coli MG1655 by electroporation.
- Transformants were grown in liquid LB with antibiotics to mid-log phase, and the killing efficiency was determined by serial dilution and spot plating onto LB, and LB + inducers (0.5 mM IPTG and 1 % arabinose).
- Viability was calculated by counting colony forming units (CFUs) on the plates and data were calculated as viable cell concentration (CFU/ml).
- EXAMPLE 2 Single-Vector Cas3-Cascade & Array: Type I CRISPR-Cas system targeting E . coli.
- a plasmid (which we call a CRISPR Guided VectorTM, CGVTM) was constructed comprising an operon with nucleotide sequences encoding a Type I Cas3 and Cascade proteins under the control of a common promoter.
- C . difficile Type IB Cas3 and Cascade was used.
- An adaptation module containing Cas1, Cas2 and Cas4 was omitted in the vector.
- a cognate CRISPR array comprising C . pulp repeat sequences and spacer sequence for targeting an E. coli host cell chromosome was also included in the vector (see Figure 2A ).
- the CGV was transformed into E. coli MG1655. Results using this synthetic operon arrangement are shown in Figure 2 .
- Fig 2B there is shown a dilution series (10 1 -10 5 ) of drop spots (5 ⁇ l) of target E. coli MG1655 cells harboring the CGV on synthetic medium (SM) agar plates with and without inducers.
- SM synthetic medium
- CRISPR/Cas induction resulted in more than 2-log 10 reductions in viable cells of E. coli MG1655 ( Fig 2C , grey bar). Growth in absence of induction is shown in black.
- E. coli MG1655 was grown in synthetic medium (SM) with shaking (250 rpm) at 37 °C. Cultures were supplemented with 10 ⁇ g/mL tetracycline when required.
- SM synthetic medium
- cas3, cas6, cas8b, cas7 and cas5 genes from C. difficile were amplified and cloned in a low copy number plasmid (pSC101 ori).
- cas3 was located in the beginning of the operon followed by cas6, cas8b, cas7 and cas5.
- an IPTG inducible single-spacer array targeting a chromosomal intergenic region in E. coli MG1655 was included in the vector under control of the IPTG-inducible Ptrc promoter ( Fig 2A ). It contains 37 nucleotides from the PKS gene (previously integrated into the genome of E.
- coli MG1655 (gtttggcgatggcgcgggtgtggttgtgcttcggcgt) (SEQ ID NO: 27). Additionally, the 3'-CCT protospacer adjacent motif (PAM) is located adjacent to the selected target sequence in the genome of E. coli MG1655.
- PAM 3'-CCT protospacer adjacent motif
- the CGV was transformed into E. coli MG1655 by electroporation. Transformants were grown in liquid SM with antibiotics to mid-log phase, and the killing efficiency was determined by serial dilution and spot plating onto LB, and LB + inducers (0.5 mM IPTG and 1 % arabinose). Viability was calculated by counting colony forming units (CFUs) on the plates and data were calculated as viable cell concentration (CFU/ml).
- E. coli MG1655 harboring the CGV was grown in liquid SM with antibiotics to mid-log phase.
- the culture was divided into two tubes and either inducers (0.5 mM IPTG and 1 % arabinose) or PBS were added. Survival of the strain was followed over time by plating the cultures in serial dilutions (10 1 -10 6 ) of drop spots (5 ⁇ l) every 60 minutes, for 2 h, on SM plates with antibiotics. Survival frequency was calculated by counting colony forming units (CFUs) on the plates and data were calculated as viable cell concentration (CFU/ml).
- EXAMPLE 3 Precision killing of target strain E. coli MG1655 in a microbiome.
- An artificial microbial consortium was constructed to study the efficiency of the CGV carrying the CRISPR-Cas system of C. difficile, to specifically target E . coli MG1655 in the presence of other microbes, mimicking the human microbiome.
- the synthetic consortium consisted of three strains (two different species) with differential antibiotic resistance profiles: a streptomycin-resistant E. coli MG1655 (target strain), an ampicillin-resistant E. coli Top10, and a chloramphenicol-resistant Lactococcus lactis NZ9000.
- a streptomycin-resistant E. coli MG1655 target strain
- an ampicillin-resistant E. coli Top10 ampicillin-resistant E. coli Top10
- a chloramphenicol-resistant Lactococcus lactis NZ9000 a chloramphenicol-resistant Lactococcus lactis NZ9000.
- BHI Brain Heart Infusion broth
- L. lactis optimal growth medium for L. lactis
- the composition of the consortium was determined by counting viable colonies on selective plates. Induction of the CRISPR system in the mixed community, resulted in > 10-fold killing of target E. coli MG1655, while leaving E.
- FIG. 4A there is shown a dilution series (10 1 -10 5 ) of drop spots (5 ⁇ l) of the synthetic consortium after 1 h induction on BHI agar plates.
- E. coli MG1655, E. coli Top10, and Lactococcus lactis NZ9000 were grown in BHI broth with shaking (250 rpm) at 30 °C. Cultures were supplemented with 1000 ⁇ g/mL streptomycin, 100 ⁇ g/mL ampicillin, or 10 ⁇ g/mL chloramphenicol, respectively.
- bacterial cultures were grown in BHI with appropriate antibiotics to mid-log phase. Cultures were washed twice in PBS to remove the antibiotics and mixed in fresh BHI broth. The mixed culture was spotted onto BHI plates with streptomycin, ampicillin or chloramphenicol to quantify the initial concentration of E. coli MG1655, E. coli Top10 and L. lactis NZ9000, respectively. The mixed culture was divided into two tubes and either inducers (0.5 mM IPTG and 1 % arabinose) or PBS were added. After 1 h induction at 30 °C, the composition of the consortium was calculated by counting colony forming units (CFUs) on selective plates and data were calculated as viable cell concentration (CFU/ml).
- CFUs colony forming units
- TetR Tet repressor
- the target host cells are cells of a genus or species selected from this Table and/or the production strain cells are cells of a genus or species selected from this Table
- Clostridium (see below) Coccochloris Coccochloris elabens Corynebacterium Corynebacterium flavescens Clostridium Corynebacterium variabile Clostridium absonum, Clostridium aceticum, Clostridium acetireducens, Clostridium acetobutylicum, Clostridium acidisoli, Clostridium aciditolerans, Clostridium acidurici, Clostridium aerotolerans, Clostridium aestuarii, Clostridium akagii, Clostridium aldenense, Clostridium aldrichii, Clostridium algidicarni, Clostridium algidixylanolyticum, Clostridium algifaecis, Clostridium algoriphilum, Clostridium alkalicellulosi, Clostridium aminophilum, Clostridium aminovalericum, Clostridium amygdalinum,
- Clostridium paraputrificum Clostridium pascui, Clostridium pasteurianum, Clostridium peptidivorans, Clostridium perenne, Clostridium perfringens, Clostridium pfennigii, Clostridium phytofermentans, Clostridium piliforme, Clostridium polysaccharolyticum, Clostridium populeti, Clostridium propionicum, Clostridium proteoclasticum, Clostridium proteolyticum, Clostridium psychrophilum, Clostridium puniceum, Clostridium purinilyticum, Clostridium putrefaciens, Clostridium putrificum, Clostridium quercicolum, Clostridium quinii, Clostidium ramosum, Clostridium rectum, Clostridium roseum, Clostridium saccharobutylicum, Clostridium saccharogumia, Clostridium saccharobutylic
- Flavobacterium cucumis E. cowanii
- Flavobacterium E. taylorae
- Flavobacterium E. dissolvens
- E. turicensis daejeonense E. gergoviae
- Flavobacterium defluvii E. helveticus Enterococcus
- Flavobacterium degerlachei E. hormaechei Enterococcus durans
- Flavobacterium E.
- Streptococcus Streptococcus agalactiae Streptococcus infantarius Streptococcus orisratti Streptococcus thermophilus Streptococcus anginosus Streptococcus iniae Streptococcus parasanguinis Streptococcus sanguinis Streptococcus bovis Streptococcus intermedius Streptococcus peroris Streptococcus sobrinus Streptococcus canis Streptococcus lactarius Streptococcus pneumoniae Streptococcus suis Streptococcus constellatus Streptococcus milleri Streptococcus Streptococcus uberis Streptococcus downei Streptococcus mitis pseudopneumoniae Streptococcus vestibularis Streptococcus dysgalactiae Streptococcus mutans Streptococcus py
- Reported activities of the promoters are given as the relative fluorescence of plasmids in strain TG1 grown in LB media to saturation.
- a suitable plasmid is EX-Ptet-S-rbsRFP-P "RFP reporter" as described at http://parts.igem.org/Part:BBa_J61002 ; insertion of a promoter element between XbaI and SpeI sites results in a RFP reporter.
Abstract
Description
- The invention relates to the production and use of Cas-encoding sequences and vectors comprising these. Aspects of the invention provide products, vectors, delivery vehicles, uses and methods for producing Cas-encoding sequences in bacterial or archaeal cells.
- The state of the art describes vectors and uses of these that employ CRISPR/Cas systems. For example, reference is made to
WO2017/118598 ,US20180140698 ,US20170246221 ,US20180273940 ,US20160115488 ,US20180179547 ,US20170175142 ,US20160024510 ,US20150064138 ,US20170022499 ,US20160345578 ,US20180155729 ,US20180200342 ,WO2017112620 ,WO2018081502 ,PCT/EP2018/066954 PCT/EP2018/066980 PCT/EP2018/071454 15/985,658 - The invention provides the following configurations.
- A nucleic acid vector for introduction into a host cell, the vector comprising a first nucleotide sequence encoding a Type I Cas3 and a second nucleotide sequence encoding one or more Cascade proteins, wherein the first and second sequences are under the control of one or more promoters comprised by the vector for expression of the proteins in the cell.
- In an example, the vector comprises an operon for expression in the cell of the Cas3 and Cascade proteins from a Cas module, the module comprising the nucleotide sequences encoding the Cas3 and Cascade proteins, and the operon comprising the Cas module under the control of a promoter for controlling the expression of both the Cas3 and Cascade proteins.
- The invention also provides a delivery vehicle comprising the vector, as well as a pharmaceutical composition comprising the vector or vehicle and a pharmaceutically acceptable diluent, excipient or carrier.
- The invention also provides a method of treating or reducing the risk of a disease or condition in a human or animal subject, the method comprising administering the vector, vehicle or compostion to the subject, and introducing the vector into target host bacterial or archaeal cells in the subject (eg, in a gut microbiota, lung, eye or blood of the subject), wherein the Cas cuts (or otherwise modifies) one or more target sequences in the target cells and the cells are killed or growth or proliferation of the cells is reduced.
- A method of amplifying copies of a DNA encoding a functional Cas protein (optionally a Cas nuclease) in a bacterial or archaeal production strain of cells, the method comprising
- (a) Providing production strain cells, each cell comprising a copy of said DNA, wherein each DNA comprises a nucleotide sequence encoding said Cas, wherein the nucleotide sequence is under the control of a promoter for controlling the expression of the Cas in the production strain cell, the DNA comprising an origin of replication that is operable in the cell for replication of the DNA;
- (b) Culturing the cells to allow replication of the DNA, whereby the DNA is amplified; and
- (c) Optionally isolating copies of the DNA,
- Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for enhancing the yield of amplified DNA produced by the production host cells.
- Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing toxicity of the Cas in the production strain.
- Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain.
- Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for promoting production cell viability during the amplification of the DNA.
- Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing the occurrence of Cas cutting of DNA.
- A method for enhancing the yield of amplified copies of a DNA construct in a population of bacterial or archaeal production strain cells, wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- A method for reducing toxicity of a functional Cas protein (optionally a Cas nuclease) in a population of bacterial or archaeal production strain cells in a process of amplifying copies of a DNA construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- A method for reducing mutation of a DNA construct encoding a functional Cas protein (optionally a Cas nuclease) in a population of bacterial or archaeal production strain cells in a process of amplifying copies of the construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- A method for promoting production cell viability of a population of bacterial or archaeal production strain cells in a process of amplifying copies of a DNA construct comprised by the cells, wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- A method for reducing the occurrence of Cas nuclease cutting of a DNA construct in a population of bacterial or archaeal production strain cells in a process of amplifying copies of the construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
-
-
Figure 1 . Type I CRISPR-Cas system of C. difficile targeting E. coli MG1655. (A) Layout of the CRISPR Guided Vector™, CGV™ Plasmid 1: pSC101 ori, pBAD promoter (induced by arabinose), cas3 and cascade genes. Plasmid 2: pCloDF13 ori, pTac promoter (induced by IPTG), CRISPR array. (B) Dilution series (101-106) of drop spots (5 µl) of E. coli MG1655 harboring the CGV on LB agar plates with and without inducers. (C) CRISPR induction killed 99.9 % of the population (grey bar). Growth in absence of induction is shown in black. CGV™ refers to a CRISPR Guided Vector™, which is a nucleic acid vector comprising nucleotide sequences encoding CRISPR/Cas components. -
Figure 2 . Type I CRISPR-Cas system of C. difficile targeting E. coli MG1655. (A) Layout of the CRISPR Guided Vector™, CGV™. pSC101 ori, pTac promoter (induced by IPTG), CRISPR array, pBAD promoter (induced by arabinose), cas3 and cascade genes. (B) Dilution series (101-106) of drop spots (5 µl) of E. coli MG1655 harboring the CGV on SM agar plates with and without inducers. (C) CRISPR induction killed 99 % of the population (grey bar). Growth in absence of induction is shown in black. CGV™ refers to a CRISPR Guided Vector™, which is a nucleic acid vector comprising nucleotide sequences encoding CRISPR/Cas components. -
Figure 3 . Time-kill curves for E. coli MG1655 harboring the CGV. (A) CRISPR induction killed 99 % of the population in 60 minutes (dashed line). Growth in absence of induction is shown in black lines. CRISPR/Cas was induced at time-point 0 and monitored until 120 minutes. (B) Dilution series (101-106) of drop spots (5 µl) on SM agar plates of E. coli MG1655 after 60 minutes of induction. -
Figure 4 . Specific killing of E. coli MG1655 with type I-B CRISPR-Cas system of C. difficile in a synthetic microbial consortium. (A) Bacteria count of a synthetic population composed of three different strains. CRISPR was induced at time-point 0 and monitored for 60 minutes. Growth in absence of induction is shown in black. CRISPR induction prompted 1-log10 reduction in viable cells of target strain E. coli MG1655, while leaving E. coli Top10 and L. lactis NZ9000 populations intact (dark grey bars). (B) Dilution series (101-106) of drop spots (5 µl) of the bacterial community mixture after 60 minutes of induction. E. coli MG1655 grows selectively on BHI+streptomycin, E. coli Top10 on ampicillin, and L. lactis NZ9000 on chloramphenicol. -
Figure 5 . Killing of E. coli MG1655 with type I-B CRISPR-Cas system of C. difficile in a synthetic microbial consortium compared to a pure culture of E. coli MG1655. (A) CRISPR induction generated 4-log10 reductions in viable cells of target strain E. coli MG1655, both in the pure culture and in the community mixture (grey bars). Growth in absence of induction is shown in black. (B) Dilution series of a pure culture of E. coli MG1655 and the bacterial community mixture on streptomycin plates with and without inducers. - The invention relates to the production and use of Cas-encoding sequences and vectors comprising these. Aspects of the invention provide products, vectors, delivery vehicles, uses and methods for producing Cas-encoding sequences in bacterial or archaeal cells.
- An aspect of the invention provides for the control of expression of Cas and optionally also Cascade proteins from single vectors, such as by regulated use of Cas modules in an operon and/or using attenuated promoters.
- An aspect of the invention provides nucleic acid vectors that are useful for introducing into target host cells of any eukaryotic or prokaryotic species (eg, ex vivo or in vitro) for expressing Type I Cas and optionally other components of a Type I CRISPR/Cas system. Usefully, the vector may in some examples therefore provide a single-vector means for introducing a complete exogenous Type I CRISPR/Cas system into a target cell for modification (eg, cutting by Cas3) of DNA in the target cell. In an example, a chromosomal target sequence (ie, protospacer that is cognate with the Cas3) is modified. In another example, an episomal DNA sequence is modified, for example a plasmid sequence or a DNA that has been introduced into the cell. The latter may be useful in a recombineering method of the invention wherein exogenous DNA in the target cell is cut by the Cas3 and optionally this produces one or more recombinogenic ends for recombination of the cut DNA with a further DNA of interest, thereby producing a recombination product in the cell. For example, in such a recombineering method, the targt cell is a recombinongenic E coli cell, eg, comprising a red/ET system. In another example, the target cell is an undesired cell (eg, a cell of a species or strain that is pathogenic to humans or animals, such as a bacterial disease-causing species or strain) and the cutting by Cas3 kills the cell. This may be useful for treating or preventing an infection in a human or animal harbouring target cells. The provision of single-vector means that express minimally a Cas endonuclease (eg, Cas3), cognate accessory proteins (eg, Cascade proteins) and at least one CRISPR array (or nucleotide sequence encoding a guide RNA (eg, a single guide RNA)), wherein the Cas, accessory proteins and array (or nucleotide sequence) comprise a functional CRISPR/Cas system is more convenient and the inventors believe more efficient for introducing into a target cell and effecting CRISPR/Cas modification of a target sequence therein than the use of 2 or 3 or more separate vectors (eg, a vector encoding the Cas nuclease and a different vector encoding the accessory proteins, and possibly a further vector comprising the array (or gRNA-encoding nucleotide sequence) which all need to transform the target cell for the system to function). This may provide one or more benefits, therefore, such as simplifying delivery (and thus the design of delivery vehicles), simplifying construction of the vector and vehicle and/or providing for better cutting or killing efficiencies. Conveniently, an example of the invention therefore uses an operon for the coordinated expression in the target cells of the Cas and accessory proteins (and optionall also the array or gRNA-encoding sequence(s)). Whilst not wishing to be bound by any particular theory, the introduction of a single vector (eg, using an operon) as per the invention may advantageously coordinate the expression of the Cas and accessory proteins (and optionally production of cRNAs or gRNAs) so that these are available to operate together without undue delay in the target cell. This may be important to tip the balance between, on the one hand the target cell using its endogenous anti-restriction, endogenous Cas or other endogenous mechanisms that seek out and degrade invading phage and DNA, and on the other hand efficient cell killing or deactivation of such mechanisms by the invading CRISPR components of the vector of the invention. In such an arms race, concerted and early operation of the CRISPR components in the cell are likely to be important to gain the upper hand and effect cell killing. The invention provides means to assist this.
- By way of example, the invention thus provides the following Concepts:-
- 1. A nucleic acid vector for introduction into a host cell, the vector comprising a first nucleotide sequence encoding a Type I Cas3 and a second nucleotide sequence encoding one or more Cascade proteins, wherein the first and second sequences are under the control of one or more promoters comprised by the vector for expression of the proteins in the cell.
- 2. The vector of
concept 1, wherein the vector comprises an operon for expression in the cell of the Cas3 and Cascade proteins from a Cas module, the module comprising the nucleotide sequences encoding the Cas3 and Cascade proteins, and the operon comprising the Cas module under the control of a promoter for controlling the expression of both the Cas3 and Cascade proteins. - 3. The vector of
concept 2, wherein- (a) the first sequence is between the promoter and the second sequence in the operon;
- (b) the operon comprises no Cas-encoding nucleotide sequences between the promoter and the first nucleotide sequence; and/or
- (c) the operon comprises (in 5' to 3' direction) the promoter, the first sequence and the second sequence.
- 4. The vector of any preceding concept, wherein each promoter is a constitutive promoter.
- 5. The vector of any one of
concepts 1 to 3, wherein the promoter is repressible (optionally repressible by a tetracycline repressor or lac repressor). - 6. The vector of any one of
concepts 1 to 3, wherein the promoter is inducible. - 7. The vector of any preceding concept, wherein the first sequence is under the control of a medium strength promoter.
- 8. The vector of any preceding concept, wherein the first sequence is under the control of a promoter that has an Anderson Score (AS) of 0.5>AS >0.1.
- 9. The vector of any preceding concept, wherein the first sequence (and optionally the second sequence) is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator.
- 10. The vector of concept 9, wherein fluorescence using the first EOU is 0.5 to 2 times the fluorescence using the second EOU.
- 11. The vector of any preceding concept, wherein the vector comprises an origin of replication that is operable in the host cell.
- 12. The vector of any preceding concept, wherein the vector comprises an origin of replication that is operable in a bacterial cell of a vector production strain, wherein the Cas3 is not operable in the production strain cell to target and cut a chromosomal sequence thereof.
- 13. The vector of concept 12, wherein the first sequence is under the control of a promoter that is capable of controlling expression of the Cas3 at a level that is not toxic to the production strain cell.
- 14. The vector of any preceding concept, wherein the vector is a high copy number vector.
- 15. The vector of any preceding concept, wherein the first nucleotide sequence or operon is comprised by a mobile genetic element.
- 16. The vector of any preceding concept, wherein the vector is devoid of a Cas adaption module.
- 17. The vector of any preceding concept, wherein the vector is devoid of nucleotide sequence encoding one, more or all of a Cas1, Cas2, Cas4, Cas6, Cas7 and Cas 8.
- 18. The vector of any preceding concept, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas11, Cas7 and Cas8a1.
- 19. The vector of concept 18, wherein the vector comprises nucleotide sequence encoding Cas3' and/or Cas3".
- 20. The vector or concept 19, wherein the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in concept 18.
- 21. The vector of any one of concepts 18 to 20, wherein the host cell comprises a Type IA CRISPR array that is cognate with the Cas3.
- 22. The vector of any one of concepts 18 to 20, wherein the host cell comprises an endogenous Type IB, C, U, D, E or F CRISPR/Cas system.
- 23. The vector of any one of
concepts 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8b1, Cas7 and Cas5. - 24. The vector of concept 23, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in concept 23.
- 25. The vector of concept 23 or 24, wherein the host cell comprises a Type IB CRISPR array that is cognate with the Cas3.
- 26. The vector of concept 23 or 24, wherein the host cell comprises an endogenous Type IA, C, U, D, E or F CRISPR/Cas system.
- 27. The vector of any one of
concepts 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas5, Cas8c and Cas7. - 28. The vector of concept 27, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in concept 27.
- 29. The vector of concept 27 or 28, wherein the host cell comprises a Type IC CRISPR array that is cognate with the Cas3.
- 30. The vector of concept 27 or 28, wherein the host cell comprises an endogenous Type IA, B, U, D, E or F CRISPR/Cas system.
- 31. The vector of any one of
concepts 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8U2, Cas7, Cas5 and Cas6. - 32. The vector of concept 31, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in concept 31.
- 33. The vector of concept 31 or 32, wherein the host cell comprises a Type IU CRISPR array that is cognate with the Cas3.
- 34. The vector of concept 31 or 32, wherein the host cell comprises an endogenous Type IA, B, C, D, E or F CRISPR/Cas system.
- 35. The vector of any one of
concepts 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas10d, Cas7 and Cas5. - 36. The vector of concept 35, wherein the vector comprises a nucleotide sequence encoding Cas3' and/or Cas3".
- 37. The vector of concept 36, wherein the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in concept 35.
- 38. The vector of any one of concepts 35 to 37, wherein the host cell comprises a Type ID CRISPR array that is cognate with the Cas3.
- 39. The vector of any one of concepts 35 to 37, wherein the host cell comprises an endogenous Type IA, B, C, U, E or F CRISPR/Cas system.
- 40. The vector of any one of
concepts 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8e, Cas11, Cas7, Cas5 and Cas6. - 41. The vector of concept 40, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in concept 40.
- 42. The vector of concept 40 or 41, wherein the host cell comprises a Type IE CRISPR array that is cognate with the Cas3.
- 43. The vector of concept 40 or 41, wherein the host cell comprises an endogenous Type IA, B, C, D, U or F CRISPR/Cas system.
- 44. The vector of any one of
concepts 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8f, Cas5, Cas7 and Cas6f. - 45. The vector of concept 44, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in concept 44, wherein the vector is devoid of nucleotide sequence encoding further Cas between the promoter and the sequence encoding the Cas3.
- 46. The vector of concept 44 or 45, wherein the host cell comprises a Type IF CRISPR array that is cognate with the Cas3.
- 47. The vector of concept 44 or 45, wherein the host cell comprises an endogenous Type IA, B, C, D, U or E CRISPR/Cas system.
- 48. The vector of any one of
concepts 1 to 17, wherein the Cas and Cascade are- (a) Type IA Cas and Cascade proteins;
- (b) Type IB Cas and Cascade proteins;
- (c) Type IC Cas and Cascade proteins;
- (d) Type ID Cas and Cascade proteins;
- (e) Type IE Cas and Cascade proteins;
- (f) Type IF Cas and Cascade proteins; or
- (g) Type IU Cas and Cascade proteins.
- 49. The vector of any preceding concept, wherein the Cas and Cascade are E coli (optionally Type IE or IF) Cas and Cascade proteins.
- 50. The vector of concept 49, wherein the E coli is ESBL-producing E. coli or E. coli ST131-O25b:H4.
- 51. The vector of any preceding concept, wherein the Cas and Cascade are
- (a) Clostridium (eg, C dificile) Cas and Cascade proteins, optionally C dificile resistant to one or more antibiotics selected from aminoglycosides, lincomycin, tetracyclines, erythromycin, clindamycin, penicillins, cephalosporins and fluoroquinolones;
- (b) Pseudomonas aeruginosa Cas and Cascade proteins, optionally P aeruginosa resistant to one or more antibiotics selected from carbapenems, aminoglycosides, cefepime, ceftazidime, fluoroquinolones, piperacillin and tazobactam; or
- (c) Klebsiella pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae) Cas and Cascade proteins.
- 52. The vector of any preceding concept, wherein the Cas and Cascade are E coli, C difficile, P aeruginosa, K pneumoniae, Pfuriosus or B halodurans Cas and Cascade proteins.
- 53. The vector of any preceding concept, wherein the Cas3 is a Cas3 of a CRISPR/Cas locus of a first bacterial or archaeal species, wherein the distance between the Cas3-encoding sequence of the locus and its cognate promoter is further than the distance between the Cas3-encoding sequence and the respective promoter comprised by the vector.
- 54. The vector of any preceding concept, wherein the distance between the promoter and the Cas3-encoding sequence and/or Cascade protein-encoding sequence(s) is shorter than in a corresponding wild-type Type I locus.
- 55. The vector of any preceding concept, wherein the vector comprises (i) a CRISPR array for producing crRNAs in the host cell and/or (ii) one or more nucleotide sequences encoding one or more guide RNAs (gRNAs or single gRNAs), wherein the crRNAs or gRNAs are cognate to the Cas3 (and optionally cognate to the Cascade proteins).
- 56. The vector of concept 55 when dependent from
concept 2, wherein the array or gRNA-encoding sequence(s) are comprised by the operon and under the control of the promoter. - 57. The vector of concept 56, wherein the array or gRNA-encoding sequence(s) are under the control of a promoter that is different from the promoter that controls the expression of the Cas3.
- 58. The vector of concept 56 or 57, wherein one or more of the crRNAs or gRNAs comprises a spacer sequence that is capable of hybridising to a target nucleotide sequence of the host cell, wherein the target sequence is adjacent a PAM, the PAM being cognate to the Cas3.
- 59. The vector of concept 58, wherein the target sequence is a chromosomal sequence of the host cell.
- 60. The vector of concept 58 or 59, wherein the Cas3 is operable to cut the target sequence.
- 61. The vector of any preceding concept, wherein the vector is a plasmid or phagemid.
- 62. A delivery vehicle comprising the vector of any preceding concept, wherein the delivery vehicle is capable of delivering the vector into the host cell.
- 63. The vehicle of concept 62, wherein the delivery vehicle is a phage, non-replicative transduction particle, nanoparticle carrier, bacterium or liposome.
- 64. The vector or vehicle of any preceding concept, wherein the host cell is a bacterial or archaeal cell, optionally, the host cell is a C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cell.
- 65. The vector or vehicle of any preceding concept for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject.
- 66. The vector or vehicle of concept 65, wherein the disease or condition is an infection of the subject with host cells (eg, bacterial cells), or wherein the disease or condition is mediated by host cells (eg, bacterial cells).
- 67. A pharmaceutical composition comprising the vector or vehicle of any preceding concept and a pharmaceutically acceptable diluent, excipient or carrier.
- 68. A method of treating or reducing the risk of a disease or condition in a human or animal subject, the method comprising administering the vector, vehicle or compostion of any preceding concept to the subject, and introducing the vector into target host bacterial or archaeal cells in the subject (eg, in a gut microbiota, lung, eye or blood of the subject), wherein the Cas cuts (or otherwise modifies) one or more target sequences in the target cells and the cells are killed or growth or proliferation of the cells is reduced.
- 69. The method of concept 68, wherein the target cells are cells of a disease pathogen species.
- 70. The method of concept 68 or 69, wherein the targt cells are C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cells.
- An aspect of the invention provides improved ways of amplifying DNA constructs in bacterial and archaeal production strain cells. For example, the DNA may be a high copy number plasmid or phagemid comprising a constitutive promoter for controlling the expression of one or more Cas proteins when the DNA has been introduced into a target host bacterial or host cell. It is desirable, according to an aspect of the invention, to consider attenuating the promoter activity during amplification of the DNA in the production strain. This is useful, since the inventors have found that Cas expression in production strains may be toxic to production strain cells, thereby reducing the yield of amplified DNA. Toxicity may be due, for example, to off-target cutting of the production strain chromosomal DNA when the Cas is a nuclease (such as Cas9 or Cas3) and/or due to relatively high levels of expression of the Cas in the cells. Additionally or alternatively, undesirably the Cas expression or activity may impose a selective pressure that favours mutation and propagation of mutated DNA constructs (such as mutation in one more or all of a CRISPR/Cas operon, Cas-encoding gene, Cascade-encoding gene, CRISPR array and gRNa-encoding sequence of the DNA construct) in production cells, thereby reducing the yield of desired amplified constructs and imposing an undesired step of separating desired from mutated DNA constructs for further formulation into useful compositions.. Such compositions may be pharmaceutical compositions, herbicides, pesticides, environmental remediation compositions etc. In one example, the promoter attenuation in production strains is achieved by using a medium strength (not high or low) promoter to control the Cas-encoding nucleotide sequence of the DNA constructs. A medium level of Cas expression may be tolerable in the production strains, and yet once the DNA is subsequently introduced into target host cells the Cas is expressed at sufficiently high levels to produce desired activity to modify (eg, cut) target sequences in target cells. In an alternative, the invention uses a repressible promoter, wherein the promoter is repressed in production strain, but not repressed in target host cells. For example, aspects of the invention use a tetracycline repressor (tetR) expressed in production strain cells that represses the promoter.
- Thus, the yield can be enhanced by one or more of
- (a) reducing toxicity of the Cas in the production strain;
- (b) reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain;
- (c) promoting production cell viability during the amplification of the DNA; and
- (d) reducing the occurrence of Cas cutting of DNA (optionally cutting of production host cell chromosomal DNA or said DNA construct).
- To this end, the invention provides Embodiments as follows:-
- 1. A method of amplifying copies of a DNA encoding a functional Cas protein (optionally a Cas nuclease) in a bacterial or archaeal production strain of cells, the method comprising
- (a) Providing production strain cells, each cell comprising a copy of said DNA, wherein each DNA comprises a nucleotide sequence encoding said Cas, wherein the nucleotide sequence is under the control of a promoter for controlling the expression of the Cas in the production strain cell, the DNA comprising an origin of replication that is operable in the cell for replication of the DNA;
- (b) Culturing the cells to allow replication of the DNA, whereby the DNA is amplified; and
- (c) Optionally isolating copies of the DNA,
In an example, promoter is a medium strength promoter. In another example, the promoter is repressed in the production strain cell. Hence, the promoter is an attenuated promoter in these examples. - 2. Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for enhancing the yield of amplified DNA produced by the production host cells.
- 3. The use of
paragraph 2, wherein the use is for enhancing said yield by- (a) reducing toxicity of the Cas in the production strain;
- (b) reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain;
- (c) promoting production cell viability during the amplification of the DNA; and/or
- (d) reducing the occurrence of Cas cutting of DNA (optionally cutting of production host cell chromosomal DNA or said DNA construct).
- 4. Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing toxicity of the Cas in the production strain.
- 5. Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain.
- 6. Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for promoting production cell viability during the amplification of the DNA.
- 7. Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing the occurrence of Cas cutting of DNA.
- 8. A method for enhancing the yield of amplified copies of a DNA construct in a population of bacterial or archaeal production strain cells, wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- 9. A method for reducing toxicity of a functional Cas protein (optionally a Cas nuclease) in a population of bacterial or archaeal production strain cells in a process of amplifying copies of a DNA construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- 10. A method for reducing mutation of a DNA construct encoding a functional Cas protein (optionally a Cas nuclease) in a population of bacterial or archaeal production strain cells in a process of amplifying copies of the construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- 11. A method for promoting production cell viability of a population of bacterial or archaeal production strain cells in a process of amplifying copies of a DNA construct comprised by the cells, wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- 12. A method for reducing the occurrence of Cas nuclease cutting of a DNA construct in a population of bacterial or archaeal production strain cells in a process of amplifying copies of the construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- 13. The use of
paragraph 5 or 7, or the method of paragraph 10 or 12, wherein the mutation or cutting is mutation or cutting of host cell chromosomal DNA or the construct DNA. - 14. The method or use of any one of
paragraphs 2 to 13, wherein the promoter is a constitutive promoter. - 15. The method or use of any preceding paragraph, wherein the promoter is repressed in the production strain cells (optionally repressed by a tetracycline repressor or a lac repressor).
- 16. The method or use of paragraph 15, wherein the promoter is PLtetO-1, PLlacO-1 or a repressible homologue thereof.
Other examples of suitable repressible promoters are Ptac (repressed by lacI) and he Leftward promoter (pL) of phage lambda (which repressed by the λcI repressor). In an example, the promoter comprises a repressible operator (eg, tetO or lacO) fused to a promoter sequence. The corresponding repressor is encoded by a nucleic acid in the production strain (eg, a chromosomally-integrated sequence or a sequence comprised by an episome) and the repressor is expressed during the DNA or vector amplification method of the invention, whereby the promoter controlling Cas expression is repressed. In delivery vehicles that are subsequently produced from isolated amplified DNA/vector, the vehicle is devoid of an expressible nucleotide sequence encoding the repressor, whereby the promoter is functional when the DNA/vector is introduced into a target host cell. For example, in the absence of the repressor the promoter is consitutively ON for expression of the Cas. The system is therefore primed to work once the DNA/vector is introduced into the host cells, and this effect can be enhanced further by using a high copy number DNA/vector comprising an origin of replication that is operable in the host cell.. A high copy number vector or DNA is also desirable in the production strain cells for enhancing yield of the DNA/vector, and by use of an attenuated promoter as described herein (eg, medium strength promoter and/or repressed promoter in the production strain cells) one can minimise Cas toxicity whilst culturing to maximise amplification and thus yield of the DNA/vector. - 17. The method or use of any preceding paragraph, wherein the promoter is a medium strength promoter.
- 18. The method or use of any preceding paragraph, wherein the promoter has an Anderson Score (AS) of 0.5>AS >0.1.
- 19. The method or use of any preceding paragraph, wherein the nucleotide sequence encoding said Cas is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator.
- 20. The method or use of paragraph 19, wherein fluorescence using the first EOU is 0.5 to 2 times the fluorescence using the second EOU.
- 21. The method or use of any preceding paragraph, wherein the nuclease is Cas3 and optionally the DNA or cell encodes cognate Cascade proteins.
- 22. The method or use of any one of
paragraphs 1 to 20, wherein the Cas is a Cas9. - 23. The method or use of any preceding paragraph, wherein the production strain cells comprise a helper phage genome that is inducible to produce phage coat proteins in the cells, wherein the method further comprises inducing production of the phage proteins and causing packaging of the amplified DNA into phage particles or non-self-replicative transduction particles, and further isolating the phage or transduction particles and optionally formulating the particles into a pharmaceutical composition for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject.
- 24. The method or use of paragraph 23, wherein the particles are capable of infecting target host cells in the subject and transducing the cells with the DNA, wherein the Cas and crRNAs (or guide RNAs, gRNAs) encoded by the DNA are expressed in the cells, the crRNAs or (gRNAs) being operable to guide the Cas to a target nucleotide sequence (optionally a chromosomal sequence) comprised by the cells, wherein the Cas cuts the target sequences in the cells, thereby killing host cells and treating or reducing the risk of the disease or condition.
- 25. The method or use of paragraph 24, wherein the host cells are bacterial or archaeal cells, optionally, the host cells are C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cells.
- 26. The method or use of any preceding paragraph, wherein each DNA is comprised by a high copy number plasmid or phagemid.
- 27. The method or use of any preceding paragraph, wherein the DNA construct comprises one or more nucleotide sequences for producing crRNAs or gRNAs that are operable for Cas nuclease targeting in target host cells.
- The invention provides the following Paragraphs, which are supported by the Examples below. Any features of the Concepts are combinable with any features of the Embodiments. Any features of the Concpets are combinable with any features of the Embodiments. Any features of the Paragraphs are combinable with any features of the Embodiments.
- Any cell herein (eg, a production strain cell or target host cell) may be a bacterial cell, archaeal cell, algal cell, fungal cell, protozoan cell, invertebrate cell, vertebrate cell, fish cell, bird cell, mammal cell, companion animal cell, dog cell, cat cell, horse cell, mouse cell, rat cell, rabbit cell, eukaryotic cell, prokaryotic cell, human cell, animal cell, rodent cell, insect cell or plant cell. Preferably, the cell is a bacterial cell. Alternatively, the cell is a human cell. Optionally, the production strain cell(s) and target host cell(s) are of the same phylum, order, family, genus, species or strain.
- In an example, the Cas is any Cas (eg, a Cas2, 3, 4, 5, or 6) of a Type I system. In this example, in an embodiment, the Cas may be fused or conjugated to a moiety that is operable to increase or reduce transcription of a gene comprising the target sequence. For example the nucleic acid encoding the Cas may comprise a nucleotide sequence encoding the moiety, wherein the Cas and moiety are expressed in the host cell as a fusion protein. In one embodiment, the Cas is N-terminal of the moiety; in another embodiment it is C-terminal to the moiety.
- 1. A nucleic acid vector for introduction into a host cell, the vector comprising a first nucleotide sequence encoding a Type I Cas3, wherein the sequence is under the control of a promoter comprised by the vector for expression of the Cas3 in the cell.
In an example, the vector is a DNA vector, eg, ssDNA vector or dsDNA vector. - 2. The vector of
paragraph 1, wherein the vector comprises a second nucleotide sequence encoding one or more Cascade proteins, wherein the first and second sequences are under the control of one or more promoters comprised by the vector for expression of the proteins in the cell. - 3. The vector of
paragraph 2, wherein the Cascade protein(s) are cognate with the Cas3.
In an example, the Cas3 is cognate with Cascade proteins encoded by the host cell and/or encoded by a second operon. Optionally, the second operon is comprised by the vector. Optionally, the second operon is comprised by a second vector that is capable of introducing the second operon into the host cell, whereby the Cas3 and Cascade proteins are expressed from the operons in the host cell and are operable with crRNA or gRNA to target the Cas to a host cell target sequence, wherein the Cas3 is capable of modifying the target sequence. - 4. The vector of
paragraph
The term "operon" is known to the skilled person such as relating to a functioning unit of DNA containing at least expressible 2 nucleotide sequences respectively encoding for an expression product (eg, a respective translatable mRNA), wherein the sequences are under common promoter control. - 5. The vector of
paragraph 4, wherein the first sequence is between the promoter and the second sequence in the operon. - 6. The vector of
paragraph
Optionally, the Cas3 is a Cas3 encoded by a CRISPR/Cas locus of a first bacterial or archaeal species, wherein in the locus the Cas3-encoding sequence is 3' of Cascade protein-encoding sequences (ie, the latter are between the Cas3 and the 5'-most promoter of the locus).
Optionally, the Cas3 is a ygcB protein (eg, wherein the production strain cell and/or host target cell is an E coli).
Optionally, the Cascade proteins comprise or consist of
cas5 (casD, csy2)
cas6 (cas6f, cse3, casE)
cas7 (csc2, csy3, cse4, casC)
cas8 (casA, cas8a1, cas8b1, cas8c, cas10d, cas8e, cse1, cas8f, csy1).
Optionally herein the promoter and the Cas3-encoding sequence are spaced no more than 150, 100, 50, 40, 30, 20 or 10bp apart, eg, from 30-45, or 30-40, or 39 or around 39bp apart.
Optionally herein a ribosome binding site and the Cas3-encoding sequence are spaced no more than 20, 15, 14, 13, 12, 11, 10, 9, 8, 7, 6, 4 or 3bp apart, eg, from 10-5, 6 or around 6bp apart. - 7. The vector of any one of
paragraphs 4 to 6, wherein the operon comprises (in 5' to 3' direction) the promoter, the first sequence and the second sequence. - 8. The vector of any preceding paragraph, wherein each promoter is a constitutive promoter.
- 9. The vector of any one of
paragraphs 1 to 7, wherein the promoter is repressible (optionally repressible by a tetracycline repressor or lac repressor). - 10. The vector of any one of
paragraphs 1 to 7, wherein the promoter is inducible. - 11. The vector of any preceding paragraph, wherein the first sequence is under the control of a weak promoter.
- 12. The vector of any one of
paragraphs 1 to 7, wherein the first sequence is under the control of a medium strength promoter. - 13. The vector of any one of
paragraphs 1 to 7, wherein the first sequence is under the control of a strong promoter.
In an example, the promoter is in combination with a Shine-Dalgarno sequence comprising the sequence 5'- aaagaggagaaa-3' (SEQ ID NO: 5) or a ribosome binding site homologue thereof. - 14. The vector of any one of
paragraphs 1 to 7, wherein the first sequence is under the control of a promoter that has an Anderson Score (AS) of AS ≥0.5.
See Table 2 for more information on Anderson Scores in relation to promoters. - 15. The vector of any one of
paragraphs 1 to 7, wherein the first sequence is under the control of a promoter that has an Anderson Score (AS) of 0.5>AS >0.1. - 16. The vector of any one of
paragraphs 1 to 7, wherein the first sequence is under the control of a promoter that has an Anderson Score (AS) of ≤0.1. - 17. The vector of any one of
paragraphs 1 to 7, wherein the first sequence (and optionally the second sequence) is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator. - 18. The vector of paragraph 17, wherein fluorescence using the first EOU is 0.5 to 2 times the fluorescence using the second EOU.
For example, fluorescence using the first EOU is 0.5 to X times the fluorescence using the second EOU, wherein X is from 3.0 to 1.0, eg, 3, 2.5, 2, 1.5 or 1, wherein fluorescence is determined using excitation at 481 nm and emission at 507 nm. Optionally, E coli cultures at OD600 of 0.3-0.5 in the exponential growth phase are used.
For example, the upstream insulator, the nucleotide sequence encoding GFP, 3' UTR, transcription terminator and downstream insulator of each EOU are as disclosed in Mutalik et al (2013). For example, the upstream insulator, the nucleotide sequence encoding GFP, 3' UTR, transcription terminator and downstream insulator of each EOU are corresponding sequences of SEQ ID NO: 4. For example, the E coli is E. coli BW25113 is grown in MOPS EZ Rich Medium (Teknova) supplemented with 50 µg/ml kanamycin (kan) at 37 °C, shaken at 900 r.p.m. For example, each EOUs is comprised by a medium copy plasmid, eg, a plasmid derived from pFAB217 comprising a p15A replication origin and a kan resistance gene. - 19. The vector of any preceding paragraph, wherein the vector comprises an origin of replication that is operable in the host cell.
- 20. The vector of any preceding paragraph, wherein the vector comprises an origin of replication that is operable in a bacterial cell of a vector production strain, wherein the Cas3 is not operable in the production strain cell to target and cut a chromosomal sequence thereof.
An example of a production strain cell is an E coli cell. A production strain cell is a cell that is used to amplify DNA encoding Cas (and optionally other components of a CRISPR/Cas system). Usefully, the strain may package the amplified DNA into transduction particles that are may be isolated to produce a composition that can be contacted with a population of target host cells (eg, bacterial, archaeal, prokaryotic, eukaryotic, human, animal, mammal, rodent, mouse, rat, rabbit, Xenopus, fish, bird, amphibian, insect, plant, amoeba or algae cells) wherein the DNA is introduced into the cells for expression of the Cas (and optional other CRISPR/Cas system components), wherein the Cas is guided to a protospacer target sequence in the host cells and modifies (eg, cuts) the sequence. In another example, the amplified DNA isolated from a population of production strain cells and is combined with a delivery vehicle (eg, a carrier bacterium, nanoparticle or liposome), wherein the delivery vehicle can be contacted with a population of target host cells (eg, bacterial, archaeal, prokaryotic, eukaryotic, human, animal, mammal, rodent, mouse, rat, rabbit, Xenopus, fish, bird, amphibian, insect, plant, amoeba or algae cells) wherein the DNA is introduced into the cells for expression of the Cas (and optional other CRISPR/Cas system components), wherein the Cas is guided to a protospacer target sequence in the host cells and modifies (eg, cuts) the sequence. - 21. The vector of paragraph 20, wherein the first sequence is under the control of a promoter that is capable of controlling expression of the Cas3 at a level that is not toxic to the production strain cell.
In an example, substantially no production strain cells are killed when the Cas3-encoding sequence is amplified therein. In another example, no more than 40, 30, 20, 10, 5, 4, 3, 2, or 1% of production strain cells are killed when the Cas3-encoding sequence is amplified therein. For example this is in a 1, 2, 3, 4, 5, 6, 7, 8 9 10, 12 or 24 hour period of culturing the cells. - 22. The vector of paragraph 20, wherein the first sequence is under the control of a promoter that controls expression of the Cas3 in the production strain cell such that the cell is capable of growth and propagation sufficient to produce at least 1000 copies of the vector.
For example this is in a 1, 2, 3, 4, 5, 6, 7, 8 9 10, 12 or 24 hour period of culturing the cells. For example, at least 104, 105, 106, 107, 108, 109, 1010, 1011, 1012, 1013, 1014, 1015, 1016, 1017 or 1018 copies of the vector are produced per 103, 104, 105, 106, 107, 108, 109, 1010, 1011, 1012, 1013, 1014, 1015, 1016, 1017 production strain cells respectively. - 23. The vector of any one of paragraphs 20 to 22, wherein the cell is capable of at least 2 or 3 logs of expansion when the vector is comprised therein.
For example, this is in a 1, 2, 3, 4, 5, 6, 7, 8 9 10, 12 or 24 hour period of culturing the cells. - 24. The vector of any preceding paragraph, wherein the vector is a high copy number vector.
- 25. The vector of any preceding paragraph, wherein the first nucleotide sequence or operon is comprised by a mobile genetic element.
Suitable mobile genetic elements, eg, transposons, are disclosed inWO2016177682 andUS20170246221 , the disclosures of which are explicitly incorporated herein for possible use in the invention and for providing one or more features for the claims herein. - 26. The vector of any preceding paragraph, wherein the vector is devoid of a Cas adaption module.
For example, the vector is devoid of nucleotide sequences encoding a Cas1, Cas2 and/or Cas4. - 27. The vector of any preceding paragraph, wherein the vector is devoid of nucleotide sequence encoding one, more or all of a Cas1, Cas2, Cas4, Cas6 (optionally Cas6f), Cas7 and Cas 8 (optionaly Cas8f).
- 28. The vector of any preceding paragraph, wherein the vector is devoid of a sequence encoding a Cas6 (optionally a Cas6f).
- 29. The vector of any one of
paragraphs 1 to 27, wherein the module encodes a Cas6 (optionally a Cas6f). - 30. The vector of any preceding paragraph, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas11, Cas7 and Cas8a1.
- 31. The vector of paragraph 30, wherein the vector comprises nucleotide sequence encoding Cas3' and/or Cas3" (optionally wherein the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in paragraph 30).
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3 (eg, Cas3' and/or Cas3"), Cas11, Cas7 and Cas8a1. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas11 sequence. Optionally, the vector comprises a Type IA CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 32. The vector of paragraph 30 or 31, wherein the host cell comprises a Type IA CRISPR array that is cognate with the Cas3.
- 33. The vector of paragraph 30 or 31, wherein the host cell comprises an endogenous Type IB, C, U, D, E or F CRISPR/Cas system.
- 34. The vector of any one of
paragraphs 1 to 29, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8b1, Cas7 and Cas5. - 35. The vector of paragraph 34, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in paragraph 34.
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3, Cas8b1, Cas7 and Cas5. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas8b1 sequence. Optionally, the vector comprises a Type IB CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 36. The vector of paragraph 34 or 35, wherein the host cell comprises a Type IB CRISPR array that is cognate with the Cas3.
- 37. The vector of paragraph 34 or 35, wherein the host cell comprises an endogenous Type IA, C, U, D, E or F CRISPR/Cas system.
- 38. The vector of any one of
paragraphs 1 to 29, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas5, Cas8c and Cas7. - 39. The vector of paragraph 38, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in paragraph 38.
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3, Cas5, Cas8c and Cas7. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas5 sequence. Optionally, the vector comprises a Type IC CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 40. The vector of paragraph 38 or 39, wherein the host cell comprises a Type IC CRISPR array that is cognate with the Cas3.
- 41. The vector of paragraph 38 or 39, wherein the host cell comprises an endogenous Type IA, B, U, D, E or F CRISPR/Cas system.
- 42. The vector of any one of
paragraphs 1 to 29, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8U2, Cas7, Cas5 and Cas6. - 43. The vector of paragraph 42, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in paragraph 42.
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3, Cas8U2, Cas7, Cas5 and Cas6. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas8U2 sequence. Optionally, the vector comprises a Type IU CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 44. The vector of paragraph 42 or 43, wherein the host cell comprises a Type IU CRISPR array that is cognate with the Cas3.
- 45. The vector of paragraph 42 or 43, wherein the host cell comprises an endogenous Type IA, B, C, D, E or F CRISPR/Cas system.
- 46. The vector of any one of
paragraphs 1 to 29, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas10d, Cas7 and Cas5. - 47. The vector of paragraph 46, wherein the vector comprises a nucleotide sequence encoding Cas3' and/or Cas3" (optionally wherein the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in paragraph 46).
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3, Cas10d, Cas7 and Cas5. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas10d sequence. Optionally, the vector comprises a Type ID CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 48. The vector of paragraph 46 or 47, wherein the host cell comprises a Type ID CRISPR array that is cognate with the Cas3.
- 49. The vector of paragraph 46 or 47, wherein the host cell comprises an endogenous Type IA, B, C, U, E or F CRISPR/Cas system.
- 50. The vector of any one of
paragraphs 1 to 29, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8e, Cas11, Cas7, Cas5 and Cas6. - 51. The vector of paragraph 50, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in paragraph 50.
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3, Cas8e, Cas11, Cas7, Cas5 and Cas6. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas11 sequence. Optionally, the vector comprises a Type IE CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 52. The vector of paragraph 50 or 51, wherein the host cell comprises a Type IE CRISPR array that is cognate with the Cas3.
- 53. The vector of paragraph 50 or 51, wherein the host cell comprises an endogenous Type IA, B, C, D, U or F CRISPR/Cas system.
- 54. The vector of any one of
paragraphs 1 to 29, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8f, Cas5, Cas7 and Cas6f. - 55. The vector of paragraph 54, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in paragraph 54, wherein the vector is devoid of nucleotide sequence encoding further Cas between the promoter and the sequence encoding the Cas3.
In one embodiment, the vector comprises nucleotide sequences (in 5' to 3' direction) that encode a Cas3, Cas8f, Cas5, Cas7 and Cas6f. Optionally, a nucleotide sequence encoding Cas6 is between the Cas3 sequence(s) and the Cas8f sequence. Optionally, the vector comprises a Type IF CRISPR array or one or more nucleotide sequences encoding single guide RNA(s) (gRNA(s)), wherein the array and each gRNA comprises repeat sequence that is cognate with the Cas3. Thus, the array is operable in a host cell when the vector has been introduced into the cell for production of guide RNAs, wherein the guide RNAs are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. Similarly, the single guide RNAs encoded by the vector in one embodiment are operable with the Cas and Cascade proteins to target and modify (eg, cut) a target nucleotide sequence in the host cell, optionally thereby killing the host cell. - 56. The vector of paragraph 54 or 55, wherein the host cell comprises a Type IF CRISPR array that is cognate with the Cas3.
- 57. The vector of paragraph 54 or 55, wherein the host cell comprises an endogenous Type IA, B, C, D, U or E CRISPR/Cas system.
- 58. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type IA Cas and Cascade proteins. - 59. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type IB Cas and Cascade proteins. - 60. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type IC Cas and Cascade proteins. - 61. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type ID Cas and Cascade proteins. - 62. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type IE Cas and Cascade proteins. - 63. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type IF Cas and Cascade proteins. - 64. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Type IU Cas and Cascade proteins. - 65. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are E coli (optionally Type IE or IF) Cas and Cascade proteins, optionally wherein the E coli is ESBL-producing E. coli or E. coli ST131-O25b:H4. - 66. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Clostridium (eg, C dificile) Cas and Cascade proteins, optionally C dificile resistant to one or more antibiotics selected from aminoglycosides, lincomycin, tetracyclines, erythromycin, clindamycin, penicillins, cephalosporins and fluoroquinolones. - 67. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Pseudomonas aeruginosa Cas and Cascade proteins, optionally P aeruginosa resistant to one or more antibiotics selected from carbapenems, aminoglycosides, cefepime, ceftazidime, fluoroquinolones, piperacillin and tazobactam. - 68. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are Klebsiella pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae) Cas and Cascade proteins. - 69. The vector of any one of
paragraphs 1 to 29, wherein the Cas and Cascade are E coli, C difficile, P aeruginosa, K pneumoniae, P furiosus or B halodurans Cas and Cascade proteins. - 70. The vector of any preceding paragraph, wherein the Cas3 is a Cas3 of a CRISPR/Cas locus of a first bacterial or archaeal species, wherein the distance between the Cas3-encoding sequence of the locus and its cognate promoter is further than the distance between the Cas3-encoding sequence and the respective promoter comprised by the vector.
The cognate promoter here is the one that controls expression of Cas3 in the wild-type locus. - 71. The vector of any preceding paragraph, wherein the distance between the promoter and the Cas3-encoding sequence and/or Cascade protein-encoding sequence(s) is shorter than in a corresponding wild-type Type I locus.
A corresponding locus is a wild-type locus of a bacterial or archaeal species or strain that comprises an endogenous CRISPR/Cas system encoding the Cas3 and/or Cascade proteins of the type that are also encoded by the vector. Thus, when the vector comprises an operon, the operon may comprise Cas3- and Cascade-encoding nucleotide sequences that are not in a natural configuration. - 72. The vector of any preceding paragraph, wherein the vector comprises (i) a CRISPR array for producing crRNAs in the host cell and/or (ii) one or more nucleotide sequences encoding one or more single guide RNAs (gRNAs), wherein the crRNAs or gRNAs are cognate to the Cas3 (and optionally cognate to the Cascade proteins).
- 73. The vector of paragraph 72 when dependent from
paragraph 4, wherein the array or gRNA-encoding sequence(s) are comprised by the operon and under the control of the promoter. - 74. The vector of paragraph 72, wherein the array or gRNA-encoding sequence(s) are under the control of a promoter that is different from the promoter that controls the expression of the Cas3.
- 75. The vector of any one of paragraphs 72 to 74, wherein one or more of the crRNAs or gRNAs comprises a spacer sequence that is capable of hybridising to a target nucleotide sequence of the host cell, wherein the target sequence is adjacent a PAM, the PAM being cognate to the Cas3.
Thus, the spacer hybridises to the protospacer to guide the Cas3 to the protospacer. Optionally, the Cas3 cuts the protospacer, eg, using exo- and/or endonuclease activity of the Cas3. Optionally, the Cas3 removes a plurality (eg, at least 2, 3,4, 5, 6, 7, 8, 9 or 10) nucleotides from the protospacer. - 76. The vector of paragraph 75, wherein the target sequence is a chromosomal sequence of the host cell.
- 77. The vector of paragraph 75 or 76, wherein the Cas3 is operable to cut the target sequence.
- 78. The vector of any preceding paragraph, wherein the vector is a plasmid or phagemid.
- 79. A delivery vehicle comprising the vector of any preceding paragraph, wherein the delivery vehicle is capable of delivering the vector into the host cell.
- 80. The vehicle of paragraph 79, wherein the delivery vehicle is a phage, non-replicative transduction particle, nanoparticle carrier, bacterium or liposome.
The phage or particles comprise phage coat proteins encapsidating DNA, wherein the DNA comprises the vector. Suitable examples of phage and particles are disclosed in USSN15/985,658 - 81. The vector or vehicle of any preceding paragraph, wherein the host cell is a bacterial or archaeal cell, optionally, the host cell is a C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cell.
- 82. The vector or vehicle of any preceding paragraph for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject.
- 83. The vector or vehicle of paragraph 82, wherein the disease or condition is an infection of the subject with host cells (eg, bacterial cells), or wherein the disease or condition is mediated by host cells (eg, bacterial cells).
- 84. A pharmaceutical composition comprising the vector or vehicle of any preceding paragraph and a pharmaceutically acceptable diluent, excipient or carrier.
- 85. A method of amplifying copies of a DNA encoding a functional Cas protein (optionally a Cas nuclease) in a bacterial or archaeal production strain of cells, the method comprising
- (a) Providing production strain cells, each cell comprising a copy of said DNA, wherein each DNA comprises a nucleotide sequence encoding said Cas, wherein the nucleotide sequence is under the control of a promoter for controlling the expression of the Cas in the production strain cell, the DNA comprising an origin of replication that is operable in the cell for replication of the DNA;
- (b) Culturing the cells to allow replication of the DNA, whereby the DNA is amplified; and
- (c) Optionally isolating copies of the DNA,
- 86. The method of paragraph 85, wherein the promoter is a constitutive promoter.
- 87. The method of paragraph 85, wherein the promoter is repressible (optionally repressible by a tetracycline repressor or a lac repressor).
- 88. The method of paragraph 85, wherein the promoter is inducible.
- 89. The method of any one of paragraphs 85 to 88, wherein the promoter is a medium strength promoter.
- 90. The method of any one of paragraphs 85 to 89, wherein the promoter has an Anderson Score (AS) of 0.5>AS >0.1.
- 91. The method of any one of paragraphs 85 to 90, wherein the nucleotide sequence encoding said Cas is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator.
- 92. The method of paragraph 91, wherein fluorescence using the first EOU is 0.5 to 2 times the fluorescence using the second EOU.
- 93. The method of any one of paragraphs 85 to 92, wherein the nuclease is Cas3 and optionally the DNA or cell encodes cognate Cascade proteins and/or one or more crRNAs that are operable for Cas nuclease targeting.
For example, the targeting is targeting of the Cas to a protospacer sequence comprised by a host cell chromosome or an episome thereof. In another example the targeting is in a recombineering method and the Cas is targeted to a protospacer sequence of a DNA that has been introduced into or amplified in the host cell. In an example of such recombineering, the host cell is an E coli cell. - 94. The method of any one of paragraphs 85 to 92, wherein the Cas is a Cas9.
- 95. The method of any one of paragraphs 85 to 92, wherein the Cas is a Type IIIA csm protein or a Type IIIB cmr protein.
- 96. The method of any one of paragraphs 85 to 92, wherein the Cas is a Csf1.
- 97. The method of any one of paragraphs 85 to 92, wherein the Cas is a Cpf1.
- 98. The method of any one of paragraphs 85 to 92, wherein the Cas is a Cas13 (optionally Cas13a or Cas 13b).
- 99. The method of any one of paragraphs 85 to 92, wherein the Cas is selected from a Cas3, Cas8a, Cas5, Cas8b, Cas8c, Cas10d, Cse1, Cse2, Csy1, Csy2, Csy3, GSU0054, Cas10, Csm2, Cmr5, Cas10, Csx11, Csx10, Csf1, Cas9, Csn2, Cas4, Cpf1, C2c1, C2c3, Cas13a, Cas13b and Cas13c.
- 100. The method of any one of paragraphs 85 to 99, wherein the production strain cells comprise a helper phage genome that is inducible to produce phage coat proteins in the cells, wherein the method further comprises inducing production of the phage proteins and causing packaging of the amplified DNA into phage particles or non-self-replicative transduction particles, and further isolating the phage or transduction particles and optionally formulating the particles into a pharmaceutical composition for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject.
- 101. The method of paragraph 100, wherein the particles are capable of infecting target host cells in the subject and transducing the cells with the DNA, wherein the Cas and crRNAs (or gRNAs) encoded by the DNA are expressed in the cells, the crRNAs or (gRNAs) being operable to guide the Cas to a target nucleotide sequence (optionally a chromosomal sequence) comprised by the cells, wherein the Cas cuts the target sequences in the cells, thereby killing host cells and treating or reducing the risk of the disease or condition.
- 102. The method of paragraph 101, wherein the host cells are bacterial or archaeal cells, optionally, the host cells are C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cells.
- 103. The method of any one of paragraphs 85 to 102, wherein each DNA is comprised by a high copy number vector, optionally a high copy number plasmid (an optionally the promoter is a constitutive promoter).
- 104. The method of any one of paragraphs 85 to 103, wherein each DNA is comprised by a vector or vehicle according to any one of
paragraphs 1 to 83. - 105. Use of an attenuated strength promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for enhancing the yield of amplified DNA produced by the production host cells.
Thus, said enhancing may be relative to the yield produced using a strong promoter, eg, a strong constitutive promoter (for example a promoter having an Anderson Score (AS) of AS ≥0.5). In another example, the strong promoter is a promoter comprised by a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of >4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator. - 106. The use of
paragraph 105, wherein the use is for enhancing said yield by- (d) reducing toxicity of the Cas in the production strain;
- (e) reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain;
- (f) promoting production cell viability during the amplification of the DNA; and/or
- (g) reducing the occurrence of Cas cutting of DNA (optionally cutting of production host cell chromosomal DNA or said DNA construct).
- 107. Use of an attenuated strength promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing toxicity of the Cas in the production strain.
- 108. Use of an attenuated strength promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain.
- 109. Use of an attenuated strength promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for promoting production cell viability during the amplification of the DNA.
- 110. Use of an attenuated strength promoter in a DNA construct comprising a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for reducing the occurrence of Cas cutting of DNA.
- 111. A method for enhancing the yield of amplified copies of a DNA construct in a population of bacterial or archaeal production strain cells, wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) that is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated strength promoter.
- 112. A method for reducing toxicity of a functional Cas protein (optionally a Cas nuclease) in a population of bacterial or archaeal production strain cells in a process of amplifying copies of a DNA construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated strength promoter.
- 113. A method for reducing mutation of a DNA construct encoding a functional Cas protein (optionally a Cas nuclease) in a population of bacterial or archaeal production strain cells in a process of amplifying copies of the construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated strength promoter.
- 114. A method for promoting production cell viability of a population of bacterial or archaeal production strain cells in a process of amplifying copies of a DNA construct comprised by the cells, wherein the construct comprises a nucleotide sequence encoding a functional Cas protein (optionally a Cas nuclease) and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated strength promoter.
- 115. A method for reducing the occurrence of Cas nuclease cutting of a DNA construct in a population of bacterial or archaeal production strain cells in a process of amplifying copies of the construct, wherein the construct comprises a nucleotide sequence encoding the Cas and the sequence is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated strength promoter.
- 116. The use of
paragraph 108 or 110, or the method of paragraph 113 or 115, wherein the mutation or cutting is mutation or cutting of host cell chromosomal DNA or the construct DNA. - 117. The use or method of any one of
paragraphs 105 to 116, wherein the promoter is a constitutive promoter. - 118. The use or method of any one of
paragraphs 105 to 117, wherein the promoter is repressible (optionally repressible by a tetracycline repressor or a lac repressor).
In an example, the promoter is a constitutive promoter and optionally the DNA is comprised by a high copy number plasmid or phagemid. - 119. The use or method of any one of
paragraphs 105 to 118, wherein the promoter is PLtetO-1, PLlacO-1 or a repressible homologue thereof.
PLlacO-1 is repressed by lac repressor (LacR). PLtetO-1 is repressed by tet repressor (TetR). - 120. The use or method of any one of
paragraphs 105 to 119, wherein the promoter is a medium strength promoter. - 121. The use or method of any one of
paragraphs 105 to 120, wherein the promoter has an Anderson Score (AS) of 0.5>AS >0.1. - 122. The use or method of any one of
paragraphs 105 to 121, wherein the nucleotide sequence encoding said Cas is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator. - 123. The use or method of paragraph 122, wherein fluorescence using the first EOU is 0.5 to 2 times the fluorescence using the second EOU.
- 124. The use or method of any one of
paragraphs 105 to 123, wherein the nuclease is Cas3 and optionally the DNA construct encodes cognate Cascade proteins. - 125. The use or method of any one of
paragraphs 105 to 123, wherein the Cas is a Cas9. - 126. The use or method of any one of
paragraphs 105 to 123, wherein the Cas is a Type IIIA csm protein or a Type IIIB cmr protein. - 127. The use or method of any one of
paragraphs 105 to 123, wherein the Cas is a Csf1. - 128. The use or method of any one of
paragraphs 105 to 123, wherein the Cas is a Cpf1. - 129. The use or method of any one of
paragraphs 105 to 123, wherein the Cas is a Cas 13 (optionally Cas13a or Cas13b). - 130. The use or method of any one of
paragraphs 105 to 123, wherein the Cas is selected from a Cas3, Cas8a, Cas5, Cas8b, Cas8c, Cas10d, Cse1, Cse2, Csy1, Csy2, Csy3, GSU0054, Cas10, Csm2, Cmr5, Cas10, Csx11, Csx10, Csf1, Cas9, Csn2, Cas4, Cpf1, C2c1, C2c3, Cas13a, Cas13b and Cas13c. - 131. The use or method of any one of
paragraphs 105 to 130, wherein the DNA construct comprises one or more nucleotide sequences for producing crRNAs or gRNAs that are operable for Cas nuclease targeting. - 132. The use or method of any one of
paragraphs 105 to 131, wherein the production strain cells comprise a helper phage genome that is inducible to produce phage coat proteins in the cells, wherein the method further comprises inducing production of the phage proteins and causing packaging of the amplified DNA into phage particles or non-self-replicative transduction particles, and further isolating the phage or transduction particles and optionally formulating the particles into a pharmaceutical composition for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject. - 133. The method of paragraph 132, wherein the particles are capable of infecting target host cells in the subject and transducing the cells with the DNA, wherein the Cas and crRNAs (or gRNAs) encoded by the DNA are expressed in the cells, the crRNAs or (gRNAs) being operable to guide the Cas to a target nucleotide sequence (optionally a chromosomal sequence) comprised by the cells, wherein the Cas cuts the target sequences in the cells, thereby killing host cells and treating or reducing the risk of the disease or condition.
- 134. The method of paragraph 133, wherein the host cells are bacterial or archaeal cells, optionally, the host cells are C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cells.
- 135. The use or method of any one of
paragraphs 105 to 134, wherein each DNA is comprised by a high copy number vector, optionally a high copy number plasmid (an optionally the promoter is a constitutive promoter). - 136. The use or method of any one of
paragraphs 105 to 135, wherein each DNA is comprised by a vector according to any one ofparagraphs 1 to 78 and 81 to 83. - There is also provided the following clauses:-
-
- 1. A nucleic acid vector for introduction into a host cell, the vector comprising a first nucleotide sequence encoding a Type I Cas3 and a second nucleotide sequence encoding one or more Cascade proteins, wherein the first and second sequences are under the control of one or more promoters comprised by the vector for expression of the proteins in the cell.
- 2. The vector of
clause 1, wherein the vector comprises an operon for expression in the cell of the Cas3 and Cascade proteins from a Cas module, the module comprising the nucleotide sequences encoding the Cas3 and Cascade proteins, and the operon comprising the Cas module under the control of a promoter for controlling the expression of both the Cas3 and Cascade proteins. - 3. The vector of
clause 2, wherein- (a) the first sequence is between the promoter and the second sequence in the operon;
- (b) the operon comprises no Cas-encoding nucleotide sequences between the promoter and the first nucleotide sequence; and/or
- (c) the operon comprises (in 5' to 3' direction) the promoter, the first sequence and the second sequence.
- 4. The vector of any preceding clause, wherein each promoter is a constitutive promoter.
- 5. The vector of any one of
clauses 1 to 3, wherein the promoter is repressible (optionally repressible by a tetracycline repressor or lac repressor). - 6. The vector of any one of
clauses 1 to 3, wherein the promoter is inducible. - 7. The vector of any preceding clause, wherein the first sequence is under the control of a medium strength promoter.
- 8. The vector of any preceding clause, wherein the first sequence is under the control of a promoter that has an Anderson Score (AS) of 0.5>AS >0.1.
- 9. The vector of any preceding clause, wherein the first sequence (and optionally the second sequence) is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator.
- 10. The vector of clause 9, wherein fluorescence using the first EOU is 0.5 to 2 times the fluorescence using the second EOU.
- 11. The vector of any preceding clause, wherein the vector comprises an origin of replication that is operable in the host cell.
- 12. The vector of any preceding clause, wherein the vector comprises an origin of replication that is operable in a bacterial cell of a vector production strain, wherein the Cas3 is not operable in the production strain cell to target and cut a chromosomal sequence thereof.
- 13. The vector of clause 12, wherein the first sequence is under the control of a promoter that is capable of controlling expression of the Cas3 at a level that is not toxic to the production strain cell.
- 14. The vector of any preceding clause, wherein the vector is a high copy number vector.
- 15. The vector of any preceding clause, wherein the first nucleotide sequence or operon is comprised by a mobile genetic element.
- 16. The vector of any preceding clause, wherein the vector is devoid of a Cas adaption module.
- 17. The vector of any preceding clause, wherein the vector is devoid of nucleotide sequence encoding one, more or all of a Cas1, Cas2, Cas4, Cas6, Cas7 and Cas 8.
- 18. The vector of any preceding clause, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas11, Cas7 and Cas8a1.
- 19. The vector of clause 18, wherein the vector comprises nucleotide sequence encoding Cas3' and/or Cas3".
- 20. The vector or clause 19, wherein the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in clause 18.
- 21. The vector of any one of clauses 18 to 20, wherein the host cell comprises a Type IA CRISPR array that is cognate with the Cas3.
- 22. The vector of any one of clauses 18 to 20, wherein the host cell comprises an endogenous Type IB, C, U, D, E or F CRISPR/Cas system.
- 23. The vector of any one of
clauses 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8b1, Cas7 and Cas5. - 24. The vector of clause 23, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in clause 23.
- 25. The vector of clause 23 or 24, wherein the host cell comprises a Type IB CRISPR array that is cognate with the Cas3.
- 26. The vector of clause 23 or 24, wherein the host cell comprises an endogenous Type IA, C, U, D, E or F CRISPR/Cas system.
- 27. The vector of any one of
clauses 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas5, Cas8c and Cas7. - 28. The vector of clause 27, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in clause 27.
- 29. The vector of clause 27 or 28, wherein the host cell comprises a Type IC CRISPR array that is cognate with the Cas3.
- 30. The vector of clause 27 or 28, wherein the host cell comprises an endogenous Type IA, B, U, D, E or F CRISPR/Cas system.
- 31. The vector of any one of
clauses 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8U2, Cas7, Cas5 and Cas6. - 32. The vector of clause 31, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in clause 31.
- 33. The vector of clause 31 or 32, wherein the host cell comprises a Type IU CRISPR array that is cognate with the Cas3.
- 34. The vector of clause 31 or 32, wherein the host cell comprises an endogenous Type IA, B, C, D, E or F CRISPR/Cas system.
- 35. The vector of any one of
clauses 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas10d, Cas7 and Cas5. - 36. The vector of clause 35, wherein the vector comprises a nucleotide sequence encoding Cas3' and/or Cas3".
- 37. The vector of clause 36, wherein the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in clause 35.
- 38. The vector of any one of clauses 35 to 37, wherein the host cell comprises a Type ID CRISPR array that is cognate with the Cas3.
- 39. The vector of any one of clauses 35 to 37, wherein the host cell comprises an endogenous Type IA, B, C, U, E or F CRISPR/Cas system.
- 40. The vector of any one of
clauses 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8e, Cas11, Cas7, Cas5 and Cas6. - 41. The vector of clause 40, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in clause 40.
- 42. The vector of clause 40 or 41, wherein the host cell comprises a Type IE CRISPR array that is cognate with the Cas3.
- 43. The vector of clause 40 or 41, wherein the host cell comprises an endogenous Type IA, B, C, D, U or F CRISPR/Cas system.
- 44. The vector of any one of
clauses 1 to 17, wherein the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8f, Cas5, Cas7 and Cas6f. - 45. The vector of clause 44, wherein the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in clause 44, wherein the vector is devoid of nucleotide sequence encoding further Cas between the promoter and the sequence encoding the Cas3.
- 46. The vector of clause 44 or 45, wherein the host cell comprises a Type IF CRISPR array that is cognate with the Cas3.
- 47. The vector of clause 44 or 45, wherein the host cell comprises an endogenous Type IA, B, C, D, U or E CRISPR/Cas system.
- 48. The vector of any one of
clauses 1 to 17, wherein the Cas and Cascade are- (a) Type IA Cas and Cascade proteins;
- (b) Type IB Cas and Cascade proteins;
- (c) Type IC Cas and Cascade proteins;
- (d) Type ID Cas and Cascade proteins;
- (e) Type IE Cas and Cascade proteins;
- (f) Type IF Cas and Cascade proteins; or
- (g) Type IU Cas and Cascade proteins.
- 49. The vector of any preceding clause, wherein the Cas and Cascade are E coli (optionally Type IE or IF) Cas and Cascade proteins.
- 50. The vector of clause 49, wherein the E coli is ESBL-producing E. coli or E. coli ST131-O25b:H4.
- 51. The vector of any preceding clause, wherein the Cas and Cascade are
- (a) Clostridium (eg, C dificile) Cas and Cascade proteins, optionally C dificile resistant to one or more antibiotics selected from aminoglycosides, lincomycin, tetracyclines, erythromycin, clindamycin, penicillins, cephalosporins and fluoroquinolones;
- (b) Pseudomonas aeruginosa Cas and Cascade proteins, optionally P aeruginosa resistant to one or more antibiotics selected from carbapenems, aminoglycosides, cefepime, ceftazidime, fluoroquinolones, piperacillin and tazobactam; or
- (c) Klebsiella pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae) Cas and Cascade proteins.
- 52. The vector of any preceding clause, wherein the Cas and Cascade are E coli, C difficile, P aeruginosa, K pneumoniae, P furiosus or B halodurans Cas and Cascade proteins.
- 53. The vector of any preceding clause, wherein the Cas3 is a Cas3 of a CRISPR/Cas locus of a first bacterial or archaeal species, wherein the distance between the Cas3-encoding sequence of the locus and its cognate promoter is further than the distance between the Cas3-encoding sequence and the respective promoter comprised by the vector.
- 54. The vector of any preceding clause, wherein the distance between the promoter and the Cas3-encoding sequence and/or Cascade protein-encoding sequence(s) is shorter than in a corresponding wild-type Type I locus.
- 55. The vector of any preceding clause, wherein the vector comprises (i) a CRISPR array for producing crRNAs in the host cell and/or (ii) one or more nucleotide sequences encoding one or more guide RNAs (gRNAs or single gRNAs), wherein the crRNAs or gRNAs are cognate to the Cas3 (and optionally cognate to the Cascade proteins).
- 56. The vector of clause 55 when dependent from
clause 2, wherein the array or gRNA-encoding sequence(s) are comprised by the operon and under the control of the promoter. - 57. The vector of clause 56, wherein the array or gRNA-encoding sequence(s) are under the control of a promoter that is different from the promoter that controls the expression of the Cas3.
- 58. The vector of clause 56 or 57, wherein one or more of the crRNAs or gRNAs comprises a spacer sequence that is capable of hybridising to a target nucleotide sequence of the host cell, wherein the target sequence is adjacent a PAM, the PAM being cognate to the Cas3.
- 59. The vector of clause 58, wherein the target sequence is a chromosomal sequence of the host cell.
- 60. The vector of clause 58 or 59, wherein the Cas3 is operable to cut the target sequence.
- 61. The vector of any preceding clause, wherein the vector is a plasmid or phagemid.
- 62. A delivery vehicle comprising the vector of any preceding clause, wherein the delivery vehicle is capable of delivering the vector into the host cell.
- 63. The vehicle of clause 62, wherein the delivery vehicle is a phage, non-replicative transduction particle, nanoparticle carrier, bacterium or liposome.
- 64. The vector or vehicle of any preceding clause, wherein the host cell is a bacterial or archaeal cell, optionally, the host cell is a C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cell.
- 65. The vector or vehicle of any preceding clause for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject.
- 66. The vector or vehicle of clause 65, wherein the disease or condition is an infection of the subject with host cells (eg, bacterial cells), or wherein the disease or condition is mediated by host cells (eg, bacterial cells).
- 67. A pharmaceutical composition comprising the vector or vehicle of any preceding clause and a pharmaceutically acceptable diluent, excipient or carrier.
- It will be understood that particular embodiments described herein are shown by way of illustration and not as limitations of the invention. The principal features of this invention can be employed in various embodiments without departing from the scope of the invention. Those skilled in the art will recognize, or be able to ascertain using no more than routine study, numerous equivalents to the specific procedures described herein. Such equivalents are considered to be within the scope of this invention and are covered by the claims. All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications and all US equivalent patent applications and patents are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. Reference is made to
WO2017/118598 ,US20180140698 ,US20170246221 ,US20180273940 ,US20160115488 ,US20180179547 ,US20170175142 ,US20160024510 ,US20150064138 ,US20170022499 ,US20160345578 ,US20180155729 ,US20180200342 ,WO2017112620 ,WO2018081502 ,PCT/EP2018/066954 PCT/EP2018/066980 PCT/EP2018/071454 USSN 15/985,658 and equivalent publications by the US Patent and Trademark Office (USPTO) or WIPO, the disclosures of which are incorporated herein by reference for providing disclosure that may be used in the present invention and/or to provide one or more features (eg, of a vector) that may be included in one or more claims herein. - The use of the word "a" or "an" when used in conjunction with the term "comprising" in the claims and/or the specification may mean "one," but it is also consistent with the meaning of "one or more," "at least one," and "one or more than one." The use of the term "or" in the claims is used to mean "and/or" unless explicitly indicated to refer to alternatives only or the alternatives are mutually exclusive, although the disclosure supports a definition that refers to only alternatives and "and/or." Throughout this application, the term "about" is used to indicate that a value includes the inherent variation of error for the device, the method being employed to determine the value, or the variation that exists among the study subjects.
- As used in this specification and claim(s), the words "comprising" (and any form of comprising, such as "comprise" and "comprises"), "having" (and any form of having, such as "have" and "has"), "including" (and any form of including, such as "includes" and "include") or "containing" (and any form of containing, such as "contains" and "contain") are inclusive or openended and do not exclude additional, unrecited elements or method steps
- The term "or combinations thereof' or similar as used herein refers to all permutations and combinations of the listed items preceding the term. For example, "A, B, C, or combinations thereof is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing with this example, expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, MB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.
- Any part of this disclosure may be read in combination with any other part of the disclosure, unless otherwise apparent from the context.
- All of the compositions and/or methods disclosed and claimed herein can be made and executed without undue experimentation in light of the present disclosure. While the compositions and methods of this invention have been described in terms of preferred embodiments, it will be apparent to those of skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit and scope of the invention. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope and concept of the invention as defined by the appended claims.
- The present invention is described in more detail in the following non-limiting Examples.
- The examples illustrate fast and precision killing of Escherichia coli strains. As a model programmable nuclease system, we used a CRISPR guided vector (CGV™) to specifically target Escherichia coli MG1655.
- A plasmid (which we call a CRISPR Guided Vector™, CGV™) was constructed comprising an operon with nucleotide sequences encoding a Type I Cas3 and Cascade proteins under the control of a common promoter. C. dificile Type IB Cas3 and Cascade was used. A cognate CRISPR array comprising C. dificile repeat sequences and spacer sequence for targeting an E. coli host cell chromosome was also introduced into target cells. An adaptation module containing Cas1, Cas2 and Cas4 was omitted in the vector (see
Fig. 1A ). In the wild-type C. dificile Type IB CRISPR/Cas locus, the cas3 gene is 3' of the Cascade genes (cas8b1, cas7 and cas5) and thus spaced away from the promoter upstream of the Cascade genes. When we tried this arrangement, we found killing of E. coli cells, but surprisingly when we changed to a synthetic operon arrangement (in 5' to 3' orientation) of promoter, cas3, cas8b1, cas7 and cas5 we saw significantly higher killing of the target E. coli cells. - Results using this synthetic operon arrangement are shown in
Figure 1 . InFig 1B there is shown a dilution series (101-106) of drop spots (5 µl) of target E. coli MG1655 cells harboring the CGV on LB agar plates with and without inducers. CRISPR/Cas induction surprisingly killed 99.9% of the population (Fig 1C , grey bar). Growth in absence of induction is shown in black. CGV™ refers to a CRISPR Guided Vector™, which is a nucleic acid vector comprising nucleotide sequences encoding CRISPR/Cas components. - We also managed to achieve desirable targeted killing of E coli cells using a similar set-up, except that E coli Type IE Cas and Cascade were used, together with a cognate array targeting host cell E coli chromosomal DNA (data not shown). In this case, a vector was used comprising (in 5' to 3' direction) a promoter controlling the expression of Cas3, Cas8e, Cas11, Cas7, Cas5 and Cas6 in an operon.
- E. coli MG1655 was grown in lysogeny broth (LB) with shaking (250 rpm) at 37 °C. When necessary, cultures were supplemented with tetracycline (10 µg/mL), and spectinomycin (400 µg/mL) .
- To construct a plasmid containing C. difficile CRISPR system under arabinose inducible pBAD promoter, cas3, cas6, cas8b, cas7 and cas5 genes from C. difficile were amplified and cloned in a low copy number plasmid (pSC101 ori). cas3 was located in the beginning of the operon followed by cas6, cas8b, cas7 and cas5. The adaptation module (consisting of cas1, cas2, and cas4) was omitted in the vector (
Fig. 1A ). A second plasmid containing an IPTG inducible single-spacer array targeting a chromosomal intergenic region in E. coli MG1655 was constructed (Fig. 1A ). The spacer was cloned under control of the IPTG-inducible Ptrc promoter, in a CloDF13 ori backbone. It contains 37 nucleotides from the genome of E. coli MG1655 (ctttgccgcgcgcttcgtcacgtaattctcgtcgcaa) (SEQ ID NO: 26). Additionally, the 3'-CCT protospacer adjacent motif (PAM) is located adjacent to the selected target sequence in the genome of E. coli MG1655 (Fig. 1A ). - To perform killing assays, both plasmids were transformed into E. coli MG1655 by electroporation. Transformants were grown in liquid LB with antibiotics to mid-log phase, and the killing efficiency was determined by serial dilution and spot plating onto LB, and LB + inducers (0.5 mM IPTG and 1 % arabinose). Viability was calculated by counting colony forming units (CFUs) on the plates and data were calculated as viable cell concentration (CFU/ml).
- A plasmid (which we call a CRISPR Guided Vector™, CGV™) was constructed comprising an operon with nucleotide sequences encoding a Type I Cas3 and Cascade proteins under the control of a common promoter. C. dificile Type IB Cas3 and Cascade was used. An adaptation module containing Cas1, Cas2 and Cas4 was omitted in the vector. A cognate CRISPR array comprising C. dificile repeat sequences and spacer sequence for targeting an E. coli host cell chromosome was also included in the vector (see
Figure 2A ). - The CGV was transformed into E. coli MG1655. Results using this synthetic operon arrangement are shown in
Figure 2 . InFig 2B there is shown a dilution series (101-105) of drop spots (5 µl) of target E. coli MG1655 cells harboring the CGV on synthetic medium (SM) agar plates with and without inducers. CRISPR/Cas induction resulted in more than 2-log10 reductions in viable cells of E. coli MG1655 (Fig 2C , grey bar). Growth in absence of induction is shown in black. - The survival of E. coli MG1655 upon induction was followed over time by plating the cultures in serial dilutions every 60 minutes, for 2 hours (
Figure 3 ). Killing curves revealed that CRISPR/Cas induction mediated rapid killing of E. coli MG1655, generating a two-log10 reduction in E. coli by the first 60 minutes.Fig 3B shows a dilution series (101-106) of drop spots (5 µl) of induced and non-induced cultures of target E. coli MG1655 on LB agar plates. - E. coli MG1655 was grown in synthetic medium (SM) with shaking (250 rpm) at 37 °C. Cultures were supplemented with 10 µg/mL tetracycline when required.
- To construct a plasmid containing C. difficile CRISPR system under arabinose inducible pBAD promoter, cas3, cas6, cas8b, cas7 and cas5 genes from C. difficile were amplified and cloned in a low copy number plasmid (pSC101 ori). cas3 was located in the beginning of the operon followed by cas6, cas8b, cas7 and cas5. Additionally, an IPTG inducible single-spacer array targeting a chromosomal intergenic region in E. coli MG1655 was included in the vector under control of the IPTG-inducible Ptrc promoter (
Fig 2A ). It contains 37 nucleotides from the PKS gene (previously integrated into the genome of E. coli MG1655) (gtttggcgatggcgcgggtgtggttgtgcttcggcgt) (SEQ ID NO: 27). Additionally, the 3'-CCT protospacer adjacent motif (PAM) is located adjacent to the selected target sequence in the genome of E. coli MG1655. - The CGV was transformed into E. coli MG1655 by electroporation. Transformants were grown in liquid SM with antibiotics to mid-log phase, and the killing efficiency was determined by serial dilution and spot plating onto LB, and LB + inducers (0.5 mM IPTG and 1 % arabinose). Viability was calculated by counting colony forming units (CFUs) on the plates and data were calculated as viable cell concentration (CFU/ml).
- To perform killing curves, E. coli MG1655 harboring the CGV was grown in liquid SM with antibiotics to mid-log phase. The culture was divided into two tubes and either inducers (0.5 mM IPTG and 1 % arabinose) or PBS were added. Survival of the strain was followed over time by plating the cultures in serial dilutions (101-106) of drop spots (5 µl) every 60 minutes, for 2 h, on SM plates with antibiotics. Survival frequency was calculated by counting colony forming units (CFUs) on the plates and data were calculated as viable cell concentration (CFU/ml).
- An artificial microbial consortium was constructed to study the efficiency of the CGV carrying the CRISPR-Cas system of C. difficile, to specifically target E. coli MG1655 in the presence of other microbes, mimicking the human microbiome.
- The synthetic consortium consisted of three strains (two different species) with differential antibiotic resistance profiles: a streptomycin-resistant E. coli MG1655 (target strain), an ampicillin-resistant E. coli Top10, and a chloramphenicol-resistant Lactococcus lactis NZ9000. To create the consortium, bacterial cultures were grown separately in Brain Heart Infusion broth (BHI, optimal growth medium for L. lactis) to mid-log phase and mixed in fresh BHI broth with and without inducers. After 1 h induction at 30 °C, the composition of the consortium was determined by counting viable colonies on selective plates. Induction of the CRISPR system in the mixed community, resulted in > 10-fold killing of target E. coli MG1655, while leaving E. coli Top10 and L. lactis NZ9000 cell populations unharmed (
Figure 4A ). InFig 4B there is shown a dilution series (101-105) of drop spots (5 µl) of the synthetic consortium after 1 h induction on BHI agar plates. - Additionally, CRISPR killing of target strain E. coli MG1655 in the synthetic microbial consortium was compared to a pure culture (ie, target strain E. coli MG1655 that is not mixed with another strain or species). Unexpectedly, in both conditions, killing of 4 logs was achieved when plated on BHI agar plates with inducers (
Figure 5A ). Thus, surprisingly the killing in the microbiome setting was as efficient as the killing in pure culture. InFig 5B there is shown a dilution series (101-105) of drop spots (5 µl) of the synthetic consortium and E. coli MG1655 in pure culture on BHI agar plates with and without inducers. - E. coli MG1655, E. coli Top10, and Lactococcus lactis NZ9000 were grown in BHI broth with shaking (250 rpm) at 30 °C. Cultures were supplemented with 1000 µg/mL streptomycin, 100 µg/mL ampicillin, or 10 µg/mL chloramphenicol, respectively.
- To create the consortium, bacterial cultures were grown in BHI with appropriate antibiotics to mid-log phase. Cultures were washed twice in PBS to remove the antibiotics and mixed in fresh BHI broth. The mixed culture was spotted onto BHI plates with streptomycin, ampicillin or chloramphenicol to quantify the initial concentration of E. coli MG1655, E. coli Top10 and L. lactis NZ9000, respectively. The mixed culture was divided into two tubes and either inducers (0.5 mM IPTG and 1 % arabinose) or PBS were added. After 1 h induction at 30 °C, the composition of the consortium was calculated by counting colony forming units (CFUs) on selective plates and data were calculated as viable cell concentration (CFU/ml).
- We engineered an E coli Top 10 production strain cell population comprising plasmid CGV DNA and an expressible sequence encoding a Tet repressor (TetR). The DNA comprised a Cas9-encoding nucleotide sequence under the control of a Tet promoter (pLtetO-1 promoter). The promoter is normally constitutively ON, but it was repressed by TetR in our cells. Thus, in this way we could successfully culture the cells and amplify the CGV without observing adverse toxicity due to Cas9 expression.
- In an experiment in the absence of repression, we did not observe any colonies of production strain bacteria, and we surmise that this was due to Cas9 toxicity. We believe, in addition to providing a way of increasing CGV yield (eg, for subsequent packaging into phage or non-self-replicative transduction particles), our method using repression can minimize selection for mutations in the DNA that would otherwise be forced by higher Cas9 expression and cutting (eg, due to CGV cutting).
- Mutalik et al, Nat Methods. 2013 Apr; 10(4):354-60. doi: 10.1038/nmeth. 2404. Epub 2013 Mar 10, "Precise and reliable gene expression via standard transcription and translation initiation elements".
TABLE 1: Example Bacteria Optionally, the target host cells are cells of a genus or species selected from this Table and/or the production strain cells are cells of a genus or species selected from this Table Abiotrophia Acidocella Actinomyces Alkalilimnicola Aquaspirillum Abiotrophia defectiva Acidocella aminolytica Actinomyces bovis Alkalilimnicola ehrlichii Aquaspirillum polymorphum Acaricomes Acidocella facilis Actinomyces denticolens Alkaliphilus Aquaspirillum Acaricomes phytoseiuli Acidomonas Actinomyces europaeus Alkaliphilus oremlandii putridiconchylium Acetitomaculum Acidomonas methanolica Actinomyces georgiae Alkaliphilus transvaalensis Aquaspirillum serpens Acetitomaculum ruminis Acidothermus Actinomyces gerencseriae Allochromatium Aquimarina Acetivibrio Acidothermus cellulolyticus Actinomyces Allochromatium vinosum Aquimarina latercula Acetivibrio cellulolyticus Acidovorax hordeovulneris Alloiococcus Arcanobacterium Acetivibrio ethanolgignens Acidovorax anthurii Actinomyces howellii Alloiococcus otitis Arcanobacterium Acetivibrio multivorans Acidovorax caeni Actinomyces hyovaginalis Allokutzneria haemolyticum Acetoanaerobium Acidovorax cattleyae Actinomyces israelii Allokutzneria albata Arcanobacterium pyogenes Acetoanaerobium noterae Acidovorax citrulli Actinomyces johnsonii Altererythrobacter Archangium Acetobacter Acidovorax defluvii Actinomyces meyeri Altererythrobacter Archangium gephyra Acetobacter aceti Acidovorax delafieldii Actinomyces naeslundii ishigakiensis Arcobacter Acetobacter cerevisiae Acidovorax facilis Actinomyces neuii Altermonas Arcobacter butzleri Acetobacter cibinongensis Acidovorax konjaci Actinomyces odontolyticus Altermonas haloplanktis Arcobacter cryaerophilus Acetobacter estunensis Acidovorax temperans Actinomyces oris Altermonas macleodii Arcobacter halophilus Acetobacter fabarum Acidovorax valerianellae Actinomyces radingae Alysiella Arcobacter nitrofigilis Acetobacter ghanensis Acinetobacter Actinomyces slackii Alysiella crassa Arcobacter skirrowii Acetobacter indonesiensis Acinetobacter baumannii Alysiella filiformis Acetobacter lovaniensis Acinetobacter baylyi Actinomyces turicensis Aminobacter Arhodomonas Acetobacter malorum Acinetobacter bouvetii Actinomyces viscosus Aminobacter aganoensis Arhodomonas aquaeolei Acetobacter nitrogenifigens Acinetobacter calcoaceticus Actinoplanes Aminobacter aminovorans Arsenophonus Acetobacter oeni Acinetobacter gerneri Actinoplanes auranticolor Aminobacter niigataensis Arsenophonus nasoniae Acetobacter orientalis Acinetobacter haemolyticus Actinoplanes brasiliensis Aminobacterium Acetobacter orleanensis Acinetobacter johnsonii Actinoplanes consettensis Aminobacterium mobile Arthrobacter Acetobacter pasteurianus Acinetobacter junii Actinoplanes deccanensis Aminomonas Arthrobacter agilis Acetobacter pornorurn Acinetobacter lwoffi Actinoplanes derwentensis Aminomonas paucivorans Arthrobacter albus Acetobacter senegalensis Acinetobacter parvus Actinoplanes digitatis Ammoniphilus Arthrobacter aurescens Acetobacter xylinus Acinetobacter radioresistens Actinoplanes durhamensis Ammoniphilus oxalaticus Arthrobacter Acetobacterium Acinetobacter schindleri Actinoplanes ferrugineus Ammoniphilus oxalivorans chlorophenolicus Acetobacterium bakii Acinetobacter soli Actinoplanes globisporus Amphibacillus Arthrobacter citreus Acetobacterium carbinolicum Acinetobacter tandoii Actinoplanes humidus Amphibacillus xylanus Arthrobacter crystallopoietes Acetobacterium dehalogenans Acinetobacter tjernbergiae Actinoplanes italicus Amphritea Arthrobacter cumminsii Acetobacterium fimetarium Acinetobacter towneri Actinoplanes liguriensis Amphritea balenae Arthrobacter globiformis Acetobacterium malicum Acinetobacter ursingii Actinoplanes lobatus Amphritea japonica Arthrobacter Acetobacterium paludosum Acinetobacter venetianus Actinoplanes missouriensis Amycolatopsis histidinolovorans Acetobacterium tundrae Acrocarpospora Actinoplanes palleronii Amycolatopsis alba Arthrobacter ilicis Acetobacterium wieringae Acrocarpospora corrugata Actinoplanes philippinensis Amycolatopsis albidoflavus Arthrobacter luteus Acetobacterium woodii Acrocarpospora Actinoplanes rectilineatus Amycolatopsis azurea Arthrobacter methylotrophus Acetofilamentum macrocephala Actinoplanes regularis Amycolatopsis coloradensis Arthrobacter mysorens Acetofilamentum rigidum Acrocarpospora Actinoplanes Amycolatopsis lurida Arthrobacter nicotianae pleiomorpha Amycolatopsis mediterranei Arthrobacter nicotinovorans Acetohalobium Actibacter teichomyceticus Amycolatopsis rifamycinica Arthrobacter oxydans Acetohalobium arabaticum Actibacter sediminis Actinoplanes utahensis Amycolatopsis rubida Arthrobacter pascens Acetomicrobium Actinoalloteichus Actinopolyspora Amycolatopsis sulphurea Arthrobacter Acetomicrobiumfaecale Actinoalloteichus Actinopolyspora halophila Amycolatopsis tolypomycina phenanthrenivorans Acetomicrobium flavidum cyanogriseus Actinopolyspora Anabaena Arthrobacter Acetonema Actinoalloteichus mortivallis Anabaena cylindrica polychromogenes Acetonema longum hymeniacidonis Actinosynnema Anabaena flos-aquae Atrhrobacter protophormiae Acetothermus Actinoalloteichus spitiensis Actinosynnema mirum Anabaena variabilis Arthrobacter Acetothermus paucivorans Actinobaccillus Actinotalea Anaeroarcus psychrolactophilus Acholeplasma Actinobacillus capsulatus Actinotalea fermentans Anaeroarcus burkinensis Arthrobacter ramosus Acholeplasma axanthum Actinobacillus delphinicola Aerococcus Anaerobaculum Arthrobacter sulfonivorans Acholeplasma brassicae Actinobacillus hominis Aerococcus sanguinicola Anaerobaculum mobile Arthrobacter sulfureus Acholeplasma cavigenitalium Actinobacillus indolicus Aerococcus urinae Anaerobiospirillum Arthrobacter uratoxydans Acholeplasma equifetale Actinobacillus lignieresii Aerococcus urinaeequi Anaerobiospirillum Arthrobacter ureafaciens Acholeplasma granularum Actinobacillus minor Aerococcus urinaehominis succiniciproducens Arthrobacter viscosus Acholeplasma hippikon Actinobacillus muris Aerococcus viridans Anaerobiospirillum thomasii Arthrobacter woluwensis Acholeplasma laidlawii Actinobacillus Aeromicrobium Anaerococcus Asaia Acholeplasma modicum pleuropneumoniae Aeromicrobium erythreum Anaerococcus hydrogenalis Asaia bogorensis Acholeplasma morum Actinobacillus porcinus Aeromonas Anaerococcus lactolyticus Asanoa Acholeplasma multilocale Actinobacillus rossii Aeromonas Anaerococcus prevotii Asanoa ferruginea Acholeplasma oculi Actinobacillus scotiae allosaccharophila Anaerococcus tetradius Asticcacaulis Acholeplasma palmae Actinobacillus seminis Aeromonas bestiarum Anaerococcus vaginalis Asticcacaulis biprosthecium Acholeplasma parvum Actinobacillus succinogenes Aeromonas caviae Asticcacaulis excentricus Acholeplasma pleciae Actinobaccillus suis Aeromonas encheleia Anaerofustis Atopobacter Acholeplasma vituli Actinobacillus ureae Aeromonas Anaerofustis stercorihominis Atopobacter phocae Achromobacter Actinobaculum enteropelogenes Anaeromusa Atopobium Achromobacter denitrificans Actinobaculum massiliense Aeromonas eucrenophila Anaeromusa acidaminophila Atopobium fossor Achromobacter insolitus Actinobaculum schaalii Aeromonas ichthiosmia Anaeromyxobacter Atopobium minutum Achromobacter piechaudii Actinobaculum suis Aeromonas jandaei Anaeromyxobacter Atopobium parvulum Achromobacter ruhlandii Actinomyces urinale Aeromonas media dehalogenans Atopobium rimae Achromobacter spanius Actinocatenispora Aeromonas popoffii Anaerorhabdus Atopobium vaginae Acidaminobacter Actinocatenispora rupis Aeromonas sobria Anaerorhabdus furcosa Aureobacterium Acidaminobacter Actinocatenispora Aeromonas veronii Anaerosinus Aureobacterium barkeri hydrogenoformans thailandica Agrobacterium Anaerosinus glycerini Aurobacterium Acidaminococcus Actinocatenispora sera Agrobacterium Anaerovirgula Aurobacterium liquefaciens Acidaminococcus fermentans Actinocorallia gelatinovorum Anaerovirgula multivorans A vibacterium Acidaminococcus intestini Actinocorallia aurantiaca Agrococcus Ancalomicrobium Avibacterium avium Acidicaldus Actinocorallia aurea Agrococcus citreus Ancalomicrobium adetum Avibacterium gallinarum Acidicaldus organivorans Actinocorallia cavernae Agrococcus jenensis Ancylobacter Avibacterium paragallinarum Acidimicrobium Actinocorallia glomerata Agromonas Ancylobacter aquaticus Avibacterium volantium Acidimicrobium ferrooxidans Actinocorallia herbida Agromonas oligotrophica Aneurinibacillus Azoarcus Acidiphilium Actinocorallia libanotica Agromyces Aneurinibacillus Azoarcus indigens Acidiphilium acidophilum Actinocorallia longicatena Agromyces fucosus aneurinilyticus Azoarcus tolulyticus Acidiphilium angustum Actinomadura Agromyces hippuratus Aneurinibacillus migulanus Azoarcus toluvorans Acidiphilium cryptum Actinomadura alba Agromyces luteolus Aneurinibacillus Acidiphilium multivorum Actinomadura atramentaria Agromyces mediolanus thermoaerophilus Acidiphilium organovorum Actinomadura Agromyces ramosus Angiococcus Azohydromonas Acidiphilium rubrum bangladeshensis Agromyces rhizospherae Angiococcus disciformis Azohydromonas australica Acidisoma Actinomadura catellatispora Akkermansia Angulomicrobium Azohydromonas lata Acidisoma sibiricum Actinomadura chibensis Akkermansia muciniphila Angulomicrobium tetraedrale Azomonas Acidisoma tundrae Actinomadura chokoriensis Albidiferax Anoxybacillus Azomonas agilis Acidisphaera Actinomadura citrea Albidiferax ferrireducens Anoxybacillus pushchinoensis Azomonas insignis Acidisphaera rubrifaciens Actinomadura coerulea Albidovulum Aquabacterium Azomonas macrocytogenes Acidithiobacillus Actinomadura echinospora Albidovulum inexpectatum Aquabacterium commune Azorhizobium Acidithiobacillus albertensis Actinomadura fibrosa Alcaligenes Aquabacterium parvum Azorhizobium caulinodans Acidithiobacillus caldus Actinomadura formosensis Alcaligenes denitrificans Azorhizophilus Acidithiobacillus ferrooxidans Actinomadura hibisca Alcaligenes faecalis Azorhizophilus paspali Acidithiobacillus thiooxidans Actinomadura kijaniata Alcanivorax Azospirillum Acidobacterium Actinomadura latina Alcanivorax borkumensis Azospirillum brasilense Acidobacterium capsulatum Actinomadura livida Alcanivorax jadensis Azospirillum halopraeferens Actinomadura Algicola Azospirillum irakense luteofluorescens Algicola bacteriolytica Azotobacter Actinomadura macra Alicyclobacillus Azotobacter beijerinckii Actinomadura madurae Alicyclobacillus Azotobacter chroococcum Actinomadura oligospora disulfidooxidans Azotobacter nigricans Actinomadura pelletieri Alicyclobacillus Azotobacter salinestris Actinomadura rubrobrunea sendaiensis Azotobacter vinelandii Actinomadura rugatobispora Alicyclobacillus vulcanalis Actinomadura umbrina Actinomadura Alishewanella verrucosospora Alishewanella fetalis Actinomadura vinacea Alkalibacillus Actinomadura viridilutea Alkalibacillus Actinomadura viridis haloalkaliphilus Actinomadura yumaensis Bacillus Bacteroides Bibersteinia Borrelia Brevinema [see below] Bacteroides caccae Bibersteinia trehalosi Borrelia afzelii Brevinema andersonii Bacteroides coagulans Bifidobacterium Borrelia americana Brevundimonas Bacteriovorax Bacteroides eggerthii Bifidobacterium adolescentis Borrelia burgdorferi Brevundimonas alba Bacteriovorax stolpii Bacteroides fragilis Bifidobacterium angulatum Borrelia carolinensis Brevundimonas aurantiaca Bacteroides galacturonicus Bifidobacterium animalis Borrelia coriaceae Brevundimonas diminuta Bacteroides helcogenes Bifidobacterium asteroides Borrelia garinii Brevundimonas intermedia Bacteroides ovatus Bifidobacterium bifidum Borrelia japonica Brevundimonas subvibrioides Bacteroides pectinophilus Bifidobacterium boum Bosea Brevundimonas vancanneytii Bacteroides pyogenes Bifidobacterium breve Bosea minatitlanensis Brevundimonas variabilis Bacteroides salyersiae Bifidobacterium catenulatum Bosea thiooxidans Brevundimonas vesicularis Bacteroides stercoris Bifidobacterium choerinum Brachybacterium Brochothrix Bacteroides suis Bifidobacterium coryneforme Brachybacterium Brochothrix campestris Bacteroides tectus Bifidobacterium cuniculi alimentarium Brochothrix thermosphacta Bacteroides thetaiotaomicron Bifidobacterium dentium Brachybacterium faecium Bacteroides uniformis Bifidobacterium gallicum Brachybacterium Brucella Bacteroides ureolyticus Bifidobacterium gallinarum paraconglomeratum Brucella canis Bacteroides vulgatus Bifidobacterium indicum Brachybacterium rhamnosum Brucella neotomae Balnearium Bifidobacterium longum Brachybacterium Bryobacter Balnearium lithotrophicum Bifidobacterium tyrofermentans Bryobacter aggregatus Balneatrix magnumBifidobacterium Brachyspira Burkholderia Balneatrix alpica merycicum Brachyspira alvinipulli Burkholderia ambifaria Balneola Bifidobacterium minimum Brachyspira hyodysenteriae Burkholderia andropogonis Balneola vulgaris Bifidobacterium Brachyspira innocens Burkholderia anthina Barnesiella pseudocatenulatum Brachyspira murdochii Burkholderia caledonica Barnesiella viscericola Bifidobacterium Brachyspir pilosicoli Burkholderia caryophylli Bartonella pseudolongum Burkholderia cenocepacia Bartonella alsatica Bifidobacterium pullorum Bradyrhizobium Burkholderia cepacia Bartonella bacilliformis Bifidobacterium ruminantium Bradyrhizobium canariense Burkholderia cocovenenans Bartonella clarridgeiae Bifidobacterium saeculare Bradyrhizobium elkanii Burkholderia dolosa Bartonella doshiae Bifidobacterium subtile Bradyrhizobium japonicum Burkholderia fungorum Bartonella elizabethae Bifidobacterium Bradyrhizobium liaoningense Burkholderia glathei Bartonella grahamii thermophilum Brenneria Burkholderia glumae Bartonella henselae Bilophila Brenneria alni Burkholderia graminis Bartonella rochalimae Bilophila wadsworthia Brenneria nigrifluens Burkholderia kururiensis Bartonella vinsonii Biostraticola Brenneria quercina Burkholderia multivorans Bavariicoccus Biostraticola tofi Brenneria quercina Burkholderia phenazinium Bavariicoccus seileri Brenneria salicis Burkholderia plantarii Bdellovibrio Bizionia Brevibacillus Burkholderia pyrrocinia Bdellovibrio bacteriovorus Bizionia argentinensis Brevibacillus agri Burkholderia silvatlantica Bdellovibrio exovorus Blastobacter Brevibacillus borstelensis Burkholderia stabilis Beggiatoa Blastobacter capsulatus Brevibacillus brevis Burkholderia thailandensis Beggiatoa alba Blastobacter denitrificans Brevibacillus centrosporus Burkholderia tropica Beijerinckia Blastococcus Brevibacillus choshinensis Burkholderia unamae Beijerinckia derxii Blastococcus aggregatus Brevibacillus invocatus Burkholderia vietnamiensis Beijerinckia fluminensis Blastococcus saxobsidens Brevibacillus laterosporus Buttiauxella Beijerinckia indica Blastochloris Brevibacillus parabrevis Buttiauxella agrestis Beijerinckia mobilis Blastochloris viridis Brevibacillus reuszeri Buttiauxella brennerae Belliella Blastomonas Brevibacterium Buttiauxellaferragutiae Belliella baltica Blastomonas natatoria Brevibacterium abidum Buttiauxella gaviniae Bellilinea Blastopirellula Brevibacterium album Buttiauxella izardii Bellilinea caldifistulae Blastopirellula marina Brevibacterium aurantiacum Buttiauxella noackiae Belnapia Blautia Brevibacterium celere Buttiauxella warmboldiae Belnapia moabensis Blautia coccoides Brevibacterium epidermidis Butyrivibrio Bergeriella Blautia hansenii Brevibacterium Butyrivibrio fibrisolvens Bergeriella denitrificans Blautia producta frigoritolerans Butyrivibrio hungatei Beutenbergia Blautia wexlerae Brevibacterium halotolerans Butyrivibrio proteoclasticus Beutenbergia cavernae Bogoriella Brevibacterium iodinum Bogoriella caseilytica Brevibacterium linens Bordetella Brevibacterium lyticum Bordetella avium Brevibacterium mcbrellneri Bordetella bronchiseptica Brevibacterium otitidis Bordetella hinzii Brevibacterium oxydans Bordetella holmesii Brevibacterium paucivorans Bordetella parapertussis Brevibacterium stationis Bordetella pertussis Bordetella petrii Bordetella trematum Bacillus B. acidiceler B. aminovorans B. glucanolyticus B. taeanensis B. lautus B. acidicola B. amylolyticus B. gordonae B. tequilensis B. lehensis B. acidiproducens B. andreesenii B. gottheilii B. thermantarcticus B. lentimorbus B. acidocaldarius B. aneurinilyticus B. graminis B. thermoaerophilus B. lentus B. acidoterrestris B. anthracis B. halmapalus B. thermoamylovorans B. licheniformis B. aeolius B. aquimaris B. haloalkaliphilus B. thermocatenulatus B. ligniniphilus B. aerius B. arenosi B. halochares B. thermocloacae B. litoralis B. aerophilus B. arseniciselenatis B. halodenitrificans B. thermocopriae B. locisalis B. agaradhaerens B. arsenicus B. halodurans B. thermodenitrificans B. luciferensis B. agri B. aurantiacus B. halophilus B. thermoglucosidasius B. luteolus B. aidingensis B. arvi B. halosaccharovorans B. thermolactis B. luteus B. akibai B. aryabhattai B. hemicellulosilyticus B. thermoleovorans B. macauensis B. alcalophilus B. asahii B. hemicentroti B. thermophilus B. macerans B. algicola B. atrophaeus B. herbersteinensis B. thermoruber B. macquariensis B. alginolyticus B. axarquiensis B. horikoshii B. thermosphaericus B. macyae B. alkalidiazotrophicus B. azotofixans B. horneckiae B. thiaminolyticus B. malacitensis B. alkalinitrilicus B. azotoformans B. horti B. thioparans B. mannanilyticus B. alkalisediminis B. badius B. huizhouensis B. thuringiensis B. marisflavi B. alkalitelluris B. barbaricus B. humi B. tianshenii B. marismortui B. altitudinis B. bataviensis B. hwajinpoensis B. trypoxylicola B. marmarensis B. alveayuensis B. beijingensis B. idriensis B. tusciae B. massiliensis B. alvei B. benzoevorans B. indicus B. validus B. megaterium B. amyloliquefaciens B. beringensis B. infantis B. vallismortis B. mesonae • B. B. berkeleyi B. infernus B. vedderi B. methanolicus a. subsp. amyloliquefaciens B. beveridgei B. insolitus B. velezensis B. methylotrophicus • B. a. subsp. plantarum B. bogoriensis B. invictae B. vietnamensis B. migulanus B. boroniphilus B. iranensis B. vireti B. mojavensis B. dipsosauri B. borstelensis B. isabeliae B. vulcani B. mucilaginosus B. drentensis B. brevis Migula B. isronensis B. wakoensis B. muralis B. edaphicus B. butanolivorans B. jeotgali B. weihenstephanensis B. murimartini B. ehimensis B. canaveralius B. kaustophilus B. xiamenensis B. mycoides B. eiseniae B. carboniphilus B. kobensis B. xiaoxiensis B. naganoensis B. enclensis B. cecembensis B. kochii B. zhanjiangensis B. nanhaiensis B. endophyticus B. cellulosilyticus B. kokeshiiformis B. peoriae B. nanhaiisediminis B. endoradicis B. centrosporus B. koreensis B. persepolensis B. nealsonii B. farraginis B. cereus B. korlensis B. persicus B. neidei B. fastidiosus B. chagannorensis B. kribbensis B. pervagus B. neizhouensis B. fengqiuensis B. chitinolyticus B. krulwichiae B. plakortidis B. niabensis B. firmus B. chondroitinus B. laevolacticus B. pocheonensis B. niacini B. flexus B. choshinensis B. larvae B. polygoni B. novalis B. foraminis B. chungangensis B. laterosporus B. polymyxa B. oceanisediminis B. fordii B. cibi B. salexigens B. popilliae B. odysseyi B. formosus B. circulans B. saliphilus B. pseudalcalophilus B. okhensis B. fortis B. clarkii B. schlegelii B. pseudofirmus B. okuhidensis B. fumarioli B. clausii B. sediminis B. pseudomycoides B. oleronius B. funiculus B. coagulans B. selenatarsenatis B. psychrodurans B. oryzaecorticis B. fusiformis B. coahuilensis B. selenitireducens B. psychrophilus B. oshimensis B. galactophilus B. cohnii B. seohaeanensis B. psychrosaccharolyticus B. pabuli B. galactosidilyticus B. composti B. shacheensis B. psychrotolerans B. pakistanensis B. galliciensis B. curdlanolyticus B. shackletonii B. pulvifaciens B. pallidus B. gelatini B. cycloheptanicus B. siamensis B. pumilus B. pallidus B. gibsonii B. cytotoxicus B. silvestris B. purgationiresistens B. panacisoli B. ginsengi B. daliensis B. simplex B. pycnus B. panaciterrae B. ginsengihumi B. decisifrondis B. siralis B. qingdaonensis B. pantothenticus B. ginsengisoli B. decolorationis B. smithii B. qingshengii B. parabrevis B. globisporus (eg, B. B. deserti B. soli B. reuszeri B. paraflexus g. subsp. Globisporus; or B. B. solimangrovi B. rhizosphaerae B. pasteurii g. subsp. Marinus) B. solisalsi B. rigui B. patagoniensis B. songklensis B. ruris B. sonorensis B. safensis B. sphaericus B. salarius B. sporothermodurans B. stearothermophilus B. stratosphericus B. subterraneus B. subtilis (eg, B. s. subsp. Inaquosorum; or B. s. subsp. Spizizeni; or B. s. subsp. Subtilis) Caenimonas Campylobacter Cardiobacterium Catenuloplanes Curtobacterium Caenimonas koreensis Campylobacter coli Cardiobacterium hominis Catenuloplanes atrovinosus Curtobacterium Caldalkalibacillus Campylobacter concisus Carnimonas Catenuloplanes castaneus albidum Caldalkalibacillus uzonensis Campylobacter curvus Carnimonas nigrificans Catenuloplanes crispus Curtobacterium citreus Caldanaerobacter Campylobacter fetus Carnobacterium Catenuloplanes indicus Caldanaerobacter subterraneus Campylobacter gracilis Carnobacterium Catenuloplanes japonicus Caldanaerobius Campylobacter helveticus alterfunditum Catenuloplanes nepalensis Caldanaerobius fijiensis Campylobacter hominis Carnobacterium divergens Catenuloplanes niger Caldanaerobius Campylobacter hyointestinalis Carnobacterium funditum Chryseobacterium polysaccharolyticus Campylobacter jejuni Carnobacterium gallinarum Chryseobacterium Caldanaerobius zeae Campylobacter lari Carnobacterium balustinum Campylobacter mucosalis maltaromaticum Caldanaerovirga Campylobacter rectus Carnobacterium mobile Citrobacter Caldanaerovirga acetigignens Campylobacter showae Carnobacterium viridans C. amalonaticus Caldicellulosiruptor Campylobacter sputorum Caryophanon C. braakii Caldicellulosiruptor bescii Campylobacter upsaliensis Caryophanon latum C. diversus Caldicellulosiruptor kristjanssonii Capnocytophaga Caryophanon tenue C. farmeri Caldicellulosiruptor owensensis Capnocytophaga canimorsus Catellatospora C. freundii Capnocytophaga cynodegmi Catellatospora citrea C. gillenii Capnocytophaga gingivalis Catellatospora C. koseri Capnocytophaga granulosa methionotrophica C. murliniae Capnocytophaga haemolytica Catenococcus C. pasteurii [1] Capnocytophaga ochracea Catenococcus thiocycli C. rodentium Capnocytophaga sputigena C. sedlakii C. werkmanii C. youngae Clostridium (see below) Coccochloris Coccochloris elabens Corynebacterium Corynebacterium flavescens Clostridium Corynebacterium variabile Clostridium absonum, Clostridium aceticum, Clostridium acetireducens, Clostridium acetobutylicum, Clostridium acidisoli, Clostridium aciditolerans, Clostridium acidurici, Clostridium aerotolerans, Clostridium aestuarii, Clostridium akagii, Clostridium aldenense, Clostridium aldrichii, Clostridium algidicarni, Clostridium algidixylanolyticum, Clostridium algifaecis, Clostridium algoriphilum, Clostridium alkalicellulosi, Clostridium aminophilum, Clostridium aminovalericum, Clostridium amygdalinum, Clostridium amylolyticum, Clostridium arbusti, Clostridium arcticum, Clostridium argentinense, Clostridium asparagiforme, Clostridium aurantibutyricum, Clostridium autoethanogenum, Clostridium baratii, Clostridium barkeri, Clostridium bartlettii, Clostridium beijerinckii, Clostridium bifermentans, Clostridium bolteae, Clostridium bornimense, Clostridium botulinum, Clostridium bowmanii, Clostridium bryantii, Clostridium butyricum, Clostridium cadaveris, Clostridium caenicola, Clostridium caminithermale, Clostridium carboxidivorans, Clostridium carnis, Clostridium cavendishii, Clostridium celatum, Clostridium celerecrescens, Clostridium cellobioparum, Clostridium cellulofermentans, Clostridium cellulolyticum, Clostridium cellulosi, Clostridium cellulovorans, Clostridium chartatabidum, Clostridium chauvoei, Clostridium chromiireducens, Clostridium citroniae, Clostridium clariflavum, Clostridium clostridioforme, Clostridium coccoides, Clostridium cochlearium, Clostridium colletant, Clostridium colicanis, Clostridium colinum, Clostridium collagenovorans, Clostridium cylindrosporum, Clostridium difficile, Clostridium diolis, Clostridium disporicum, Clostridium drakei, Clostridium durum, Clostridium estertheticum, Clostridium estertheticum estertheticum, Clostridium estertheticum laramiense, Clostridium fallax, Clostridium felsineum, Clostridium fervidum, Clostridium fimetarium, Clostridium formicaceticum, Clostridium frigidicarnis, Clostridium frigoris, Clostridium ganghwense, Clostridium gasigenes, Clostridium ghonii, Clostridium glycolicum, Clostridium glycyrrhizinilyticum, Clostridium grantii, Clostridium haemolyticum, Clostridium halophilum, Clostridium hastiforme, Clostridium hathewayi, Clostridium herbivorans, Clostridium hiranonis, Clostridium histolyticum, Clostridium homopropionicum, Clostridium huakuii, Clostridium hungatei, Clostridium hydrogeniformans, Clostridium hydroxybenzoicum, Clostridium hylemonae, Clostridium jejuense, Clostridium indolis, Clostridium innocuum, Clostridium intestinale, Clostridium irregulare, Clostridium isatidis, Clostridium josui, Clostridium kluyveri, Clostridium lactatifermentans, Clostridium lacusfryxellense, Clostridium laramiense, Clostridium lavalense, Clostridium lentocellum, Clostridium lentoputrescens, Clostridium leptum, Clostridium limosum, Clostridium litorale, Clostridium lituseburense, Clostridium ljungdahlii, Clostridium lortetii, Clostridium lundense, Clostridium magnum, Clostridium malenominatum, Clostridium mangenotii, Clostridium mayombei, Clostridium methoxybenzovorans, Clostridium methylpentosum, Clostridium neopropionicum, Clostridium nexile, Clostridium nitrophenolicum, Clostridium novyi, Clostridium oceanicum, Clostridium orbiscindens, Clostridium oroticum, Clostridium oxalicum, Clostridium papyrosolvens, Clostridium paradoxum, Clostridium paraperfringens (Alias: C. welchii), Clostridium paraputrificum, Clostridium pascui, Clostridium pasteurianum, Clostridium peptidivorans, Clostridium perenne, Clostridium perfringens, Clostridium pfennigii, Clostridium phytofermentans, Clostridium piliforme, Clostridium polysaccharolyticum, Clostridium populeti, Clostridium propionicum, Clostridium proteoclasticum, Clostridium proteolyticum, Clostridium psychrophilum, Clostridium puniceum, Clostridium purinilyticum, Clostridium putrefaciens, Clostridium putrificum, Clostridium quercicolum, Clostridium quinii, Clostidium ramosum, Clostridium rectum, Clostridium roseum, Clostridium saccharobutylicum, Clostridium saccharogumia, Clostridium saccharolyticum, Clostridium saccharoperbutylacetonicum, Clostridium sardiniense, Clostridium sartagoforme, Clostridium scatologenes, Clostridium schirmacherense, Clostridium scindens, Clostridium septicum, Clostridium sordellii, Clostridium sphenoides, Clostridium spiroforme, Clostridium sporogenes, Clostridium sporosphaeroides, Clostridium stercorarium, Clostridium stercorarium leptospartum, Clostridium stercorarium stercorarium, Clostridium stercorarium thermolacticum, Clostridium sticklandii, Clostridium straminisolvens, Clostridium subterminale, Clostridium sufflavum, Clostridium sulfidigenes, Clostridium symbiosum, Clostridium tagluense, Clostridium tepidiprofundi, Clostridium termitidis, Clostridium tertium, Clostridium tetani, Clostridium tetanomorphum, Clostridium thermaceticum, Clostridium thermautotrophicum, Clostridium thermoalcaliphilum, Clostridium thermobutyricum, Clostridium thermocellum, Clostridium thermocopriae, Clostridium thermohydrosulfuricum, Clostridium thermolacticum, Clostridium thermopalmarium, Clostridium thermopapyrolyticum, Clostridium thermosaccharolyticum, Clostridium thermosuccinogenes, Clostridium hermosulfurigenes, Clostridium thiosulfatireducens, Clostridium tyrobutyricum, Clostridium uliginosum, Clostridium ultunense, Clostridium villosum Clostridium vincentii, Clostridium viride, Clostridium xylanolyticum, Clostridium xylanovorans Dactylosporangium Deinococcus Delftia Echinicola Dactylosporangium aurantiacum Deinococcus aerius Delftia acidovorans Echinicola pacifica Dactylosporangium fulvum Deinococcus apachensis Desulfovibrio Echinicola vietnamensis Dactylosporangium matsuzakiense Deinococcus aquaticus Desulfovibrio desulfuricans Dactylosporangium roseum Deinococcus aquatilis Diplococcus Dactylosporangium thailandense Deinococcus caeni Diplococcus pneumoniae Dactylosporangium vinaceum Deinococcus radiodurans Deinococcus radiophilus Enterobacter Enterobacter kobei Faecalibacterium Flavobacterium E. aerogenes E. ludwigii Faecalibacterium prausnitzii Flavobacterium antarcticum E. amnigenus E. mori Fangia Flavobacterium aquatile E. agglomerans E. nimipressuralis Fangia hongkongensis Flavobacterium E. arachidis E. oryzae Fastidiosipila aquidurense E. asburiae E. pulveris Fastidiosipila sanguinis Flavobacterium balustinum E. cancerogenous E. pyrinus Fusobacterium Flavobacterium croceum E. cloacae E. radicincitans Fusobacterium nucleatum Flavobacterium cucumis E. cowanii E. taylorae Flavobacterium E. dissolvens E. turicensis daejeonense E. gergoviae E. sakazakii Enterobacter soli Flavobacterium defluvii E. helveticus Enterococcus Flavobacterium degerlachei E. hormaechei Enterococcus durans Flavobacterium E. intermedius Enterococcus faecalis denitrificans Enterococcus faecium Flavobacterium filum Erwinia Flavobacterium flevense Erwinia hapontici Flavobacterium frigidarium Escherichia Flavobacterium mizutaii Escherichia coli Flavobacterium okeanokoites Gaetbulibacter Haemophilus Ideonella Janibacter Gaetbulibacter saemankumensis Haemophilus aegyptius Ideonella azotifigens Janibacter anophelis Gallibacterium Haemophilus aphrophilus Idiomarina Janibacter corallicola Gallibacterium anatis Haemophilus felis Idiomarina abyssalis Janibacter limosus Gallicola Haemophilus gallinarum Idiomarina baltica Janibacter melonis Gallicola barnesae Haemophilus haemolyticus Idiomarina fontislapidosi Janibacter terrae Garciella Haemophilus influenzae Idiomarina loihiensis Jannaschia Garciella nitratireducens Haemophilus paracuniculus Idiomarina ramblicola Jannaschia cystaugens Geobacillus Haemophilus parahaemolyticus Idiomarina seosinensis Jannaschia helgolandensis Geobacillus thermoglucosidasius Haemophilus parainfluenzae Idiomarina zobellii Jannaschia pohangensis Geobacillus stearothermophilus Haemophilus Ignatzschineria Jannaschia rubra Geobacter paraphrohaemolyticus Ignatzschineria larvae Geobacter bemidjiensis Haemophilus parasuis Janthinobacterium Geobacter bremensis Haemophilus pittmaniae Ignavigranum Janthinobacterium Geobacter chapellei Hafnia Ignavigranum ruoffiae agaricidamnosum Geobacter grbiciae Hafnia alvei Ilumatobacter Janthinobacterium lividum Geobacter hydrogenophilus Hahella Ilumatobacter fluminis Jejuia Geobacter lovleyi Hahella ganghwensis Ilyobacter Jejuia pallidilutea Geobacter metallireducens Halalkalibacillus Ilyobacter delafieldii Jeotgalibacillus Geobacter pelophilus Halalkalibacillus halophilus Ilyobacter insuetus Jeotgalibacillus Geobacter pickeringii Helicobacter Ilyobacter polytropus alimentarius Geobacter sulfurreducens Helicobacter pylori Ilyobacter tartaricus Jeotgalicoccus Jeotgalicoccus halotolerans Geodermatophilus Geodermatophilus obscurus Gluconacetobacter Gluconacetobacter xylinus Gordonia Gordonia rubripertincta Kaistia Labedella Listeria ivanovii Micrococcus Nesterenkonia Kaistia adipata Labedella gwakjiensis L. marthii Micrococcus luteus Nesterenkonia holobia Kaistia soli Labrenzia L. monocytogenes Micrococcus lylae Nocardia Kangiella Labrenzia aggregata L. newyorkensis Moraxella Nocardia argentinensis Kangiella aquimarina Labrenzia alba L. riparia Moraxella bovis Nocardia corallina Kangiella koreensis Labrenzia alexandrii L. rocourtiae Moraxella nonliquefaciens Nocardia Labrenzia marina L. seeligeri Moraxella osloensis otitidiscaviarum Kerstersia Labrys L. weihenstephanensis Nakamurella Kerstersia gyiorum Labrys methylaminiphilus L. welshimeri Nakamurella multipartita Kiloniella Labrys miyagiensis Listonella Nannocystis Kiloniella laminariae Labrys monachus Listonella anguillarum Nannocystis pusilla Klebsiella Labrys okinawensis Macrococcus Natranaerobius K. granulomatis Labrys portucalensis Macrococcus bovicus Natranaerobius K. oxytoca Marinobacter thermophilus K. pneumoniae Lactobacillus Marinobacter algicola Natranaerobius trueperi K. terrigena [see below] Marinobacter bryozoorum Naxibacter K. variicola Laceyella Marinobacter flavimaris Naxibacter alkalitolerans Kluyvera Laceyella putida Meiothermus Neisseria Kluyvera ascorbata Lechevalieria Meiothermus ruber Neisseria cinerea Kocuria Lechevalieria aerocolonigenes Methylophilus Neisseria denitrificans Kocuria roasea Legionella Methylophilus Neisseria gonorrhoeae Kocuria varians [see below] methylotrophus Neisseria lactamica Kurthia Listeria Microbacterium Neisseria mucosa Kurthia zopfii L. aquatica Microbacterium Neisseria sicca L. booriae ammoniaphilum Neisseria subflava L. cornellensis Microbacterium arborescens Neptunomonas L. fleischmannii Microbacterium liquefaciens Neptunomonas japonica L. floridensis Microbacterium oxydans L. grandensis L. grayi L. innocua Lactobacillus L. acetotolerans L. catenaformis L. mali L. parakefiri L. sakei L. acidifarinae L. ceti L. manihotivorans L. paralimentarius L. salivarius L. acidipiscis L. coleohominis L. mindensis L. paraplantarum L. sanfranciscensis L. acidophilus L. collinoides L. mucosae L. pentosus L. satsumensis Lactobacillus agilis L. composti L. murinus L. perolens L. secaliphilus L. algidus L. concavus L. nagelii L. plantarum L. sharpeae L. alimentarius L. coryniformis L. namurensis L. pontis L. siliginis L. amylolyticus L. crispatus L. nantensis L. protectus L. spicheri L. amylophilus L. crustorum L. oligofermentans L. psittaci L. suebicus L. amylotrophicus L. curvatus L. oris L. rennini L. thailandensis L. amylovorus L. delbrueckii subsp. L. panis L. reuteri L. ultunensis L. animalis bulgaricus L. pantheris L. rhamnosus L. vaccinostercus L. antri L. delbrueckii subsp. L. parabrevis L. rimae L. vaginalis L. apodemi delbrueckii L. parabuchneri L. rogosae L. versmoldensis L. aviarius L. delbrueckii subsp. lactis L. paracasei L. rossiae L. vini L. bifermentans L. dextrinicus L. paracollinoides L. ruminis L. vitulinus L. brevis L. diolivorans L. parafarraginis L. saerimneri L. zeae L. buchneri L. equi L. homohiochii L. jensenii L. zymae L. camelliae L. equigenerosi L. iners L. johnsonii L. gastricus L. casei L. farraginis L. ingluviei L. kalixensis L. ghanensis L. kitasatonis L. farciminis L. intestinalis L. kefiranofaciens L. graminis L. kunkeei L. fermentum L. fuchuensis L. kefiri L. hammesii L. leichmannii L. fornicalis L. gallinarum L. kimchii L. hamsteri L. lindneri L. fructivorans L. gasseri L. helveticus L. harbinensis L. malefermentans L. frumenti L. hilgardii L. hayakitensis Legionella Legionella adelaidensis Legionella drancourtii Candidatus Legionella jeonii Legionella quinlivanii Legionella anisa Legionella dresdenensis Legionella jordanis Legionella rowbothamii Legionella beliardensis Legionella drozanskii Legionella lansingensis Legionella rubrilucens Legionella birminghamensis Legionella dumoffii Legionella londiniensis Legionella sainthelensi Legionella bozemanae Legionella erythra Legionella longbeachae Legionella santicrucis Legionella brunensis Legionella fairfieldensis Legionella lytica Legionella shakespearei Legionella busanensis Legionella fallonii Legionella maceachernii Legionella spiritensis Legionella cardiaca Legionella feeleii Legionella massiliensis Legionella steelei Legionella cherrii Legionella geestiana Legionella micdadei Legionella steigerwaltii Legionella cincinnatiensis Legionella genomospecies Legionella monrovica Legionella taurinensis Legionella clemsonensis Legionella gormanii Legionella moravica Legionella tucsonensis Legionella donaldsonii Legionella gratiana Legionella nagasakiensis Legionella tunisiensis Legionella gresilensis Legionella nautarum Legionella wadsworthii Legionella hackeliae Legionella norrlandica Legionella waltersii Legionella impletisoli Legionella oakridgensis Legionella worsleiensis Legionella israelensis Legionella parisiensis Legionella yabuuchiae Legionella jamestowniensis Legionella pittsburghensis Legionella pneumophila Legionella quateirensis Oceanibulbus Paenibacillus Prevotella Quadrisphaera Oceanibulbus indolifex Paenibacillus thiaminolyticus Prevotella albensis Quadrisphaera granulorum Oceanicaulis Pantoea Prevotella amnii Quatrionicoccus Oceanicaulis alexandrii Pantoea agglomerans Prevotella bergensis Quatrionicoccus Oceanicola Prevotella bivia australiensis Oceanicola batsensis Paracoccus Prevotella brevis Oceanicola granulosus Paracoccus alcaliphilus Prevotella bryantii Quinella Oceanicola nanhaiensis Paucimonas Prevotella buccae Quinella ovalis Oceanimonas Paucimonas lemoignei Prevotella buccalis Oceanimonas baumannii Pectobacterium Prevotella copri Ralstonia Oceaniserpentilla Pectobacterium aroidearum Prevotella dentalis Ralstonia eutropha Oceaniserpentilla haliotis Pectobacterium atrosepticum Prevotella denticola Ralstonia insidiosa Oceanisphaera Pectobacterium Prevotella disiens Ralstonia mannitolilytica Oceanisphaera donghaensis betavasculorum Prevotella histicola Ralstonia pickettii Oceanisphaera litoralis Pectobacterium cacticida Prevotella intermedia Ralstonia Oceanithermus Pectobacterium carnegieana Prevotella maculosa pseudosolanacearum Oceanithermus desulfurans Pectobacterium carotovorum Prevotella marshii Ralstonia syzygii Oceanithermus profundus Pectobacterium chrysanthemi Prevotella melaninogenica Ralstonia solanacearum Oceanobacillus Pectobacterium cypripedii Prevotella micans Ramlibacter Oceanobacillus caeni Pectobacterium rhapontici Prevotella multiformis Ramlibacter henchirensis Oceanospirillum Pectobacterium wasabiae Prevotella nigrescens Ramlibacter tataouinensis Oceanospirillum linum Planococcus Prevotella oralis Planococcus citreus Prevotella oris Planomicrobium Prevotella oulorum Raoultella Planomicrobium okeanokoites Prevotella pallens Raoultella ornithinolytica Plesiomonas Prevotella salivae Raoultella planticola Plesiomonas shigelloides Prevotella stercorea Raoultella terrigena Proteus Prevotella tannerae Rathayibacter Proteus vulgaris Prevotella timonensis Rathayibacter caricis Prevotella veroralis Rathayibacter festucae Providencia Rathayibacter iranicus Providencia stuartii Rathayibacter rathayi Pseudomonas Rathayibacter toxicus Pseudomonas aeruginosa Rathayibacter tritici Pseudomonas alcaligenes Rhodobacter Pseudomonas anguillispetica Rhodobacter sphaeroides Pseudomonas fluorescens Ruegeria Pseudoalteromonas Ruegeria gelatinovorans halop lanktis Pseudomonas mendocina Pseudomonas pseudoalcaligenes Pseudomonas putida Pseudomonas tutzeri Pseudomonas syringae Psychrobacter Psychrobacter faecalis Psychrobacter phenylpyruvicus Saccharococcus Sagittula Sanguibacter Stenotrophomonas Tatlockia Saccharococcus thermophilus Sagittula stellata Sanguibacter keddieii Stenotrophomonas Tatlockia maceachernii Saccharomonospora Salegentibacter Sanguibacter suarezii maltophilia Tatlockia micdadei Saccharomonospora azurea Salegentibacter salegens Saprospira Streptococcus Tenacibaculum Saccharomonospora cyanea Salimicrobium Saprospira grandis Tenacibaculum Saccharomonospora viridis Salimicrobium album Sarcina [also see below] amylolyticum Saccharophagus Salinibacter Sarcina maxima Streptomyces Tenacibaculum discolor Saccharophagus degradans Salinibacter ruber Sarcina ventriculi Streptomyces Tenacibaculum Saccharopolyspora Salinicoccus Sebaldella achromogenes gallaicum Saccharopolyspora erythraea Salinicoccus alkaliphilus Sebaldella termitidis Streptomyces cesalbus Tenacibaculum Saccharopolyspora gregorii Salinicoccus hispanicus Streptomyces cescaepitosus lutimaris Saccharopolyspora hirsuta Salinicoccus roseus Serratia Streptomyces cesdiastaticus Tenacibaculum Saccharopolyspora hordei Salinispora Serratia fonticola Streptomyces cesexfoliatus mesophilum Saccharopolyspora rectivirgula Salinispora arenicola Serratia marcescens Streptomyces fimbriatus Tenacibaculum Saccharopolyspora spinosa Salinispora tropica Sphaerotilus Streptomyces fradiae skagerrakense Saccharopolyspora taberi Salinivibrio Sphaerotilus natans Streptomyces fulvissimus Salinivibrio costicola Streptomyces griseoruber Saccharothrix Salmonella Sphingobacterium Streptomyces griseus Tepidanaerobacter Saccharothrix australiensis Salmonella bongori Sphingobacterium multivorum Streptomyces lavendulae Tepidanaerobacter Saccharothrix coeruleofusca Salmonella enterica Staphylococcus Streptomyces syntrophicus Saccharothrix espanaensis Salmonella subterranea [see below] phaeochromogenes Tepidibacter Saccharothrix longispora Salmonella typhi Streptomyces Tepidibacter Saccharothrix mutabilis thermodiastaticus formicigenes Saccharothrix syringae Streptomyces tubercidicus Tepidibacter Saccharothrix tangerinus thalassicus Saccharothrix texasensis Thermus Thermus aquaticus Thermus filiformis Thermus thermophilus Staphylococcus S. arlettae S. equorum S. microti S. schleiferi S. agnetis S. felis S. muscae S. sciuri S. aureus S. fleurettii S. nepalensis S. simiae S. auricularis S. gallinarum S. pasteuri S. simulans S. capitis S. haemolyticus S. petrasii S. stepanovicii S. caprae S. hominis S. pettenkoferi S. succinus S. carnosus S. hyicus S. piscifermentans S. vitulinus S. caseolyticus S. intermedius S. pseudintermedius S. warneri S. chromogenes S. kloosii S. pseudolugdunensis S. xylosus S. cohnii S. leei S. pulvereri S. condimenti S. lentus S. rostri S. delphini S. lugdunensis S. saccharolyticus S. devriesei S. lutrae S. saprophyticus S. epidermidis S. lyticans S. massiliensis Streptococcus Streptococcus agalactiae Streptococcus infantarius Streptococcus orisratti Streptococcus thermophilus Streptococcus anginosus Streptococcus iniae Streptococcus parasanguinis Streptococcus sanguinis Streptococcus bovis Streptococcus intermedius Streptococcus peroris Streptococcus sobrinus Streptococcus canis Streptococcus lactarius Streptococcus pneumoniae Streptococcus suis Streptococcus constellatus Streptococcus milleri Streptococcus Streptococcus uberis Streptococcus downei Streptococcus mitis pseudopneumoniae Streptococcus vestibularis Streptococcus dysgalactiae Streptococcus mutans Streptococcus pyogenes Streptococcus viridans Streptococcus equines Streptococcus oralis Streptococcus ratti Streptococcus Streptococcus faecalis Streptococcus tigurinus Streptococcus salivariu zooepidemicus Streptococcus ferus Uliginosibacterium Vagococcus Vibrio Virgibacillus Xanthobacter Vagococcus carniphilus Vibrio aerogenes Virgibacillus Xanthobacter agilis Uliginosibacterium gangwonense Vagococcus elongatus Vibrio aestuarianus halodenitrificans Xanthobacter Ulvibacter Vagococcus fessus Vibrio albensis Virgibacillus aminoxidans Ulvibacter litoralis Vagococcus fluvialis Vibrio alginolyticus pantothenticus Xanthobacter Umezawaea Vagococcus lutrae Vibrio campbellii Weissella autotrophicus Umezawaea tangerina Vagococcus salmoninarum Vibrio cholerae Weissella cibaria Xanthobacter flavus Undibacterium Variovorax Vibrio cincinnatiensis Weissella confusa Xanthobacter tagetidis Undibacterium pigrum Variovorax boronicumulans Vibrio coralliilyticus Weissella halotolerans Xanthobacter viscosus Ureaplasma Variovorax dokdonensis Vibrio cyclitrophicus Weissella hellenica Xanthomonas Ureaplasma urealyticum Variovorax paradoxus Vibrio diazotrophicus Weissella kandleri Xanthomonas Variovorax soli Vibrio fluvialis Weissella koreensis albilineans Ureibacillus Veillonella Vibrio furnissii Weissella minor Xanthomonas alfalfae Ureibacillus composti Veillonella atypica Vibrio gazogenes Weissella Xanthomonas Ureibacillus suwonensis Veillonella caviae Vibrio halioticoli paramesenteroides arboricola Ureibacillus terrenus Veillonella criceti Vibrio harveyi Weissella soli Xanthomonas Ureibacillus thermophilus Veillonella dispar Vibrio ichthyoenteri Weissella thailandensis axonopodis Ureibacillus thermosphaericus Veillonella montpellierensis Vibrio mediterranei Weissella viridescens Xanthomonas Veillonella parvula Vibrio metschnikovii Williamsia campestris Veillonella ratti Vibrio mytili Williamsia marianensis Xanthomonas citri Veillonella rodentium Vibrio natriegens Williamsia maris Xanthomonas codiaei Venenivibrio Vibrio navarrensis Williamsia serinedens Xanthomonas Venenivibrio stagnispumantis Vibrio nereis Winogradskyella cucurbitae Vibrio nigripulchritudo Winogradskyella Xanthomonas Verminephrobacter Vibrio ordalii thalassocola euvesicatoria Verminephrobacter eiseniae Vibrio orientalis Xanthomonas fragariae Vibrio parahaemolyticus Wolbachia Xanthomonas fuscans Verrucomicrobium Vibrio pectenicida Wolbachia persica Xanthomonas gardneri Verrucomicrobium spinosum Vibrio penaeicida Xanthomonas hortorum Vibrio proteolyticus Wolinella Xanthomonas hyacinthi Vibrio shilonii Wolinella succinogenes Xanthomonas perforans Vibrio splendidus Xanthomonas phaseoli Vibrio tubiashii Zobellia Xanthomonas pisi Vibrio vulnificus Zobellia galactanivorans Xanthomonas populi Zobellia uliginosa Xanthomonas theicola Zoogloea Xanthomonas Zoogloea ramigera translucens Zoogloea resiniphila Xanthomonas vesicatoria Xylella Xylella fastidiosa Xylophilus Xylophilus ampelinus Xenophilus Yangia Yersinia mollaretii Zooshikella Zobellella Xenophilus azovorans Yangia pacifica Yersinia philomiragia Zooshikella ganghwensis Zobellella denitrificans Yersinia pestis Zobellella taiwanensis Xenorhabdus Yaniella Yersinia pseudotuberculosis Zunongwangia Xenorhabdus beddingii Yaniella flava Yersinia rohdei Zunongwangia profunda Zeaxanthinibacter Xenorhabdus bovienii Yaniella halotolerans Yersinia ruckeri Zymobacter Zeaxanthinibacter Xenorhabdus cabanillasii Yeosuana Yokenella Zymobacter palmae enoshimensis Xenorhabdus doucetiae Yeosuana aromativorans Yokenella regensburgei Zymomonas Zhihengliuella Xenorhabdus griffiniae Yersinia Yonghaparkia Zymomonas mobilis Zhihengliuella Xenorhabdus hominickii Yersinia aldovae Yonghaparkia alkaliphila Zymophilus halotolerans Xenorhabdus koppenhoeferi Yersinia bercovieri Zavarzinia Zymophilus paucivorans Xylanibacterium Xenorhabdus nematophila Yersinia enterocolitica Zavarzinia compransoris Zymophilus raffinosivorans Xylanibacterium ulmi Xenorhabdus poinarii Yersinia entomophaga Xylanibacter Yersinia frederiksenii Xylanibacter oryzae Yersinia intermedia Yersinia kristensenii TABLE 3: Anderson Promoter Collection SEQ ID NO: Identifier Sequence" Measured Strengthb 6 BBa_J23119 ttgacagctagctcagtcctaggtataatgctagc n/a 7 BBa_J23100 ttgacggctagctcagtcctaggtacagtgctagc 1 8 BBa_J23101 tttacagctagctcagtcctaggtattatgctagc 0.7 9 BBa_ J23102 ttgacagctagctcagtcctaggtactgtgctagc 0.86 10 BBa_J23103 ctgatagctagctcagtcctagggattatgctagc 0.01 11 BBa_J23104 ttgacagctagctcagtcctaggtattgtgctagc 0.72 12 BBa_J23105 tttacggctagctcagtcctaggtactatgctagc 0.24 13 BBa_J23106 tttacggctagctcagtcctaggtatagtgctagc 0.47 14 BBa_J23107 tttacggctagctcagccctaggtattatgctagc 0.36 15 BBa_J23108 ctgacagctagctcagtcctaggtataatgctagc 0.51 16 BBa_J23109 tttacagctagctcagtcctagggactgtgctagc 0.04 17 BBa_J23110 tttacggctagctcagtcctaggtacaatgctagc 0.33 18 BBa_123111 ttgacggctagctcagtcctaggtatagtgctagc 0.58 19 BBa_J23112 ctgatagctagctcagtcctagggattatgctagc 0 20 BBa_J23113 ctgatggctagctcagtcctagggattatgctagc 0.01 21 BBa_123114 tttatggctagctcagtcctaggtacaatgctagc 0.1 22 BBa_J23115 tttatagctagctcagcccttggtacaatgctagc 0.15 23 BBa_J23116 ttgacagctagctcagtcctagggactatgctagc 0.16 24 BBa_J23117 ttgacagctagctcagtcctagggattgtgctagc 0.06 25 BBa_J23118 ttgacggctagctcagtcctaggtattgtgctagc 0.56 a: also shown in the Anderson Catalog, see http://parts.igem.org/Promoters/Catalog/Anderson
b: Strength is the Anderson Score (AS), eg, a strength of 1 is a AS of 1. Reported activities of the promoters are given as the relative fluorescence of plasmids in strain TG1 grown in LB media to saturation. A suitable plasmid is EX-Ptet-S-rbsRFP-P "RFP reporter" as described at http://parts.igem.org/Part:BBa_J61002; insertion of a promoter element between XbaI and SpeI sites results in a RFP reporter. - Aspects of the invention are disclosed in the following numbered statements
- 1. A nucleic acid vector for introduction into a host cell, the vector comprising a first nucleotide sequence encoding a Type I Cas3 and a second nucleotide sequence encoding one or more Cascade proteins, wherein the first and second sequences are under the control of one or more promoters comprised by the vector for expression of the proteins in the cell.
- 2. The vector of
statement 1, wherein the vector comprises an operon for expression in the cell of the Cas3 and Cascade proteins from a Cas module, the module comprising the nucleotide sequences encoding the Cas3 and Cascade proteins, and the operon comprising the Cas module under the control of a promoter for controlling the expression of both the Cas3 and Cascade proteins. - 3. The vector of
statement 2, wherein- (a) the first sequence is between the promoter and the second sequence in the operon;
- (b) the operon comprises no Cas-encoding nucleotide sequences between the promoter and the first nucleotide sequence; and/or
- (c) the operon comprises (in 5' to 3' direction) the promoter, the first sequence and the second sequence.
- 4. The vector of any preceding statement, wherein first sequence is under the control of a promoter that has an Anderson Score (AS) of 0.5>AS >0.1.
- 5. The vector of any preceding statement, wherein the first sequence (and optionally the second sequence) is under the control of a promoter and translation initiation site (TIS) combination that is capable of producing expression of green fluorescent protein (GFP) from a first expression operating unit (EOU) in E. coli strain BW25113 cells with a fluorescence of from 0.5 to 4 times the fluorescence produced in E. coli strain BW25113 cells using a second EOU comprising a P10 promoter (SEQ ID NO: 1) combined with a BCD14 TIS (SEQ ID NO: 2), wherein the EOUs differ only in their promoter and TIS combinations, wherein each EOU comprises (in 5' to 3' direction) an upstream initiator, the respective promoter, the respective TIS, a nucleotide sequence encoding GFP, a 3' UTR, a transcription terminator and a downstream insulator.
- 6. The vector of any preceding statement, wherein the vector is devoid of a Cas adaption module; and/or wherein the vector is devoid of nucleotide sequence encoding one, more or all of a Cas1, Cas2, Cas4, Cas6, Cas7 and Cas 8.
- 7. The vector of any preceding statement, wherein the vector is a high copy number vector.
- 8. The vector of any preceding statement, wherein
- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas11, Cas7 and Cas8a1;
- (b) the vector comprises nucleotide sequence encoding Cas3' and/or Cas3"; and
- (c) the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in (a); and
- (d) optionally the host cell comprises an endogenous Type IB, C, U, D, E or F CRISPR/Cas system.
- 9. The vector of any one of
statements 1 to 7, wherein- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8b1, Cas7 and Cas5; and
- (b) the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in (a); and
- (c) optionally the host cell comprises an endogenous Type IA, C, U, D, E or F CRISPR/Cas system.
- 10. The vector of any one of
statements 1 to 7, wherein- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas5, Cas8c and Cas7; and
- (b) the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in (a); and
- (c) optionally the host cell comprises an endogenous Type IA, B, U, D, E or F CRISPR/Cas system.
- 11. The vector of any one of
statements 1 to 7, wherein- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8U2, Cas7, Cas5 and Cas6; and
- (b) the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in (a); and
- (c) optionally the host cell comprises an endogenous Type IA, B, C, D, E or F CRISPR/Cas system.
- 12. The vector of any one of
statements 1 to 7, wherein- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas10d, Cas7 and Cas5;
- (b) the vector comprises a nucleotide sequence encoding Cas3' and/or Cas3"; and
- (c) the nucleotide sequences encoding the Cas3' and/or Cas3" are between the promoter and the sequence(s) recited in (a); and
- (d) optionally the host cell comprises an endogenous Type IA, B, C, U, E or F CRISPR/Cas system.
- 13. The vector of any one of
statements 1 to 7, wherein- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8e, Cas11, Cas7, Cas5 and Cas6; and
- (b) the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in (a); and
- (c) optionally the host cell comprises an endogenous Type IA, B, C, D, U or F CRISPR/Cas system.
- 14. The vector of any one of
statements 1 to 7, wherein- (a) the vector comprises (optionally in 5' to 3' direction) nucleotide sequence encoding one, more or all of Cas8f, Cas5, Cas7 and Cas6f;
- (b) the vector comprises a nucleotide sequence encoding Cas3 between the promoter and the sequence(s) recited in (a); and
- (c) the vector is devoid of nucleotide sequence encoding further Cas between the promoter and the sequence encoding the Cas3; and
- (d) optionally the host cell comprises an endogenous Type IA, B, C, D, U or E CRISPR/Cas system.
- 15. The vector of any one of
statements 1 to 7, wherein the Cas and Cascade are- (a) Type IB Cas and Cascade proteins; or
- (b) Type IE Cas and Cascade proteins.
- 16. The vector of any preceding statement, wherein the Cas3 is a Cas3 of a CRISPR/Cas locus of a first bacterial or archaeal species, wherein the distance between the Cas3-encoding sequence of the locus and its cognate promoter is further than the distance between the Cas3-encoding sequence and the respective promoter comprised by the vector; or the vector of any preceding statement, wherein the distance between the promoter and the Cas3-encoding sequence and/or Cascade protein-encoding sequence(s) is shorter than in a corresponding wild-type Type I locus.
- 17. The vector of any one of
statements 1 to 7, wherein the Cas and Cascade are E coli Cas and Cascade proteins; or Clostridium (eg, C dificile) Cas and Cascade proteins. - 18. The vector of any preceding statement, wherein the vector comprises (i) a CRISPR array for producing crRNAs in the host cell and/or (ii) one or more nucleotide sequences encoding one or more guide RNAs (gRNAs or single gRNAs), wherein the crRNAs or gRNAs are cognate to the Cas3 (and optionally cognate to the Cascade proteins).
- 19. The vector of statement 18 when dependent from
statement 2, wherein the array or gRNA-encoding sequence(s) are comprised by the operon and under the control of the promoter; or wherein the array or gRNA-encoding sequence(s) are under the control of a promoter that is different from the promoter that controls the expression of the Cas3. - 20. A delivery vehicle comprising the vector of any preceding statement, wherein the delivery vehicle is capable of delivering the vector into the host cell; optionally wherein the delivery vehicle is a phage, non-replicative transduction particle, nanoparticle carrier, bacterium or liposome.
- 21. The vector or vehicle of any preceding statement, wherein the host cell is a bacterial or archaeal cell (optionally, the host cell is a C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-025b:H4), H pylori, S pneumoniae or S aureus cell); or the cell is a eukaryotic cell (optionally a human cell, an animal cell, a plant cell or a yeast cell).
- 22. The vector or vehicle of any preceding statement for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject; optionally wherein the disease or condition is an infection of the subject with host cells (eg, bacterial cells), or wherein the disease or condition is mediated by host cells (eg, bacterial cells).
- 23. A pharmaceutical composition comprising the vector or vehicle of any preceding statement and a pharmaceutically acceptable diluent, excipient or carrier.
Claims (21)
- A method for enhancing the yield of amplified copies of a DNA construct in a population of bacterial or archaeal production strain cells, wherein the construct comprises a nucleotide sequence encoding a Cas nuclease that is under the control of a promoter, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, wherein the promoter is an attenuated promoter.
- Use of an attenuated promoter in a DNA construct comprising a nucleotide sequence encoding a Cas nuclease that is under the control of the promoter, in a method of amplifying copies of the DNA in a population of bacterial or archaeal production strain cells, the method comprising culturing the cells to allow replication of the DNA thereby amplifying the DNA in the cells, for enhancing the yield of amplified DNA produced by the production host cells.
- The method claim 1 or use of claim 2, wherein enhancing said yield is by(a) reducing toxicity of the Cas in the production strain;(b) reducing mutation of the DNA (optionally the Cas-encoding sequence) in the production strain;(c) promoting production cell viability during the amplification of the DNA; and/or(d) reducing the occurrence of Cas cutting of DNA (optionally cutting of production host cell chromosomal DNA or said DNA construct).
- The method or use of claim 3, wherein the mutation or cutting is mutation or cutting of host cell chromosomal DNA or the construct DNA.
- The method or use of any preceding claim wherein the promoter is a constitutive promoter.
- The method or use of any preceding claim, wherein the promoter is repressed in the production strain cells (optionally repressed by a tetracycline repressor or a lac repressor).
- The method or use of claim 6, wherein the promoter is PLtetO-1, PLlacO-1 or a repressible homologue thereof.
- The method or use of any preceding claim, wherein the promoter is a medium strength promoter.
- The method or use of any preceding claim, wherein the promoter has an Anderson Score (AS) of 0.5>AS >0.1.
- The method or use of any preceding claim, wherein the nuclease is selected from a Cas3, Cas8a, Cas5, Cas8b, Cas8c, Cas10d, CseI, Cse2, CsyI, Csy2, Csy3, GSU0054, Cas10, Csm2, Cmr5, Csx11, Csx10, CsfI, Cas9, Csn2, Cas4, Cpf1, C2c1, C2c3, Cas13a, CasI3b and Cas13c.
- The method or use of claim 10, wherein the nuclease is Cas9.
- The method or use of claim 10, wherein the nuclease is Cpf1.
- The method or use of any preceding claim, wherein the nuclease is Cas3 and optionally the DNA or cell encodes cognate Cascade proteins.
- The method or use of any preceding claim, wherein the production strain cells comprise a helper phage genome that is inducible to produce phage coat proteins in the cells, wherein the method further comprises inducing production of the phage proteins and causing packaging of the amplified DNA into phage particles or non-self-replicative transduction particles, and further isolating the phage or transduction particles and optionally formulating the particles into a pharmaceutical composition for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject.
- The method or use of claim 14, wherein the particles are capable of infecting target host cells in the subject and transducing the cells with the DNA, wherein the Cas and crRNAs (or guide RNAs, gRNAs) encoded by the DNA are expressed in the cells, the crRNAs or (gRNAs) being operable to guide the Cas to a target nucleotide sequence (optionally a chromosomal sequence) comprised by the cells, wherein the Cas cuts the target sequences in the cells, thereby killing host cells and treating or reducing the risk of the disease or condition.
- The method or use of claim 15, wherein the host cells are bacterial or archaeal cells, optionally, the host cells are C dificile, P aeruginosa, K pneumoniae (eg, carbapenem-resistant Klebsiella pneumoniae or Extended-Spectrum Beta-Lactamase (ESBL)-producing K pneumoniae), E coli (eg, ESBL-producing E. coli, or E. coli ST131-O25b:H4), H pylori, S pneumoniae or S aureus cells.
- The method or use of any preceding claim, wherein each DNA is comprised by a high copy number plasmid or phagemid.
- The method or use of any preceding claim, wherein the DNA construct comprises one or more nucleotide sequences for producing crRNAs or gRNAs that are operable for Cas nuclease targeting in target host cells.
- The method or use of any preceding claim, wherein the repressor is encoded by a nucleic acid in the production strain strain (eg, a chromosomally-integrated sequence or a sequence comprised by an episome) and the repressor is expressed during the DNA amplification method, whereby the promoter controlling Cas expression is repressed.
- The method or use of claim 14, or any one of claims 15 to 19 when dependent from claim 14, wherein the phage or particles are devoid of an expressive nucleotide sequence encoding the repressor, whereby the promoter is functional when the DNA is introduced into a target host cell.
- Phage or transduction particles obtained according to claim 14-20 comprising a nucleotide sequence encoding a Cas nuclease under the control of a repressible promoter, optionally formulated into a pharmaceutical composition, for administration to a human or animal subject for treating or reducing the risk of a disease or condition in the subject, wherein the administration is to the gut microbiota.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1816700.7A GB201816700D0 (en) | 2018-10-14 | 2018-10-14 | Products, uses & methods |
GBGB1817509.1A GB201817509D0 (en) | 2018-10-27 | 2018-10-27 | Products, uses & methods |
US16/201,736 US11851663B2 (en) | 2018-10-14 | 2018-11-27 | Single-vector type I vectors |
EP19202999.9A EP3636763A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19202999.9A Division EP3636763A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3831947A1 true EP3831947A1 (en) | 2021-06-09 |
Family
ID=70159814
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22193567.9A Pending EP4170036A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
EP19202999.9A Pending EP3636763A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
EP20217137.7A Pending EP3831947A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22193567.9A Pending EP4170036A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
EP19202999.9A Pending EP3636763A1 (en) | 2018-10-14 | 2019-10-14 | Products, uses & methods |
Country Status (12)
Country | Link |
---|---|
US (3) | US11851663B2 (en) |
EP (3) | EP4170036A1 (en) |
JP (1) | JP2022512695A (en) |
KR (1) | KR20210076952A (en) |
CN (1) | CN113423835A (en) |
AU (1) | AU2019362312A1 (en) |
BR (1) | BR112021007003A2 (en) |
CA (1) | CA3115910A1 (en) |
DE (1) | DE112019005139T5 (en) |
IL (1) | IL282178A (en) |
SG (1) | SG11202103781TA (en) |
WO (1) | WO2020078893A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016177682A1 (en) | 2015-05-06 | 2016-11-10 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
GB201712733D0 (en) | 2017-08-08 | 2017-09-20 | Snipr Tech Ltd | Methods & cells |
US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
GB202007943D0 (en) | 2020-05-27 | 2020-07-08 | Snipr Biome Aps | Products & methods |
GB202015255D0 (en) | 2020-09-26 | 2020-11-11 | Snipr Biome Aps | Synthetic viruses |
WO2022082362A1 (en) * | 2020-10-19 | 2022-04-28 | 陈振暐 | Non-pathogenic bacterial gene expression system and transformant for metabolizing tyrosine, use thereof for preparing composition for reducing urinary toxins, and method for metabolizing tyrosine using same |
EP4346881A1 (en) * | 2021-05-26 | 2024-04-10 | The Regents of The University of Michigan | Crispr-cas3 systems for targeted genome engineering |
AU2022331230A1 (en) * | 2021-08-20 | 2024-03-21 | Gra&Green Inc. | Polynucleotide including site-specific nuclease expression cassette |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150064138A1 (en) | 2013-09-05 | 2015-03-05 | Massachusetts Institute Of Technology | Tuning microbial populations with programmable nucleases |
US20160024510A1 (en) | 2013-02-07 | 2016-01-28 | The Rockefeller University | Sequence specific antimicrobials |
US20160115488A1 (en) | 2012-12-12 | 2016-04-28 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
WO2016177682A1 (en) | 2015-05-06 | 2016-11-10 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
US20160345578A1 (en) | 2015-05-29 | 2016-12-01 | North Carolina State University | Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids |
US20170022499A1 (en) | 2014-04-03 | 2017-01-26 | Massachusetts Institute Of Techology | Methods and compositions for the production of guide rna |
US20170175142A1 (en) | 2012-12-12 | 2017-06-22 | The Broad Institute Inc. | Crispr-cas systems and methods for altering expression of gene products |
WO2017112620A1 (en) | 2015-12-22 | 2017-06-29 | North Carolina State University | Methods and compositions for delivery of crispr based antimicrobials |
WO2017118598A1 (en) | 2016-01-10 | 2017-07-13 | Snipr Technologies Limited | Recombinogenic nucleic acid strands in situ |
WO2018081502A1 (en) | 2016-10-28 | 2018-05-03 | Massachusetts Intitute Of Technology | Synthetic bacteriophages and bacteriophage compositions |
US20180140698A1 (en) | 2016-06-05 | 2018-05-24 | Snipr Technologies Limited | Selectively altering microbiota for immune modulation |
US20180155729A1 (en) | 2015-06-15 | 2018-06-07 | North Carolina State University | Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials |
US20180200342A1 (en) | 2015-07-13 | 2018-07-19 | Institut Pasteur | Improving sequence-specific antimicrobials by blocking dna repair |
US20180273940A1 (en) | 2018-04-30 | 2018-09-27 | Snipr Biome Aps | Treating and preventing microbial infections |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4626504A (en) | 1983-07-01 | 1986-12-02 | Lubrizol Genetics, Inc. | DNA transfer vector for gram-negative bacteria |
DE4208785A1 (en) | 1992-03-19 | 1993-09-23 | Degussa | METHOD FOR DETECTING INSERTION ELEMENTS (IS ELEMENTS) OR TRANSPOSONS |
AU2002365188A1 (en) | 2001-11-07 | 2003-07-30 | Musc Foundation For Research Development | Nucleic acid delivery and expression |
CA2396611A1 (en) | 2002-07-31 | 2004-01-31 | Plant Bioscience Limited | Materials and methods for generating genetic disruptions in bacterial cells |
WO2005046579A2 (en) | 2003-10-06 | 2005-05-26 | Gangagen, Inc. | Defined dose therapeutic phage |
PT1916903E (en) | 2005-08-26 | 2010-09-03 | Danisco | Use of crispr associated genes (cas) |
US8445639B2 (en) | 2006-05-15 | 2013-05-21 | Avidbiotics Corporation | Recombinant bacteriophage and methods for their use |
ES2719789T3 (en) | 2007-03-02 | 2019-07-16 | Dupont Nutrition Biosci Aps | Crops with improved phage resistance |
WO2010011961A2 (en) | 2008-07-25 | 2010-01-28 | University Of Georgia Research Foundation, Inc. | Prokaryotic rnai-like system and methods of use |
WO2010075424A2 (en) | 2008-12-22 | 2010-07-01 | The Regents Of University Of California | Compositions and methods for downregulating prokaryotic genes |
US8241498B2 (en) | 2009-03-28 | 2012-08-14 | Phage Biocontrol Research, Llc | Process for remediating biofouling in water systems with virulent bacteriophage |
US8252576B2 (en) | 2010-08-11 | 2012-08-28 | Phage Biocontrol Research, Llc | Use of prokaryote viruses to remediate bio-fouling |
JP5947311B2 (en) | 2010-12-09 | 2016-07-06 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | Use of chimeric antigen receptor modified T cells for the treatment of cancer |
US9730967B2 (en) | 2011-02-04 | 2017-08-15 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
WO2012164565A1 (en) | 2011-06-01 | 2012-12-06 | Yeda Research And Development Co. Ltd. | Compositions and methods for downregulating prokaryotic genes |
CA2853707A1 (en) | 2011-10-28 | 2013-05-02 | Regeneron Pharmaceuticals, Inc. | Genetically modified t cell receptor mice |
US9637739B2 (en) | 2012-03-20 | 2017-05-02 | Vilnius University | RNA-directed DNA cleavage by the Cas9-crRNA complex |
JP6562837B2 (en) | 2012-04-30 | 2019-08-21 | ソノマシューティカルズ・エルエルシー | The therapeutic use of Chardonnay seed products |
CN113967253A (en) | 2012-05-15 | 2022-01-25 | 百时美施贵宝公司 | Immunotherapy by disrupting PD-1/PD-L1 signaling |
JP6343605B2 (en) | 2012-05-25 | 2018-06-13 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Methods and compositions for RNA-dependent target DNA modification and RNA-dependent transcriptional regulation |
WO2013187556A1 (en) | 2012-06-14 | 2013-12-19 | Scripps Korea Antibody Institute | Novel antibody specific for clec14a and uses thereof |
MX2015000433A (en) | 2012-07-13 | 2016-04-28 | Univ Pennsylvania | Use of cart19 to deplete normal b cells to induce tolerance. |
PL3494997T3 (en) | 2012-07-25 | 2020-04-30 | The Broad Institute, Inc. | Inducible dna binding proteins and genome perturbation tools and applications thereof |
US11060148B2 (en) | 2012-10-16 | 2021-07-13 | Dana-Farber Cancer Institute, Inc. | Diagnosing and treating colorectal cancer |
WO2014093694A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
EP3011035B1 (en) * | 2013-06-17 | 2020-05-13 | The Broad Institute, Inc. | Assay for quantitative evaluation of target site cleavage by one or more crispr-cas guide sequences |
US20160145645A1 (en) * | 2013-06-19 | 2016-05-26 | Sigma-Aldrich Co. Llc | Targeted integration |
SG11201602979RA (en) | 2013-10-17 | 2016-05-30 | Univ Singapore | Chimeric receptor that triggers antibody-dependent cell cytotoxicity against multiple tumors |
US10144770B2 (en) | 2013-10-17 | 2018-12-04 | National University Of Singapore | Chimeric receptors and uses thereof in immune therapy |
US10752906B2 (en) | 2013-11-05 | 2020-08-25 | President And Fellows Of Harvard College | Precise microbiota engineering at the cellular level |
EP3375877A1 (en) | 2013-11-18 | 2018-09-19 | Crispr Therapeutics AG | Crispr-cas system materials and methods |
KR102170502B1 (en) | 2013-12-11 | 2020-10-28 | 리제너론 파마슈티칼스 인코포레이티드 | Methods and compositions for the targeted modification of a genome |
AU2014361826A1 (en) * | 2013-12-12 | 2016-06-23 | Massachusetts Institute Of Technology | Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for targeting disorders and diseases using particle delivery components |
EP3099173A4 (en) | 2014-01-29 | 2017-09-20 | Synphagen LLC. | Therapeutic phages and methods for delivery of nucleic acids for therapeutic uses |
RU2690670C2 (en) | 2014-03-12 | 2019-06-05 | Ида Рисерч Энд Дивелопмент Ко., Лтд | Reduced levels or activity of systemic regulatory t cells for treating disease or cns injury |
AU2015231413B2 (en) | 2014-03-19 | 2020-04-23 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of PI3K-gamma mediated disorders |
EP3122870B1 (en) | 2014-03-25 | 2022-06-29 | Ginkgo Bioworks Inc. | Methods and genetic systems for cell engineering |
JP2017512481A (en) | 2014-04-08 | 2017-05-25 | ノースカロライナ ステート ユニバーシティーNorth Carolina State University | Methods and compositions for RNA-dependent transcriptional repression using CRISPR-related genes |
JP6849435B2 (en) | 2014-04-14 | 2021-03-24 | ネメシス バイオサイエンス リミティド | Therapeutic |
GB201406968D0 (en) | 2014-04-17 | 2014-06-04 | Green Biologics Ltd | Deletion mutants |
GB201406970D0 (en) | 2014-04-17 | 2014-06-04 | Green Biologics Ltd | Targeted mutations |
EP3166974A1 (en) | 2014-07-11 | 2017-05-17 | Genentech, Inc. | Anti-pd-l1 antibodies and diagnostic uses thereof |
EP3186368B1 (en) | 2014-08-25 | 2020-01-15 | Geneweave Biosciences Inc. | Non-replicative transduction particles and transduction particle-based reporter systems |
EP3633032A3 (en) | 2014-08-28 | 2020-07-29 | North Carolina State University | Novel cas9 proteins and guiding features for dna targeting and genome editing |
EP3659621A1 (en) | 2014-09-13 | 2020-06-03 | Novartis AG | Combination therapies for cancer |
CA2959428A1 (en) | 2014-09-19 | 2016-03-24 | Regeneron Pharmaceuticals, Inc. | Chimeric antigen receptors |
US10920208B2 (en) | 2014-10-22 | 2021-02-16 | President And Fellows Of Harvard College | Evolution of proteases |
AU2015334468B2 (en) | 2014-10-23 | 2021-06-17 | Institut Gustave Roussy | Methods and products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker |
WO2016100882A1 (en) | 2014-12-19 | 2016-06-23 | Novartis Ag | Combination therapies |
US20160347836A1 (en) | 2015-05-28 | 2016-12-01 | Bristol-Myers Squibb Company | Treatment of hodgkin's lymphoma using an anti-pd-1 antibody |
CA2987129A1 (en) | 2015-06-01 | 2016-12-08 | The University Of Chicago | Treatment of cancer by manipulation of commensal microflora |
GB201514510D0 (en) | 2015-08-14 | 2015-09-30 | Nemesis Bioscience Ltd | Delivery vehicle |
EP3943093A1 (en) | 2015-09-10 | 2022-01-26 | Université catholique de Louvain | Use of pasteurized akkermansia for treating cancer |
WO2017058751A1 (en) | 2015-09-28 | 2017-04-06 | North Carolina State University | Methods and compositions for sequence specific antimicrobials |
US10947559B2 (en) | 2015-10-16 | 2021-03-16 | Astrazeneca Ab | Inducible modification of a cell genome |
TWI808055B (en) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Combination therapies of hdac inhibitors and pd-1 inhibitors |
AU2017335732A1 (en) | 2016-09-27 | 2019-04-04 | Board Of Regents, The University Of Texas System | Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome |
IT201600102542A1 (en) | 2016-10-12 | 2018-04-12 | Univ Degli Studi Di Trento | Plasmid and lentiviral system containing a self-limiting Cas9 circuit that increases its safety. |
EP3358015A1 (en) * | 2017-02-03 | 2018-08-08 | Eligo Bioscience | Optimized vector for delivery in microbial populations |
WO2018217351A1 (en) | 2017-05-24 | 2018-11-29 | Tets Viktor Veniaminovich | Methods for treating and preventing diseases |
WO2018217981A1 (en) | 2017-05-26 | 2018-11-29 | North Carolina State University | Altered guide rnas for modulating cas9 activity and methods of use |
WO2018222969A1 (en) | 2017-06-02 | 2018-12-06 | Board Of Regents, The University Of Texas System | Specific bacterial species and metabolite that improves immune checkpoint inhibitor therapy efficacy |
WO2018226853A1 (en) | 2017-06-07 | 2018-12-13 | The Rockefeller University | Enhancement of crispr gene editing or target destruction by co-expression of heterologous dna repair protein |
GB201710126D0 (en) | 2017-06-25 | 2017-08-09 | Snipr Tech Ltd | Vectors & Methods |
CN111051510A (en) | 2017-06-25 | 2020-04-21 | 斯尼普技术有限公司 | Altering microbial populations and modifying microbial populations |
GB201712733D0 (en) | 2017-08-08 | 2017-09-20 | Snipr Tech Ltd | Methods & cells |
CN107557378A (en) | 2017-09-19 | 2018-01-09 | 安徽大学 | Gene cas7 3 eukaryotic gene edit methods in a kind of type CRISPR Cas systems based on I |
US20190160120A1 (en) | 2017-11-29 | 2019-05-30 | Snipr Biome Aps | Dna, methods etc |
FR3081881A1 (en) | 2018-06-04 | 2019-12-06 | IFP Energies Nouvelles | OPTIMIZED GENETIC TOOL FOR MODIFYING CLOSTRIDIUM BACTERIA |
WO2020072253A1 (en) | 2018-10-01 | 2020-04-09 | North Carolina State University | Recombinant type i crispr-cas system and uses thereof for screening for variant cells |
WO2020072250A1 (en) | 2018-10-01 | 2020-04-09 | North Carolina State University | Recombinant type i crispr-cas system and uses thereof for genome modification and alteration of expression |
US10711267B2 (en) * | 2018-10-01 | 2020-07-14 | North Carolina State University | Recombinant type I CRISPR-Cas system |
US20220170048A1 (en) | 2018-10-01 | 2022-06-02 | North Carolina State University | Recombinant type i crispr-cas system and uses thereof for killing target cells |
US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
-
2018
- 2018-11-27 US US16/201,736 patent/US11851663B2/en active Active
-
2019
- 2019-10-14 EP EP22193567.9A patent/EP4170036A1/en active Pending
- 2019-10-14 BR BR112021007003-6A patent/BR112021007003A2/en unknown
- 2019-10-14 EP EP19202999.9A patent/EP3636763A1/en active Pending
- 2019-10-14 CA CA3115910A patent/CA3115910A1/en active Pending
- 2019-10-14 WO PCT/EP2019/077760 patent/WO2020078893A1/en active Application Filing
- 2019-10-14 AU AU2019362312A patent/AU2019362312A1/en active Pending
- 2019-10-14 JP JP2021520393A patent/JP2022512695A/en active Pending
- 2019-10-14 EP EP20217137.7A patent/EP3831947A1/en active Pending
- 2019-10-14 KR KR1020217014428A patent/KR20210076952A/en unknown
- 2019-10-14 DE DE112019005139.3T patent/DE112019005139T5/en active Pending
- 2019-10-14 SG SG11202103781TA patent/SG11202103781TA/en unknown
- 2019-10-14 CN CN201980082699.1A patent/CN113423835A/en active Pending
-
2021
- 2021-02-03 US US17/166,941 patent/US11629350B2/en active Active
- 2021-03-08 US US17/195,157 patent/US11578333B2/en active Active
- 2021-04-08 IL IL282178A patent/IL282178A/en unknown
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160115488A1 (en) | 2012-12-12 | 2016-04-28 | The Broad Institute Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
US20170175142A1 (en) | 2012-12-12 | 2017-06-22 | The Broad Institute Inc. | Crispr-cas systems and methods for altering expression of gene products |
US20180179547A1 (en) | 2012-12-12 | 2018-06-28 | The Broad Institute, Inc. | Crispr-cas component systems, methods and compositions for sequence manipulation |
US20160024510A1 (en) | 2013-02-07 | 2016-01-28 | The Rockefeller University | Sequence specific antimicrobials |
US20150064138A1 (en) | 2013-09-05 | 2015-03-05 | Massachusetts Institute Of Technology | Tuning microbial populations with programmable nucleases |
US20170022499A1 (en) | 2014-04-03 | 2017-01-26 | Massachusetts Institute Of Techology | Methods and compositions for the production of guide rna |
US20170246221A1 (en) | 2015-05-06 | 2017-08-31 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
WO2016177682A1 (en) | 2015-05-06 | 2016-11-10 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
US20160345578A1 (en) | 2015-05-29 | 2016-12-01 | North Carolina State University | Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids |
US20180155729A1 (en) | 2015-06-15 | 2018-06-07 | North Carolina State University | Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials |
US20180200342A1 (en) | 2015-07-13 | 2018-07-19 | Institut Pasteur | Improving sequence-specific antimicrobials by blocking dna repair |
WO2017112620A1 (en) | 2015-12-22 | 2017-06-29 | North Carolina State University | Methods and compositions for delivery of crispr based antimicrobials |
WO2017118598A1 (en) | 2016-01-10 | 2017-07-13 | Snipr Technologies Limited | Recombinogenic nucleic acid strands in situ |
US20180140698A1 (en) | 2016-06-05 | 2018-05-24 | Snipr Technologies Limited | Selectively altering microbiota for immune modulation |
WO2018081502A1 (en) | 2016-10-28 | 2018-05-03 | Massachusetts Intitute Of Technology | Synthetic bacteriophages and bacteriophage compositions |
US20180273940A1 (en) | 2018-04-30 | 2018-09-27 | Snipr Biome Aps | Treating and preventing microbial infections |
Non-Patent Citations (7)
Title |
---|
BERTRAM RALPH ET AL: "The application of Tet repressor in prokaryotic gene regulation and expression", vol. 1, no. 1, 1 January 2008 (2008-01-01), pages 2 - 16, XP002703937, ISSN: 0256-8551, Retrieved from the Internet <URL:http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7915.2007.00001.x/abstract> [retrieved on 20070824], DOI: 10.1111/J.1751-7915.2007.00001.X * |
BIKARD DAVID ET AL: "Using CRISPR-Cas systems as antimicrobials", CURRENT OPINION IN MICROBIOLOGY, vol. 37, 6 September 2017 (2017-09-06), pages 155 - 160, XP085276928, ISSN: 1369-5274, DOI: 10.1016/J.MIB.2017.08.005 * |
GIANLUCA PETRIS ET AL: "Hit and go CAS9 delivered through a lentiviral based self-limiting circuit", NATURE COMMUNICATIONS, vol. 8, 22 May 2017 (2017-05-22), pages 15334, XP055557740, DOI: 10.1038/ncomms15334 * |
LUTZ R ET AL: "INDEPENDENT AND TIGHT REGULATION OF TRANSCRIPTIONAL UNITS IN ESCHERICHIA COLI VIA THE LACR/O, THE TETR/O AND ARAC/L1-L2 REGULATORY ELEMENTS", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, vol. 25, no. 6, 1 January 1997 (1997-01-01), pages 1203 - 1210, XP001084137, ISSN: 0305-1048, DOI: 10.1093/NAR/25.6.1203 * |
MUTALIK ET AL.: "Precise and reliable gene expression via standard transcription and translation initiation elements", NAT METHODS, vol. 10, no. 4, 10 March 2013 (2013-03-10), pages 354 - 60, XP055753988, DOI: 10.1038/nmeth.2404 |
SHOTA NAKADE ET AL: "Cas9, Cpf1 and C2c1/2/3-What's next?", BIOENGINEERED, vol. 8, no. 3, 31 January 2017 (2017-01-31), US, pages 265 - 273, XP055549637, ISSN: 2165-5979, DOI: 10.1080/21655979.2017.1282018 * |
ZHANG JINGFANG ET AL: "Drug Inducible CRISPR/Cas Systems", COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, vol. 17, 30 July 2019 (2019-07-30), Sweden, pages 1171 - 1177, XP055797793, ISSN: 2001-0370, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709367/pdf/main.pdf> DOI: 10.1016/j.csbj.2019.07.015 * |
Also Published As
Publication number | Publication date |
---|---|
US20210163960A1 (en) | 2021-06-03 |
US11851663B2 (en) | 2023-12-26 |
AU2019362312A1 (en) | 2021-05-20 |
DE112019005139T5 (en) | 2021-07-15 |
EP4170036A1 (en) | 2023-04-26 |
US20210189406A1 (en) | 2021-06-24 |
WO2020078893A1 (en) | 2020-04-23 |
KR20210076952A (en) | 2021-06-24 |
US11629350B2 (en) | 2023-04-18 |
US11578333B2 (en) | 2023-02-14 |
SG11202103781TA (en) | 2021-05-28 |
IL282178A (en) | 2021-05-31 |
EP3636763A1 (en) | 2020-04-15 |
CN113423835A (en) | 2021-09-21 |
CA3115910A1 (en) | 2020-04-23 |
JP2022512695A (en) | 2022-02-07 |
BR112021007003A2 (en) | 2021-07-27 |
US20200115716A1 (en) | 2020-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11578333B2 (en) | Single-vector type I vectors | |
US10300138B2 (en) | Selectively altering microbiota for immune modulation | |
US20230330167A1 (en) | Phage and transduction particles | |
US11891629B2 (en) | Propagator cells and methods for propagating phage, in particular for delivering CRISPR-Cas components via probiotic organisms | |
JP2021000092A (en) | Method for cell engineering and genetic system | |
EP3973052A1 (en) | Phage and transduction particles | |
WO2019002218A2 (en) | Altering microbial populations & modifying microbiota | |
US20220162270A1 (en) | Methods, uses & compositions | |
KR20210136997A (en) | Iterative genome editing in microorganisms | |
US20220226396A1 (en) | Antibacterial agents & methods | |
US20240141365A1 (en) | Single-vector type i vectors | |
GB2596822A (en) | Methods | |
AU2021348243A1 (en) | Synthetic viruses | |
US20220275380A1 (en) | Plasmids | |
CA3171200A1 (en) | Multiplex crispr/cas system for modifying cell genomes | |
CA3172911A1 (en) | Antibacterial methods & cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17P | Request for examination filed |
Effective date: 20201223 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 3636763 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
17Q | First examination report despatched |
Effective date: 20210521 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40057854 Country of ref document: HK |